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„You cannot hope to build a better world without improving the individuals. To that end each 
of us must work for his own improvement, and at the same time share a general responsibility 
for all humanity, our particular duty being to aid those to whom we think we can be most 
useful.“ Marie Curie 
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Der experimentelle Teil der vorliegenden Arbeit wurde in der Zeit von September 2003 bis 
März 2008 am Institut für Technische und Makromolekulere Chemie der Rheinische-
Westfälischen Technischen Hochschule Aachen unter Anleitung von Univ.-Prof.Dr.Walter 
Leitner angefertigt.  
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Abstract (English) 
 
In this thesis the synthesis and application of novel chiral monodentate phosphorous 
triamide (PTA) ligands is presented.  
First, a small library of chiral PTAs based on three different chiral diamine backbones has 
been prepared through a convenient modular synthetic approach. The study significantly 
increases the knowledge about the synthesis, purification, stability and structural features 
of these compounds. The prepared ligand library was evaluated in the asymmetric 
hydrogenation as well as in two different asymmetric C-C bond forming reactions. All 
tested structurally very different PTAs show poor performance in the Rh catalysed 
hydrogenation of dimethyl itaconate. In contrast, better results could be obtained in the Cu 
catalysed Michael-addition of diethyl zink to cyclohexenone where enantioselectivity 
values up to 60 % have been achieved. Good conversions, selectivities and promising 
enantioselectivity of 63 % was attained in the Ni catalysed hydrovinylation of styrene at 
relatively high reaction temperature.  
The results of this thesis demonstrate that chiral PTAs are accessible and can provide 
significant levels of enantioselectivity in asymmetric catalysis. Their steric and electronic 
properties can be fine-tuned by the variation of the amine components. 
In general, the behaviour of these ligands is significantly different from the related 
phosphites or phosphoramidites and their potential in enantioselective catalysis is not yet 
fully explored. 
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Abstract (German) 
 
Diese Doktorarbeit befasst sich mit der Synthese und Anwendung von neuartigen chiralen 
Phosphor(III)triamiden (PTA). 
Zunächst wurde eine kleine Bibliothek chiraler PTA basierend auf drei verschiedenen 
chiralen Diamineinheiten über eine modulare Syntheseroute entwickelt. Die Ergebnisse 
bieten Einsicht in die Synthese und Reinigung sowie die Stabilität und Struktur dieser 
neuen Verbindungen. Die erhaltene Ligandenbibliothek wurde in der asymmetrischen 
Hydrierung sowie in zwei asymmetrischen C-C Knüpfungsreaktionen getestet. Alle 
getesteten Liganden haben sich in der Rhodium-katalysierten asymmetrischen Hydrierung 
von Dimethylitakonat als nicht geeignet erwiesen. Gute Ergebnisse wurden in der Kupfer-
katalysierten Michael-Addition von Diethylzink an Cyklohexenon erhalten: 
Enantioselektivitäten von bis zu 60 % wurden erreicht. Hohe Umsätze, gute Selektivitäten 
und ein Enantiomerenüberschuss von 63 % wurden in der Nickel-katalysierten 
Hydrovinylierung von Styrol bei relativ hoher Reaktionstemperatur erzielt. 
Allgemein verhielten sich die dargestellten Liganden sehr unterschiedlich im Gegensatz 
zu verwendeten Phosphiten und Phosphoramiditen. Die Ergebnisse der vorliegenden 
Arbeit zeigen den Zugang zu chiralen PTA, und dass mit ihnen beachtliche 
Enantioselektivitäten in der asymmetrischen Katalyse erreicht werden konnten. Die 
sterischen und elektronischen Eigenschaften der PTA können weitgehend über die Wahl 
der Aminkomponenten eingestellt werden. Das volle Anwendungspotential dieser neuen 
Ligandenklasse ist noch lange nicht ausgeschöpft. 
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1. Introduction 
 
1.1 Background and motivation 
The need for enantiomerically pure compounds tremendously raised in the last decades. There 
are numerous examples in medicinal applications where the two enantiomers of a chiral 
molecule have dramatically different effects.1 Nowadays, the principle of “racemic switches”2 
plays an important role in the commercialisation of drugs consisting exclusively of single 
enantiomers and has a profound influence on the further development of fine chemical and 
drug manufacturing.Enatiomerically pure compounds can be obtained by derivatisation of 
substances coming from the chiral pool.3 This approach has the limitation that often only one 
enantiomer is accessible. Alternatively, pure enantiomers can be isolated through the 
separation of a racemic mixture 4 by crystallisation, chromatography, or kinetic resolution. 
Although this strategy is frequently used in the industry, it leads only to a maximum yield of 
50% if the undesired enantiomer can not be effectively racemised. Enantioenriched 
compounds are also provided by enantioselective synthesis using chiral reaction 
media,5,6chiral auxiliaries7 or chiral catalysts,8 although only the latter two strategies have 
been extensively studied and developed to useful and widely applicable synthetic tools. 
In particular, enantioselective catalysis is an extremely elegant and efficient approach as the 
chiral target is produced in a large quantity employing tiny amounts of a non-racemic 
chemical mediator, also called multiplication of chirality.9 Among the different classes of 
enantioselective catalysts, transition metal complexes have a prominent role. They are able to 
catalyse a variety of chemical transformations and their activities and selectivities can be 
effectively tailored using appropriate ligands. Consequently, ligand development goes hand in 
hand with catalyst development and represents a challenging area in catalysis research. 
Despite more than three decades of ligand development, the rational design of ligands is still 
in its infancy as it is not possible yet to predict and define a ligand structure, which would 
provide sufficient activity combined with high enantioselectivity for a certain transformation. 
Hence, ligand design follows a rather heuristic approach and focuses on the search of lead 
structures and on their subsequent variations.  
One way to find a lead structure is the combinatorial synthetic approach. This approach is 
viable when the ligands are prepared through relatively simple synthetic routes from easily 
available building blocks to give a ligand library, which is then evaluated in benchmark 
catalytic reactions using one appropriate or a set of substrates. The ligand synthesis and 
testing process can also be automatized, and optimised for high throughput screening.10 On 
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the basis of the lead structure, systematic variations in the ligand allow for studying the 
influence of these structural changes on activity, chemo- and enantioselectivity for a particular 
reaction. Moreover, selectivity models can be derived to correlate and rationalise the obtained 
results.11 This approach together with mechanistic investigations can help to understand the 
origins of enantiomeric induction and form the basis of a systematic ligand optimization.  
Chiral phosphorous compounds are one of the most powerful and versatile classes of ligands 
for controlling the enantioselectivity of transition metal catalysed reactions.12 First examples 
were reported in the 60´s when Knowles and Horner applied a chiral-at-phosphorous 
monodentate phosphine (1) in the hydrogenation of dehydro amino acids.13 This was the first 
time when a chirally modified Wilkinson-catalyst led to an enantioselective transformation, 
albeit with rather low optical yield (15% ee). By variation of the substituents at the 
phosphorous, the enantioselectivity was improved to 88% using the CAMP ligand (2).14  
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Figure 1: Ligands applied in the early development of asymmetric hydrogenation of amino acids 
 
Shortly after, Kagan discovered a bidentate phosphine, DIOP (3), which resulted in similarly 
high ee values (up to 83%) for the same reaction.15 The distinct features of DIOP - the C2 
symmetry, the bisphosphinic chelating nature and the chirality which moved from the 
phosphorous to the backbone - became the three main design criteria for the next ligand 
generations. In the year 2000, three groups independently reported highly efficient 
hydrogenation (ee >99%) using monodentate phosphorous ligands.16 Most nobably, these 
ligands were phosphorous acid derivatives rather than the original phosphines such as 1 and 2. 
Although phosphines are still the most widely used chiral ligands12 they are often tedious to 
prepare, not easily modified (notable exception the Josiphos ligand family17) and frequently 
very sensitive towards oxygen, which limits their application. In contrast, ligands formally 
derived from phosphoric acid are easily synthesised and their availability grew in the last two 
decades. Nearly all possible substitution patterns on phosphorous have been explored. They 
are in general quite stable towards oxidation, but can be hydrolysis sensitive. Some of them 
 11 
are recent additions to the set of so-called privileged ligands18 achieving excellent 
performance in a variety of transition metal catalysed transformations and have already found 
industrial applications.19 Moreover, phosphites, phosphonites, phosphinites, 
phosphoramidites, phosphorodiamidites, phosphonamidites, phosphonodiamidites, 
phosphinous amides and combination thereof are readily prepared via modular synthetic 
approaches and broad structural diversity can be introduced using a large reservoir of chiral 
and achiral (di)alcohols, (di)amines and aminoalcohols as building blocks.  
 
Even if they belong to the family of phosphorous acid derivatives and should be accessible 
through a modular synthetic approach, phosphorus triamides (PTA) (Figure 2) are 
significantly underrepresented as ligands in the literature20 and only very few applications in 
asymmetric catalysis have been reported (Chapter 2.2.1.5).  
P
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Figure 2: Schematic structure of PTAs containing a chelating diamine 
 
1.2 Objective 
 
The main objective of this work is the synthesis of chiral monodentate phosphorous triamides 
and their application in transition metal catalysed enantioselective transformations. At the 
beginning of this PhD thesis (September 2003), no investigation on the use of chiral PTA in 
the asymmetric catalysis was present in the literature. 
First, reliable synthetic procedures and a suitable purification and isolation methodology for 
PTA should be developed. The aim was to make a PTA ligand library accessible with 
structural variations including both steric and electronic diversity. The incorporation of a 
diamine as a common chiral building block was envisaged to introduce stability and rigidity 
to the ligand backbone and to simplyfy the way of preparation. We intended to use (R,R)-1,2-
cyclohexyl-diamine, (Ra)-2,2'-binaphthyl-diamine as C2-symmetric, and N-phenyl-2-
aminomethyl-pyrrolidine as C1-symmetric diamine counterparts, and to accomplish the 
further electronic and steric tuning by variation of the substituents on the nitrogens. Also, we 
selected a variety of chiral and achiral secondary amines as monoamine components. This 
study should significantly increase the structural data available for this class of compounds 
and give the first indication on their coordination ability to transition metals. 
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For catalytic application, we selected reactions where monodentate phosphorous ligands have 
already shown a proven potential. First choice was the Rh-catalysed hydrogenation of 
dimethyl-itaconate, where monodentate phosphines and phosphoramidites have been applied 
with excellent results. Further attention focused on two different C=C bond forming reactions. 
Asymmetric copper catalysed Michael addition of diethyl zink to cyclohexenone was selected 
as an appropriate test reaction, while some of the ligand structures in the library were 
explored in the more challenging nickel catalysed asymmetric hydrovinylation of styrene.  
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2. State of the art 
 
2.1 Phosphorous triamides (PTA) 
2.1.1 Phosphorous acid derived ligands 
 
For a long time, phosphines have been a dominant class of ligands for asymmetric transition 
metal catalysis. Recently, chiral compounds formally derived from the trivalent phosphorous 
acid H3PO3 became more and more popular as ligands or as a part of hetero bidentate ligands, 
in which case they serve as a second donor. For instance, the electronically dissymmetrical 
phosphine-phosphite BINAPHOS21 still represents the benchmark for asymmetric 
hydroformylation and other Rhodium based systems. The phosphine-phosphoramidite 
QUINAPHOS belongs to the most active and enantioselective ligands for C=C 
hydrogenation.22 The QUIPHOS ligand (a phosphorodiamidite-N ligand) reported by Buono 
is a further example of hetero bidentate ligands, which was applied in Pd-catalysed allylic 
alkylation with excellent results.23 C2-symmetric diphosphites belong to the class of homo-
bidentate ligands, and have been successfully used in the Rh-catalysed asymmetric 
hydrogenation by Reetz.28 As an early example for industrial application, bidentate 
phosphinites based on sugar derived backbone, have been used for the Rh catalysed 
hydrogenation in the production of L-dopa by Isis Pharma.24 Similarly, various sugar 
backbone derived bidentate phosphites have been prepared by Claver and coworkers, showing 
excellent results in the hydrogenation of a variety of substrates. 25 
The first successful application of monodentate phosphoramidites in the asymmetric catalysis 
was reported by Feringa for the Cu-catalysed Michael addition.26 Since then phosphonites16, 
phosphoramidites27 and phosphites28 have been successfully utilised in the enantioselective 
hydrogenation and confirmed the potential of monodentate, phosphorous acid derived ligands 
for the asymmetric catalysis.  
Depending on the substitution pattern at the trivalent phosphorous atom, several classes of 
phosphorous acid derived compounds can be distinguished. If the phosphorous is linked only 
to nitrogen and/or oxygen heteroatoms, four different combinations can be defined (Figure 3). 
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Figure 3: Phosphorous acid derivatives with N/O heteroatoms only 
 
Five further variations are possible if the ligand contains one or two phosphorous-carbon 
bonds and additional nitrogen- and/or oxygen-phosphorous bonds. Though these compounds 
do not strictly belong to the class of phosphorus acid derivatives, they can be included in this 
listing because they often contain identical building blocks and are prepared using similar 
synthetic approaches (Figure 4). 
Almost in all the reported examples, the ligand contains a cyclic structure, in which the 
phosphorous is embedded in a heterocyclic ring. This not only increases the stability of the 
compounds, but also strongly simplifies their preparation.  
Among the above discussed ligand class collection, phosphosrous triamides are clearly 
underrepresented and only very recently, in paralel to the work described in this PhD thesis, 
first examples of chiral phosphoramidites were independently reported (Chapter 2.1.2).  
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Figure 4: Phosphorous ligands with C- and N- or O-P bonds 
 
2.1.2 PTA as synthetic intermediates and derivatising agents  
 
The synthesis of ligands formally derived from phosphoric acid usually starts from chiral 
diols or diamines, which in a cyclisation step react to an intermediate, containing phosphorous 
in a heterocyclic ring. Reactive P(III) compounds, mostly phosphorous trichloride or 
tris(dimethylamino)phosphine (an achiral PTA29) are used for this purpose.  
The QUIPHOS ligand30 is prepared through a chiral PTA intermediate which is obtained by 
the reaction of P(NMe2)3 with (S)-2-Anilinomethyl-pyrrolidine by liberation of two 
equivalents of volatile dimethylamine. Then, the exocyclic P-N bond is cleaved with the 
corresponding alcohol, giving the desired ligand in nearly quantitative yield. The driving 
force in both synthetic steps is the continuous removal of gaseous dimethylamine which is the 
only byproduct (Scheme 1). 
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Scheme 1: Preparation of QUIPHOS through a phosphorous triamide reaction intermediate  
 
The same principle was applied by Feringa 31, Kee 32 and Alexakis 33 who have established an 
elegant method for the determination of enantiomeric excesses of chiral alcohols, amines, 
tiols and phosphorous acid esters by means of 31P NMR spectroscopy using α-
phenylethylamine (Scheme 2) and (R,R)-1,2-cyclohexyl-diamine based chiral PTAs, as 
derivatizing agents.  
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Scheme 2: Method for determination of optical purity of alcohols by using chiral PTA 
 
The derivatisation with a variety of chiral substrates occurs quantitatively at room 
temperature, in a time range from some minutes up to 8 hours. The products of the reaction 
are diastereomeric mixtures exhibiting distinct 31P signals, whereby their ratio directly 
indicates the optical purity of the starting material. 
 
 
2.1.3 Achiral PTA: electronic features and coordination abilities 
 
Moloy and Petersen have investigated a range of achiral phosphorous ligands in terms of their 
electronic properties and coordination abilities.34 Among the studied structures, two PTAs 
have been included with similar steric features, but very different π-acidic character (Figure 
5). 
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Figure 5:  Sterically similar but electronically different achiral PTAs 
 
The crystal structure analysis of 5 and 4
 
has shown that the two PTA ligands have practically 
identical cone angles. As a result, any differences in reactivity are attributable to their 
electronic features. Competition complexation studies have shown that 4 easily exchanges 5 
from its rhodium complex. The better σ-donor the ligand is, the stronger its ability to form the 
expected rhodium complex. The IR stretching frequencies of CO of the prepared 
trans[RhCl(CO)L2] complexes show, that the basicity of 4 is comparable to that of common 
trialkylphosphines35 (ν(CO)=1952 cm-1), whereas 5 possesses strong π-acidic properties, 
comparable with those of phosphites 36 (ν(CO)=2024 cm-1).  
Both compounds can be prepared by the reaction of PCl3 with three equivalents of the 
appropriate heterocycle in the presence of a base. Compound 4 is very sensitive towards air 
and moisture whereas 5 can be handled on air. This is in agreement with their level of 
basicity, and shows that the stability of PTA is strongly dependent on the nature of the amines 
present in the ligand structure.  
 
2.1.4 Proazaphosphatranes: structure and applications 
 
Proazaphosphatranes introduced by Verkade in 198937 are a class of PTAs with unique 
chemical and structural properties (Figure 5). They are strong non-ionic bases (pKa ~ 16) and 
have found application in organic synthesis38 as stoichiometric bases39 and promoters of base-
catalysed reactions.40 The phosphorous is bound by a terdendate amine resulting in a bicyclic 
structure which renders these compounds particularly resistant towards hydrolysis. The high 
basicity of the phosphorous can be explained by the electron donating effect of the alkyl 
groups directly bound to the nitrogens. Moreover, it is further increased due to the 
transannular nitrogen-lone pair, which interacts with the phosphorous.   
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Figure 6: General structure of proazaphosphatranes 
 
More recently, achiral proazaphosphatrane ligands were successfully used in the palladium 
catalysed Buchwald-Hartwig amination of aryl chlorides41 as well as in Suzuki42 and Stille43 
cross-coupling reactions.  
The group of H. Yamamoto synthesised a chiral proazaphosphatrane (7) starting from 
S-proline (Figure 6), which was used for promoting the kinetic resolution of 1-phenylethanol 
with sterically hindered trialkylsilyl chlorides although without observing any 
enantioinduction. Very poor enantioselectivity (up to 15% ee) was obtained using 7 as chiral 
catalyst in the addition of diethyl zinc to benzaldehyde.44 
 
 
2.1.5 Chiral phosphorous triamides in asymmetric catalysis 
2.1.5.1 The first chiral PTA based on the binaphthyl diamine framework 
 
While this thesis was in progress, a first example for the use of a PTA as ligand for transition 
metal catalysed enantioselective transformations was reported by Reetz who described the 
synthesis of PTA 8 based on the binaphthyldiazaphospholidine backbone (Scheme 3).45  
 
 
N
N
CH3
CH3
P Cl
N
N
CH3
CH3
P
NEt2
BH3
1. Et2NH / NEt3
2. BH3 .THF
74% 8 
Scheme 3: The first chiral PTA used in asymmetric catalysis 
 
Ligand 8 was obtained as BH3-adduct as neither the free ligand nor its diaminophophorous-
chloride precursor could be isolated and properly characterised due to their instability. The 
free ligand was in situ liberated from 8 prior to catalytic experiments. In the hydroformylation 
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of styrene good activity, but only low enantioselectivity was obtained. In Rh catalysed 
hydrogenation of dimethyl-itaconate no conversion was observed (Scheme 4). 
 
[Rh(CO)2Cl]2 / Ligand
CO/H2
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*
[Rh(cod)2]BF4 / Ligand
H2
Ph Ph
CHO
H3CO(O)C C(O)OCH3
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conv = 100%; iso/n = 78%; ee = 37%
no conversion
 
 
Scheme 4: Application of PTA in the asymmetric hydroformylation and hydrogenation 
 
The latter result is surprising if compared with the structurally related phosphoramidites (e.g. 
Monophos16b) which provide excellent results in the same reaction. Another limitation is the 
low stability of the ligand, which probably renders this type of the PTA structure less suitable 
for a modular synthetic approach. 
 
1.1.5.2 PTA ligand library based on the bis-(sulfonyl)-diazaphospholidine moiety  
 
Gennari and coworkers prepared a variety of ligands containing the electron poor 
bis(sulfonyl)diazaphospholidine moiety.46 Introducing electron withdrawing substituents on 
the nitrogens of the chiral diamine leads to a much higher ligand stability. This was the first 
time when a library of phosphorous triamides consisting of different diamine and monoamine 
backbones has been synthetised. However, the variation of the electronic features was not 
included in this study. 
In Figure 7 all ligands described by Gennari and based on the 2,2´-diaminobinaphthyl 
backbone are shown. A variety of mesyl-substituted ligands with small (dimethyl) and 
medium size (benzyl) monoamine, as well as bulky chiral secondary amine counterparts were 
included. The substituents on the diamine were also varied from mesyl to tosyl as well as 
para- and meta- methoxyphenyl-sulfone.  
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Figure 7: Binaphthyl-diamine based chiral PTAs described in reference [46] 
 
For ligands based on (R,R)-1,2-diaminocyclohexane, mesyl substituted ones, with small 
(methyl) and bulky (isopropyl) monoamine counterparts were described. Also, ligands based 
on the tosyl substituted (R,R)-1,2-diaminocyclohexane combined with sterically demandig 
achiral (isopropyl) and chiral bis((R,R)-α-methylbenzylamine) monoamines have been 
prepared (Figure 8). 
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Figure 8: Cyclohexyl-diamine based chiral PTAs described in reference [46] 
 
Three additional PTA containing the (R,R)-1,2-diphenylethylenediamine backbone have been 
prepared, both with mesyl- and tosyl-substituted diamines, with achiral monoamine 
counterparts (Figure 9). 
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Figure 9: (R,R)-1,2-diphenylethylenediamine based chiral PTAs described in reference [46] 
 
All these ligands were synthetised by the reaction of the lithiated diamine or monoamine with 
the corresponding phosphorous chlorides, analogously to common phosphoric acid 
derivatives. After filtration of the formed LiCl, the ligands were directly applied in catalysis 
without any further purification procedure. The ligand library was evaluated only in the Cu-
catalysed conjugate addition of diethyl-zinc to cyclohexenone (Scheme 5). 
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Scheme 5: Cu catalysed Michael-addition of Et2Zn to cyclohexenone 
 
Taking into account that the benchmark system in this reaction provides enantioselectivites up 
to 98 %,47 poor results were obtained within the described PTA (ee´s ranged from 0 to 20 %). 
As an exception, the ligand consisting of the bis-mesylated-binaphthyldiamine backbone and 
dimethyl amine gave good enantioselectivity of 75 %. As conclusions, the authors conclude 
that “ligands containing the 1,1’-binaphthyl-2,2’-diamine scaffold gave superior results” and 
that “it is also evident that small amine substituents at phosphorus are preferable.”46 
 
2.1.5.3 P-chiral PTA and their application in the allylic substitution 
 
Tsarev et al. synthesised a variety of ligands based on the diazaphospholidine moiety using 
(S)-phenyl-pyrrolidin-2-yl-methylamine and used them in the Pd-catalysed allylic substitution 
of 1,3-diphenylallyl acetate with different nucleophiles.48  
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Scheme 6: Synthesis of PTAs starting from (S)-phenyl-pyrrolidin-2-yl-methylamine 
 
Although most of the synthetised ligands were phosphorous diamidites, two PTAs were also 
reported (Scheme 6). Because the applied (S)-phenyl-pyrrolidin-2-yl-methylamine is C1 
symmetric, the ligands contain an additional chiral centre on the phosphorous. Ligand 10 
formed diastereoselectively with R configuration at the phosphorous, whereas compound 9 
was obtained as a 97 : 3 mixture of the Rp and Sp diastereomers, and was applied in the 
catalysis without further separation. 
PTA 9 provided fairly good enantioselectivity of 62 %, whereas 10 possessing less steric bulk 
gave an enantioselectity of only 15 % in the allylic sulfonation (Scheme 7).  
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Scheme 7: Pd-catalysed allylic substitution with [pTolSO2Na] as nucleophile 
 
Using benzylamine as nucleophile, ligand 9 resulted in moderate enantioselectivity of 51 %, 
whereas 10 lead to a racemic product. When dimethyl malonate was used as nucleophile, both 
ligands gave poor conversions. In this case however, 10 turned out to be better both in terms 
of activity and enantioselectivity, resulting in 55% ee and 10 % conversion. Only 2 % 
conversion could be achieved with 9. 
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2.1.6 Summary 
 
In comparison with other phosphorous acid derived ligand classes the family of phosphorous 
triamides is significantly underrepresented in the literature. The available synthetic 
procedures, and known achiral and chiral PTA structures were described in Chapter 2.1. For 
the testing of our novel PTA ligand library, three benchmark reactions were chosen. In 
Chapter 2.2. the rhodium catalysed asymmetric hydrogenation will be briefly introduced. 
Asymmetric copper catalysed Michael addition will be described in Chapter 2.3. and 
asymmetric nickel catalysed hydrovinylation will be discussed in Chapter 2.4.  
 
2.2 Rh catalysed asymmetric hydrogenation  
 
2.2.1 General aspects 
 
Rhodium catalysed asymmetric hydrogenation is a method for the catalytic reduction of 
prochiral olefins with hydrogen gas (Scheme 8). 
 
HOOC NHCOMe
[Rh]
+ H2 ∗
HOOC NHCOMe
 
 
Scheme 8: Asymmetric hydrogenation of 2-acetamidocinnamic acid 
 
The preferred substrates for this reaction are functionalised unsaturated olefins: carboxylic 
acids, esters, enones, which most commonly bear a carbonyl group in the beta position to the 
olefinic double bond. This plays an important role in the coordination of the substrate to the 
metal during the catalysis. (Figure 10) 
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Figure 10: Typical substrates for the asymmetric hydrogenation 
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The more challenging non-functionalised olefins normally require Ir based systems. Here, 
only the rhodium based catalysts are described briefly. The extensive development in the field 
makes it difficult to give a comprehensive and detailed description of all the reported ligands. 
As discussed in Chapter 1.1., the early ligand development started with the chiral 
modification of the Wilkinson catalyst by Knowles, Horner and Kagan. 13,14,15  After the first 
promising results, another important breakthrough followed in 1980 when Noyori introduced 
the axially chiral bidentate ligand BINAP for this transformation. 49 In 1991, Burk designed 
the strongly electron donating bis-phospholane, DuPhos and achived excellent results with a 
broad range of olefins. 50 The C1 symmetric, planary chiral ferrocene-based, modular Josiphos 
ligand family represents another important addition to the set of bidentate hydrogenation 
ligands. 51 The bidentate phosphine-phosphoramidite ligand, QUINAPHOS, and its 
derivatives also belong to one of the most active and enantioselective catalysts for this 
transformation and can be utilised for a broad range of substrates.22 
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Figure 11: Successful bidentate phosphine ligands for the asymmetric hydrogenation 
 
The intensive search for new structures resulted hundreds of new ligands in the last decade, 
via structural modification of the above mentioned seminal ligands, or de novo synthesis 
improving the catalytic efficiency and broadening the substrate scope.52  
As example for new generation ligands, developed by Zhang, are the TangPhos 53 and 
PennPhos 54 both containing the rigid and electron-rich phosphacyclic motif also incorporated 
in the DuPhos ligand. Both ligands exhibit excellent enantioselectivity and reactivity towards 
a broad range of substrates including simple ketones, β-keto-esters and imines. Inspired by the 
axially chiral BINAP but taking advantage from the flexibility of the biphenyl backbone, the 
TunePhos ligand family has been developed. 55 In this case the two aromatic rings of a 
biphenyl backbone are linked with a tunable bridge, resulting in ligands with well defined 
dihedral and bite angles. The length of the linking spacer varies form C1 to C6 and covers a 
broad range of the mentioned parameters, allowing for the evaluation of a number of different 
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substrates. In many cases, these ligands give comparable or superior results to the parent 
BINAP. 
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Figure 12: Successful bidentate phosphine ligands for the asymmetric hydrogenation 
 
Since 1999, the commonly accepted rule that chelating bidentate ligands have a superior 
performance in this transformation has been reconsidered. With the introduction of new chiral 
monodentate phosphorous ligands, mostly phosphites, phosphonites or phosphoramidites, the 
same or even higher levels of enantioselectivity could be reached. In this case, two ligands 
coordinate to the rhodium, mostly restricting each others conformational freedom. 56  
Among the first successful phosphite structures was the ligand based on binol and 1,4:3,6-
dianhydro-D-mannite developed by Reetz for the hydrogenation of dimethyl itaconate.28 This 
group also introduced phosphonites based on the same chiral backbone (Chapter 2.1.1., 
Figure 4.). A variety of further different binaphtyl framework-based phosphite and 
phosphonite ligands have been synthetised, containing simple achiral- or sugar based chiral 
alcohols.57 Also, the conformationally flexible biphenol has been envisaged for ligand 
synthesis with different substituents on the aromatic rings almost in every position.58 
The first notable phosphoramidite appeared in 2000, when Feringa reported the 
hydrogenation of dehydroamino-acids, itaconic acid and its methyl esters with the MonoPhos 
(Chapter 2.1.1., Figure 3.) and showed that this structure exhibits fast reaction and high 
enantioselectivities for a variety of dehydroamino acids, reaching even 99% ee for 2-
acetamidoacrylic acid and its methyl ester.59 Further investigation focused on the variation of 
the binaphthyl moiety, in the 3, 3´ as well as in the 6, 6´position60, and on the modification of 
the diamine side by replacing the simple dimethylamino moiety with sterically more 
demanding amines. For example the phosphoramidite, bearing a diethylamino group instead 
of the dimethyl, led to enantioselectivities of 99.9 % for N-acetyldehydroamino esters and 
99.6 % for enamides.61  
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As already mentioned in Chapter 2.1., the relatively simple and modular synthesis of these 
phosphorous acid derived ligands represents a huge advantage of these structures over the first 
and second generation bidentate phosphines. Moreover, the fact that they are often available 
from cheap building blocks opened the possibilities for the automatization of the synthetic 
procedure and such high throughput parallel ligand screening. In industry, this approach 
(called instant ligand library protocol) helps to minimise the time to market pressure, cost of 
catalyst, and lack of robustness of the process. With a parallel synthetic reactor developed at 
DSM, 96 mostly MonoPhos derived ligand structures can be synthetised and tested within a 
few hours.62  
It has been also shown the first time by Reetz, that not only 2 equivalens of monodentate 
phosphorous ligands can be utilised, but also mixtures of different phosphorous species.63 The 
most successful combinations are the mixtures of phosphinites with phosphites.64 
Heterocombinations of different phosphoramidites or even mixtures of chiral with achiral 
ligands have also been investigated.65 In is interting to note, that these units, are directly 
combined in some of the extremely successful ligands e.g. QUINAPHOS.  
 
2.2.2 Mechanism of the reaction 
 
The mechanism of the enantioselective hydrogenation is based on the mechanism determined 
for simple achiral olefins with the Wilkinson catalyst.66 First investigations were undertaken 
in the eighties, most importantly detailed kinetic measurements by Halpern67 and 
characterisation of the reactive intermediates by different methods (para hydrogen NMR 
measurements, X-ray analyses) by Brown, Schrock, Osborn and Kagan.68 Based on these 
investigations, the following key points can be concluded: 
-The cationic bisphosphine rhodium complexes, in the absence of reactant, are present as bis-
solvates in polar solvents (e.g. methanol) and the reactivity of these complexes towards 
hydrogen is low. 
-After introducing a typical dehydroamino-acid substrte, complexation of the olefin takes 
place, actig as a bidenate ligand due to the C=O functional group. This way, as the 
diphosphine ligand is chiral, two diastereomeric Rh-enamide complex are generated which 
are in equilibrium with each other. In the case of the DIPAMP ligand and (Z)-N-
Benzoyldehydrophenylalanin, their ratio corresponds to 10:1. 
-Only the disfavoured diastereomer reacts with hydrogen at lower temperatures, while an 
alkylhydride complex is formed which decomposes to the product above -50 oC.  
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The suggested mechanism, where all the depicted intermediates are characterised by NMR is 
depicted in Scheme 9. 
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Scheme 9: The “classical” mechanism for enantioselective hydrogenation with ligand (R,R)-DIPAMP 
 
New developments concerning the mechanism were added by Gridnev, Imamoto and Brown 
in the late nineties. In 2000 Brown and Bargon has proposed another catalytic cycle, in which 
the substrate addition to the reactive rhodium species follows after the addition of hydrogen, 
also called the dihydride route.69 With low temperature NMR measurements it was possible to 
identify the dihydrid-ligand complex, bearing an agostically bound hydrid.70 When reacting 
these species with the substrate the enantioselectivity was higher than the one achieved with 
the isolated substrate-ligand complexes. Finally, an in situ hydrogenation was performed, in 
which case the enantioselectivity values were between these two results. This elegantly 
demonstrated the legitimity of the dihydride route.  
Although the precise source of enantioselectivity in hydrogenations using monodentate 
phosphoramidite ligands has not yet fully defined, preliminary mechanistic studies have been 
performed with the MonoPhos ligand.71 The reaction is faster at ligand/rhodium ratios of less 
than two. If the ratio exceeds three, the catalysis stops. Assuming a reaction mechanism in 
which the substrate is bound to the rhodium in a bidentate fashion, the oxidative addition of 
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H2 to the rhodium complex would be impossible if more than two ligands are bound to the 
metal. Changing the Rh/L ratios over 0.5-3 range, the enantioselectivity values remain 
practically constant. This strongly suggests that the same active catalyst species as depicted in 
Scheme 9 operates under these conditions.  
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2.3 Copper catalysed Michael addition of Et2Zn to enones 
 
2.3.1 General aspects 
 
Conjugate additions of organometallic reagents to activated double bonds are one of the most 
versatile methodologies in the class of carbon-carbon bond forming reactions. The products of 
these transformations are useful for further functionalisation.47 A variety of compounds, 
especially diamines, imines, soft phosphorous or sulphur ligands together with a number of 
organometallic reagents (organolithium, Grignard- and organozinc reagents) have been 
investigated in this reaction, reaching moderate levels of enantioselectivity.8  
A specific example for conjugate addition of organometallic reagents to activated double 
bonds is the copper catalysed Michael addition of diethyl-zink to enones (Scheme 10). Since 
the first report of Alexakis,72 many different P(III) ligands have been evaluated in this 
reaction for over two decades, among which monodentate phosphoramidites turned out to 
provide the cleanest and fastest formation of β-alkylated ketones.  
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Scheme 10: Cu catalysed Michael-addition of Et2Zn to cyclohexenone 
 
The main difficulty in reaching the desired enantioselectivity in this reaction is the presence 
of equilibria between the various organocopper species among which reactive achiral 
complexes can also be present. High enantioselectivity has therefore to be the result of a 
strong ligand acceleration effect.73 Excellent chemo- and regioselectivities could be the first 
time obtained with a variety of 1,2-binaphthol-backbone based phosphoramidites in a 
relatively short time,26 but the real breakthrough was achieved after introducing one additional 
chiral element to the monoamine site of the ligand framework. With phosphoramidite 11 also 
called the Feringa ligand (Figure 13),74 enantioselectivities exceeding 98% and turnover 
frequencies of 3000 h-1were realised even at catalyst loadings of only 0.5%. 
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Figure 13: The Feringa ligand 
 
Up to this point this is the most succesfull benchmark ligand not only for conjugate addition 
of Et2Zn to cyclohexenone, but to a broad variety of substrates.47,75 This is remarkable taking 
into account the usual high substrate specificity of organocopper reagents.76 High optical 
yields can also be achieved with conformationally tunable biphenyl-based 
phosphoramidites,77 Pfaltz´s phosphite-oxazolines78 and Josiphos-type ligands.79   
After the initial success in the addition of Et2Zn on C=C double bonds, a plethora of 
substrates and a variety of organometallic species such as diphenyl-zink80 and Grignard-
reagents81 have been used with the same type of substrates. The reaction has also been further 
developed to a tandem process, resulting not only in chiral 1,2-unsaturated ketones, but in 
diverse chiral products.82 
 
2.3.2 Mechanism of the reaction 
 
Recently a detailed mechanistic study on the reaction has been published by Schrader,83 who 
has supported the early kinetic experiments by Krauss and Smith,84 and the NMR study of 
Ullenius and Smith.85 The results are most consistent with a mechanism where intermediate B, 
which is in equilibrium with the starting material, reacts in an irreversible process to give the 
conjugate adduct E. This study is also in agreement with the previous postulation of Alexakis86 
and Feringa87 about the catalytic cycle (Scheme 11). 
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Scheme 11: Postulated mechanism of the Cu-catalysed Michael addition 
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Scheme 12: Product formation steps in detail 
 
Both assumed an initial alkyl transfer from Et2Zn to the copper centre (B) followed by the 
coordination of the RZnX species to the enone carbonyl and a formation of a π-complex 
between the Cu alkyl species and the double bond of the substrate (C). Then a metallation of 
the Cu (I) at the β-position of the enone double bond follows, resulting in the formation of 
intermediate D where copper is present in a higher oxidation state (III). Reductive elimination 
with simultaneous alkyl transfer to the gamma carbon of the enone forms the rate determining 
step (Scheme 12). The resulting enolate (E) is further reacted to a corresponding product (F) 
with an appropriate electrophile. 
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2.4 Nickel catalysed asymmetric hydrovinylation 
 
Hydrovinylation is a codimerisation reaction between ethylene and another olefin partner.88 It 
comprises the formal addition of a vinyl group and a hydrogen atom across a double bond. 
The reaction has drawn a lot of interest particularly because it uses ethylene as an available 
carbon feedstock and cheap vinyl source. The first asymmetric hydrovinylation (and at the 
same time one of the very early examples of metal mediated asymmetric catalytic reactions) 
was reported by Bogdanović for norbornene.89  
In general, the hydrovinylation products may serve as useful starting materials for a variety of 
transformations involving the reactivity at the double bond. High added value optically active 
products can be obtained when pro-chiral olefins are used as reagents. In this respect, a 
substrate like 2-methoxy-6-vinylnaphthalene is especially important, because its 
hydrovinylation product could be used as precursor for the synthesis of antiinflamatory agents 
(e.g.Naproxen).90 Similarly, the hydrovinylation of styrene and styrene derivatives is very 
interesting as it would also provide an alternative route to 2-arylpropionic acids, which are 
also antiinflammatory drugs.91 The discussion here will focus on the Ni-catalysed 
hydrovinylation of styrene, which is the most popular benchmark substrate (Scheme 13). 
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Scheme 13: Nickel catalysed hydrovinylation of styrene  
 
The reaction is particularly challenging as together with the primary product 3-phenyl-1 
butene a number of side products may be formed, mostly due to “undesired” consecutive side 
processes. First of all, the isomerisation of 3-phenyl-1-butene to the thermodynamically more 
stable achiral E- and Z-2-phenyl-2-butene can take place. Secondly, the addition of further 
ethylene units to the 3-phenyl-1-butene and its achiral isomers can lead to oligomer 
formation. These side processes are usually catalysed by the same nickel catalyst responsible 
for the hydrovinylation reaction and become pronounced with increasing temperature and 
styrene conversion. Moreover, some nickel catalysts are also able to promote 
homodimerisation, oligo- or even polymerisation of styrene and/or ethylene, which further 
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enlarge the product spectrum. Therefore, a catalys is required which is able to control the 
chemo-, regio- and enantioselectivity at the same time. 
Catalyst systems based on metals other than Ni have been also investigated in the asymmetric 
hydrovinylation reactions although with less success: palladium,92 platinum,93 ruthenium,94 
cobalt95 and iridium.96 
Therefore, the following chapters we will only focus on the ligand development and 
mechanism concerning the nickel catalysed hydrovinylation. 
 
 
2.4.1 Ligand development for the nickel catalysed hydrovinylation 
 
For many years, the state of the art was defined by the azaphospholene ligand 12 (Figure 14) 
developed by Wilke et al. in the early 80´s.97 This ligand was obtained by the reaction of 
myrthenal and phenylethylamine as a mixture of diastereomers together with other 
phosphorous containing compounds. This so-called “mixtura mirabilis” was nevertheless 
tested in the hydrovinylation of styrene leading to surprisingly good results. Later, the 
diastereomer responsible for the excellent results in the hydrovinylation was crystallised and 
its absolute configuration could be determined as “all-R”.98 
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Figure 14: Wilke´s ligand with all chiral centers with R configuration 
 
The catalyst system based on [Ni(allyl)X]2 (X=Cl or Br), all(R)-10 and aluminium 
sesquichloride (Et3Al2Cl3) was applied in the hydrovinylation of a variety of substrates with 
moderate to excellent results. An isolated yield of 97%, an enantioselectivity of 95% and a 
TON of 1890 h-1 could be achieved in the hydrovinylation of styrene at -60 °C under 
optimised reaction conditions.97  Particularly impressive is the TOF of 750 h-1 obtained with 
this catalyst system at the low reaction temperature. The tedious preparation of all(R)-10 
hampered the application of this system in larger scales, but attempts to simplify the ligand 
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structure remained unsuccessful for a long time.99 Hence, the research has moved towards the 
examination of alternative ligand frameworks. 
The group of RajanBabu has been the most active in the area. In 1993, they applied Hayashi´s 
2-diphenylphosphino-2´-methoxy-1,1´-binaphthyl 13 (MOP)100 in the hydrovinylation of 
styrene derivatives.101 This system gave nearly quantitative yield for 2-methoxy-6-vinyl-
naphthalene with good enantioselectivity of 62 % at a catalyst loading of 0.7 mol % at -70 oC. 
This study has shown that the combination of monodentate phosphine ligands which bear a 
hemilabile methoxy group with a weakly coordinating anion like BARF is decisive for the 
catalyst performance. A minor modification of the MOP structure, i.e. the exchange of the 
methoxy with a benzyloxy group (14), resulted in an improvement of the enantioselectivity to 
80%. The chemical yield (97 %) and chemoselectivity (99 %) were also high.102  
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Figure 15: MOP and modified MOP ligand used in the hydrovinylation 
 
The same group reported on the use of carbohydrate derived phosphorous ligands103 as well as 
1-aryl-2,5-phospholanes104 as promising lead structures for the hydrovinylation (Figure 16). 
The carbohydrate based ligand 15 led to 81 % ee (89% selectivity) in the hydrovinylation of 
styrene at a catalyst loading of 1 mol%, while phospholane 16 provided somewhat higher ee 
(88 %) with perfect selectivity. The latter catalyst is able to mediate the hydrovinylation of the 
electron rich 4-isobutylstyrene with very high selectivity and an enantioselectivity of 91% ee. 
By lowering the catalyst loading from 0.7 to 0.07 mol%, a TON of 1428 h-1 could be achieved 
albeit at the expense of the enantioselectivity (72 %).104  
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Figure 16: Ligands introduced by RajanBabu for the hydrovinylation  
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In 2002 Leitner and Franciò reported the use of BINAPHOSQUIN-type105 ligands and the 
Feringa ligand in the hydrovinyaltion of styrene.106  These phosphoramidites provided 
excellent results, comparable with those achieved with 12 in the hydrovinylation of styrenes. 
The applied protocol comprised the use of [Ni(allyl)X]2 (X = Cl, Br) as metal precursor and 
NaBARF as activator. 
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Figure 17: Phosphoramidites successfully applied in the hydrovinylation  
 
Among the BINAPHOSQUIN family, the ligand (Ra,RC)-17 containing a chlorine atom in the 
8 position and a butyl substituent at the stereocenter resulted in full styrene conversion, 99% 
selectivity and 91% ee at -78 °C and a catalyst loading of 0.25 mol%.107 The simultaneous 
achievement of excellent chemo- and enantioselectivity places this system among the best 
known catalyst for this transformation. 
The Feringa ligand 11 proved to be even more efficient as it combines outstanding selectivity 
with unprecedented activity. For instance, at -60 °C and at a very low catalyst loading of 0.02 
mol% 89 % conversion within 4 h was achieved with perfect selectivity and 91 % ee, 
corresponding to a TOF of 1025 h-1. At higher catalyst loading and lower temperature this 
system led to 95% ee. Thus, for the first time, a modular and easily accessible ligand class 
was introduced which provided high chemo and enantioselectivities coupled with outstanding 
activities. Investigations of RajanBabu showed that 11 was the ligand of choice also for the 
hydrovinylation of a range of 1,3-dienes including norbornene.108,109 
Recently, Zhou et al. introduced a phosphoramidite ligand based on aromatic spiro-diol (18), 
which provided high enantioselectivities up to 99 % in the hydrovinylation of α-alkyl-
vinylarenes resulting in the formation of quaternary carbon stereocenters. Catalyst loading of 
5-10 mol% is required for accomplishing this difficult transformation.110 
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2.4.2 The mechanism of nickel catalysed hydrovinylation  
 
Based on the generally accepted mechanism proposed by Wilke and Bogdanovic (Scheme 
14),111 the group of Leitner carried out a detailed DFT study in order to understand the origins 
of the asymmetric induction in the [Ni]/Feringa catalysed styrene hydrovinylation.112 
As also earlier studies have stated,113 the catalytic cycle starts with a cationic Ni hydride 
species, which after the coordination of styrene results in the formation of instable 
intermediate B. This species rapidly evolves into the more stable intermediate C in which the 
styrene moiety is η3-bonded to the nickel in an allyl-type coordination. In the next step, 
ethylene coordination generates intermediate D. Then, the actual C-C bond forming reaction 
takes place resulting in the intermediate E which undergoes a β-hydride elimination yielding 
the product and the starting Ni-H species. The anion interacts differently with the cationic 
complexes in the various steps of the catalytic cycle. It has been experimentally shown that 
the nature of the anion plays an important role in terms of activity and enantioselectivity.101,106  
The calculations performed by Hölscher et al. also included anion and solvation effects. They 
supported the above described mechanism and showed that a phenyl group in the appropriate 
position of the ligand structure plays a significant role in obtaining high values of 
enantioselectivity. The performance of the catalytically active system is largely affected by 
the hemilabile coordination of one phenyl ring of the phosphoramidite ligand. This allows for 
styrene coordination only in two possible ways, resulting in two diasteromeric nickel 
complexes. The following hydride transfer step for these two species is energetically 
different, one clearly preferred over the other. Hence, it was concluded that the 
enantiodiscrimination takes place already at this stage of the reaction and that the subsequent 
C-C bond formation step is not relevant for the enantioselectivity. 
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Scheme 14: Mechanism of hydrovinylation    
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3. Results and Discussion 
 
3.1. Synthesis of novel phosphorous triamide ligands 
 
The goal of this thesis is to explore the synthesis and application of a small library of 
monodentate phosphorous triamides with geometrical diversity, and with different electronic 
properties. These variations can be accomplished by introducing: 1) electron-donating or -
withdrawing groups at the nitrogen atoms of the diamine backbone and secondary amines 
with different basicity as monoamine counterparts; 2) substituents with different steric bulk; 
3) chiral and achiral monoamines; 4) additional P-chirality to the structure.  
Scheme 15 illustrates the different amine combinations as well as the general structure of the 
target PTA ligands. We decided to keep the cyclic structure on one side of the ligand 
framework, which imparts stability and rigidity to the backbone and also simplifies the way of 
preparation. For this purpose C2-symmetric (R,R)-1,2-cyclohexyl-diamine and (Ra)-2,2'-
binaphthyl-diamine are used as diamine counterparts. The electronic and steric tuning can be 
accomplished by the variation of the substituents on the nitrogens, i.e methyl vs. tosyl. Using 
(S)-N-phenyl-2-aminomethyl-pyrrolidine (a C1-symmetric diamine), ligands with an 
additional chiral centre on the phosphorous can be obtained. 
A variety of chiral and achiral monoamine components has been selected. Cyclic (piperidine, 
pyrrolidine, morpholine), aliphatic branched (diisopropylamine) and linear (dibutylamine), 
sterically more demanding aromatic (dibenzylamine, diphenylamine), and smaller aromatic 
(pyrrol) achiral, as well as two chiral (bis-(α-methyl-benzyl)-amine, α-methyl-benzylamine) 
secondary amines will be applied in the ligand synthesis. 
In Chapter 3.1.3 ligand synthesis based on the binaphthyl-diamine framework is presented. 
Here, we describe a Feringa-ligand analogue PTA and some synthetic difficulties which 
emerged using binaphthyl diamines for the ligand synthesis instead of binol.  
Chapter 3.1.4 discusses the preparation of a set of ligands based on the (R,R)-1,2-cyclohexyl-
diamine moiety.  
Chapter 3.1.5 deals with P-chiral ligands bearing the (S)-N-phenyl-2-aminomethyl-
pyrrolidine backbone and details concerning diastereomer separation are given.  
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Scheme 15: Amines of choice for the desired PTA ligand library 
 
 
3.1.1. Synthetic strategies 
 
Phosphorous triamides, like other phosphorous acid derivatives, are accessible from two 
convergent synthetic routes starting from PCl3 (Scheme 16). Route A includes first the 
formation of the chlorodiaminophosphine 19 which is subsequently converted into the final 
PTA by the reaction with a desired monoamine. Alternatively, Route B comprises first the 
formation of the dichloroaminophosphine 20, which is then reacted with a diamine. These 
transformations can be accomplished in the presence of a base as hydrochloride acceptor 
(typically triethylamine or DMAP) or by previous deprotonation of the monoamine or 
diamine with n-BuLi.  
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Scheme 16: Possible synthetic routes for preparation of PTAs 
 
As it will be shown later in detail, the two synthetic routes are complementary, but not in all 
cases equivalent. Route B is favoured when the secondary amine counterpart is not 
nucleophilic enough (e.g. because of steric hindrance). In this case, it has to be first reacted 
with PCl3, the most reactive phosphorous halide species. Route B is also the method of choice, 
when the diamine counterpart is to be varied. Route A on the other hand is applied when a 
library of ligands with different monoamine counterparts should be prepared.  
An important factor is that any of the desired routes requires sufficient stability of the 
phosphorous-chloride intermediates. In the next chapters specific examples will be described 
concerning this aspect. 
The synthetic strategies for the preparation of chiral phosphoramides were extensively 
investigated by Denmark. Although the phosphorous in these compounds is present in the 
oxidation state 5, we adopted the described synthetic methodologies for the preparation of our 
PTA library and utilized similar or identical chiral diamine motifs.114 
 
 
3.1.2 General considerations concerning the synthesis of PTAs 
 
PTAs, as indicated in the literature45 and demonstrated by our own investigations, are 
sometimes extremely labile and sensitive compounds. Not only the ligands itself but also the 
reaction intermediates can be rapidly hydrolysed and/or oxidized, mostly giving a complex 
mixture of phosphorous containing species. Moreover, in contrast to the majority of 
phosphoric acid derivatives, where the synthesis is followed by an appropriate purification 
 41 
step (mainly crystallisation or column chromatography), they often decompose during the 
distillation, hydrolyse on column and are oily materials which hardly crystallize. Therefore, 
the synthetic route leading to the ligand should be as “clean” as possible. This means that after 
a simple treatment (removal of the formed hydrochloride salt or LiCl), no other substances 
(phosphorous containing compounds, unreacted starting amines or remnants of bases) should 
be present in the final product except of the desired ligand.  
We have found a convenient and general purification method which minimises secondary 
reactions and decomposition of the primary products and was used for all of the described 
ligands: A simple filtration through a short pad of degassed and dry neutral aluminium oxide 
allows for the removal of the base hydrochlorides and LiCl efficiently (clearly much more 
effective than filtration through PTFE filter pad or celite: see Chapter 7.4 Appendices). The 
small amount of unreacted amines can be eliminated in the same step using non-polar solvents 
(e.g. toluene) for the filtration. This purification method is effective for relatively “clean” 
product mixtures containing mainly LiCl or ammonium hydrochlorides and starting amines in 
addition to the desired product.  
Therefore, it is of fundamental importance to carefully optimize the synthesis by choosing not 
only the best route but also the most suited base for the deprotonation of the starting amine. 
When butyl-lithium is used for the deprotonation, the stoichiometry must be rigorously 
respected, because an excess would lead to side reactions in the following synthesis step. Less 
than one equivalent on the other hand would result in unreacted amine impurities in the 
product. Much more convenient is to use alternative bases like DMAP or triethylamine. 
However these may not always be sufficiently strong for the use with less basic diamines 
(Chapter 3.1.4) or monoamines (pyrrol, dibenzyl amine). 
The applicability of a synthetic route to PTAs basically depends on two factors: 1.) The 
corresponding phosphorous chloride intermediate should be readily accessible 2.) It should be 
stable enough for further modification. As mentioned earlier, PCl3 can first be reacted with 
the monoamine or with the diamine. In some cases, both reactions proceed in a clear manner, 
giving the corresponding phosphorous chloride intermediates as exclusive products (Chapter 
3.1.5). There are examples, however, when only one of the routes is feasible (Chapter 3.1.3, 
ligand L1). Some of the phosphorous chloride or dichloride intermediates, however, even if 
formed as only products, decompose rapidly in the course of isolation and must be therefore 
reacted in situ to the ligand. (Chapter 3.1.4, ligands L5-L12) 
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Scheme 17: Possible difficulties in the preparation of new PTAs 
 
The number of possibilities for the preparation of a desired PTA according to the above 
depicted Scheme 17 is 8, if the matter of intermediate isolation is to be taken into account, 
then 16. It becomes clear, that the difficulty in the synthesis of PTA is not the reactivity itself 
as we deal with nucleophilic substitution reactions, with relatively reactive phosphorous 
species, which proceed easily at room temperature. But knowledge and experience is required 
to choose the best and sometimes only possible way for providing a synthetically useful 
procedure. The results presented in this thesis are hoped to provide useful guidelines in this 
respect (see Chapter 5.) Moreover, the operations during the synthesis and ligand screening 
should be performed with care, fully excluding oxygen and moisture, due to the instability of 
the ligands. 
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3.1.3. Synthesis of PTAs based on Ra-2,2´-diamino-binaphthyl backbone 
 
3.1.3.1. Theoretical aspects of structure and stability 
 
The Feringa ligand (11) is one of the priviledged structures in the class of phosphorous acid 
derivatives, as it is suitable for a range of transition metal catalysed transformations. Some 
phosphoramidites, when substituted in the 3,3´ position of the binaphthyl ring, show higher 
performance in terms of enantioselectivity115. It is argued that the presence of substituents in 
this position of the binaphthyl framework increases the steric bulk near the phosphorous, 
transferring the chiral information coming from the backbone closer to the central atom 
(Figure 18, structure A). By exchanging the two oxygen atoms with nitrogens, this should be 
even more pronounced: due to the substituents on the nitrogen, the steric effect would move 
even closer to the phosphorous and could thus influence the enantiomeric control more 
strongly (Figure 14, structure B). 
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Figure 18: Possible modifications of the phosphoramidite ligand structure  
 
The question arises, whether these novel compounds would possess the same stability as the 
analogous phosphoramidites and if the synthetic procedure and isolation would remain 
relatively simple. Also, the electronic properties of the phosphorous might change after 
substituting two electron withdrawing oxygens to less electronegative nitrogens. Moreover, 
the nature of substituents on the nitrogens might have a large effect on the stability as well as 
activity and selectivity of the ligands. 
 
DFT-calculations for the formal syntheses (gas phase reactions) show a general trend in the 
reaction enthalpy values among two different PTA ligands and the Feringa ligand as well as 
the corresponding phosphorous chloride intermediates. Binol reacts with PCl3 giving the 
corresponding phosphorous chloride and 2 equivalents of hydrogen chloride in a slightly 
exothermic manner (-1.1 kcal/mol). The same reactions for 2,2´-diamino-binaphthyl and 
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bis(dimethyl)-2,2´-diamino-binaphthyl are fairly endothermic with enthalpy values of 18.5 
kcal/mol and 21.2 kcal/mol respectively, showing a pronounced difference in the formation 
energies of the diol- and diamine- derived phosphorous chlorides, the latter being 
thermodynamically less favoured (Scheme 18). 
 
X
X
R
R
PCl3
X
X
P Cl
R
R
2 HCl+ +
R = H             X = O           d E=  -1.1 kcal/mol
R = H             X= NH         d E= 18.5 kcal/mol
R= Me            X= NH         d E= 21.2 kcal/mol
 
 
X
X
R
R
X
X
P N
R
R
2 HClNP
Cl
Cl
+
R = H                        X = O                    dE = 1.1  kcal/mol
R = H                        X= NH                  dE = 26.0 kcal/mol
R = Me                      X = NH                 dE = 32.0 kcal/mol
+
 
 
Scheme 18: Enthalpies for the formation (gas phase reaction) of different binaphthyl derived ligands  
 
The same trend can be found for the ligand formations by Route B as shown in Scheme 18. An 
enthalpy value of only 1.1 kcal/mol, was calcultated for the formation of the Feringa ligand, 
whereas 26 kcal/mol and 32.0 kcal/mol were found for the formation of both PTAs (Scheme 
18).  
It has to be taken into account that these calculations correspond to reactions in the gas phase. 
In reality, the driving force towards the product formation in solution is the precipitation of 
hydrochloride salts of the bases during the reactions or of solid LiCl when BuLi is utilised for 
the deprotonation of the diamines or binol. This makes all the synthetic routes possible in 
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principle. However, these energetic contributions are approximately the same for all the 
considered reactions, it is reasonably safe to say that these calculations represent a general 
relative trend and reflect that PTAs are more challenging in the synthesis and handling as 
compared to phosphoramidites.  
In order to address these fundamental questions experimentally, we set to synthetise PTA 
ligands which would serve as analogues for the Feringa ligand and investigate their 
performance in the asymmetric catalysis. 
 
3.1.3.2 Synthesis of Ra-2,2´-binaphthyl-diamine based PTA 
 
The Feringa ligand is synthetised starting from binol and PCl3, then the obtained phosphorous 
chloride is reacted with (R,R)-bis(α-methyl benzyl)-amine in the presence of triethylamine or 
BuLi to form the desired product, which is then purified by column chromatography followed 
by crystallisation. 
We applied the same synthetic route (Route A) using (Ra)-2,2´-diamino-binaphthyl; (Ra)-N,N-
dimethyl-2,2´-diamino-binaphthyl and (Ra)-N,N-diethyl-2,2´-diamino-binaphthyl instead of 
binol in the presence of different bases without success (Scheme 19). The phosphorous 
chloride precursors turned out to be sensitive, which is in agreement with the DFT 
calculations (Chapter 3.1.3.1 Scheme 17) and literature data45. They quickly decompose to a 
mixture of phosphorous containing species during the isolation. Also the in-situ addition of 
the chiral secondary amine resulted in the formation of a mixture of phosphorous containing 
species. Therefore, Route A was abandoned. 
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Scheme 19: Attempts for the preparation of Feringa analogous PTA via Route A 
 
Next, Route B was explored using different bases and various reaction conditions (Scheme 21 
and Scheme 22). The preparation of the corresponding amino-phosphorous-dichloride 
intermediate was carried out successfully. (The synthesis of this compound was later 
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independently reported by Gennari46). (R,R)-bis(α-methyl benzyl)-amine and its (S,S) 
enantiomer were reacted with PCl3 giving the desired aminophosphorous dichloride products 
(R,R)-21 and (S,S)-21 in very good yield (95%) and high purity after extraction with pentane. 
Optimizing the reaction conditions, it was found that DMAP is the base of choice for the 
reaction, which can be conveniently performed at 70 oC in toluene.  
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Scheme 20: Synthesis and 31P NMR spectrum of the phosphorous-aminodichloride precursor (S,S)-21 
after penatane extraction 
 
(R,R)-21 was further reacted with various (R)-2,2´-binaphthyl-diamine derivatives: (R)-2,2´-
diamino-binaphthyl, (R)-N,N-2,2´-dimethyl-diamino-binaphthyl and (R)-N,N-2,2´-diethyl-
diamino-binaphthyl. Moreover (R)-2,2´-bis(ethoxycarbonylamino)-1,1´-binaphthyl was 
applied, hoping for a better ligand stability due to the electron withdrawing substituens on the 
nitrogens. Despite of varying the type and concentration of base (triethylamine, Hünigs base 
and DMAP), solvent and reaction temperature, only a complex mixture of phosphorous 
containing species was obtained in all cases (Scheme 21).  
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Scheme 21: Attempts for the preparation of Feringa analogous PTA via RouteB 
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Finally, Route B could be successfully applied after deprotonation of (R)-N,N´-2,2´-dimethyl-
diamino-binaphthyl with BuLi (Scheme 22). The reaction proceeds overnight at room 
temperature and the crude products can be isolated after the formed lithium chloride is 
carefully removed by filtration of the reaction mixture over degassed and dry aluminium 
oxide. Even by careful handling, and using exactly two equivalents of BuLi, an oxide side 
product and about 15 % unreacted amine is present in the crude mixture, as indicated by 31P 
NMR and 1H NMR spectra. Further extraction with pentane as well as column 
chromatography on silica (analogously to the Feringa ligand) was not possible and also 
various crystallisation attempts failed. However, very clean product was crystallised from dry 
benzene by slow evaporation of the solvent, under inert atmosphere.  
(S,S)-21 and (R,R)-21 was used for the synthesis of L1 and L2, respectively. The chemical 
shifts and configuration of the two new PTA ligands are shown in Table 1. 
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Scheme 22: Successful preparation of L1 with an analogous structure to the Feringa ligand (11) 
 
Table 1: Chemical shift of 11 and the analogous PTA 
Ligand Configuration Solvent 
31P NMR 
δ (ppm) 
Yield after crystallisation 
(%) 
11 Ra,S,S CDCl3 145.3 - 
L1 Ra,S,S CD2Cl2 140.6 31 
L2 Ra,R,R C6D6 137.5 67 
 
 
3.1.3.3 Comparison of NMR spectra of the novel PTA with the Feringa ligand  
 
The aliphatic part of the room temperature 1H NMR spectrum of the Ra,S,S Feringa ligand is 
illustrated below in Figure 19. The methyl signals of the chiral secondary amine show one 
duplet at 1.62 ppm, and the methylene protons are indicated as one quartet at 4.40 ppm, which 
means that there is a free rotation around the P-N axis. In the 1H NMR spectrum taken at -80 
oC this rotation is frozen, so in this case two signals at 1.45 ppm and 1.85 ppm for the methyl- 
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and two at 4.22 ppm and 4.58 ppm for the methylene protons appear. In both of the novel 
PTA the rotation around the exocyclic P-N bond is fixed already at room temperature. In the 
Ra,S,S diastereomer (L1), the two methyl groups of the secondary amine part appear as 
duplets at 1.62 ppm and 1.95 ppm; the methylene protons give rise to two multiplets at 4.21 
ppm and 4.62 ppm. 
A large split between the two methyl signals of the binaphthyl-diamine backbone can be 
observed at 3.25 ppm and 2.10 ppm. The latter upfield shift could be a result of the shielding 
current effect of the phenyl groups belonging to the secondary amine backbone, as confirmed 
by the X-ray structure analysis of L1 (Chapter 3.1.3.4). The two sides of the binaphthyl 
diamine backbone are not equivalent as indicated by 1H and 13C NMR spectra, this also shows 
that the ligand is not C2 symmetric at room temperature. The diastereomeric L2 shows similar 
spectral properties. 
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 Figure 19: Comparison of the Feringa ligand with L1 in solution 
 
3.1.3.4 Comparison of the solid state structures of L1 with the Feringa ligand  
 
An additional proof for the highly dissymmetric arrangement of the ligand backbone is 
evidenced by the X-ray structure of L1 (Figure 16 and 17). The secondary amine part is 
sharply twisted towards one side of the binaphthyl backbone. All three P-N bond lengths are 
different: 1.716 Ǻ (P-N1), 1.741 Ǻ (P-N2) for the P-N bonds in the phosphorous heterocycle 
and 1.680 Ǻ for the exocyclic P-N3 bond. The exocyclic nitrogen displays a trigonal planar 
geometry with a sum of all angles of 359.5o around the nitrogen. Also the two nitroges 
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embedded in the heterocycle show a pronounced sp2 character: N2 with a sum of angles of 
353.9o around the nitrogen, followed by N1 with 339.9o. Also, there is a relatively large 
difference of 9o between the N1-P-C1 (114.5o) and N2-P-C2 (123.9o) angles showing that the 
phosphorous containing heterocycle is not symmetric.  
As previously stated, one reason for constructing “Feringa-analogous” PTA was to transfer 
the chiral information from the binaphthyl backbone closer to the phosphorous atom. If this 
condition would be fulfilled, the two methyl groups would point into different directions, one 
“above” the N1-P-N2 plane, and one below. In reality, however, due to the nearly planar 
nature of nitrogens N1 and N2, the two methyl groups are “forced” to reside almost in the 
plane defined by N1-P-N2.  
Interestingly, the methyl group on the N1 nitrogen is located between the two phenyl groups 
of the secondary amine part (Figure 20), which would explain the large difference in the 1H 
NMR shifts of the two methyl groups: 2.1 ppm and 3.5 ppm, respectively (Chapter 3.1.3.3.), 
assuming a similar arrangement in solution. 
 
 
 
Figure 20: Molecular structure of L1 in the solid state as revealed by single crystal X-Ray diffraction: 
front view  
P 
N1 
N2 
N3 
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Figure 21: Molecular structure of L1 in the solid state as revealed by single crystal X-Ray diffraction: 
side view 
 
The chiral secondary amine part also shows a dissymmetric arrangement. The two methyl 
groups point into the same direction and the aromatic rings are placed nearly perpendicular to 
each other.  
The solid state structure of L1 compares well to that of the Feringa ligand, as demonstrated in 
Figure 22 where the two structures are superimposed. The bond distances in the phosphorous 
heterocycle are shorter in the Feringa ligand with 1.664 Ǻ (P-O1) vs 1.716 Ǻ (P-N1).and 1.661 
Ǻ (P-O2) vs 1.742 Ǻ (P-N2) as well as the exocyclic P-N3 distance with 1.658 Ǻ vs 1.680 Ǻ. 
The two dihedral angles concerning the binaphthyl part are also slightly different with 59o for 
L1 and 52.2o for the Feringa ligand. These data indicate that the only significant steric 
difference is the presence of the methyl groups on the nitrogens (N1,N2) and a slightly 
different arrangement of the two phenyl groups of the secondary amines. Thus, the hypothesis 
was verified that it should be possible to control this position selectively in PTAs as compared 
to the corresponding phosphoramidites. 
Bond distance (Ǻ) 
P-N3 1.6801(12) 
P-N1 1.7163(13) 
P-N2 1.7416(12) 
  
Angle (o) 
N1-P-N3 109.62(6) 
N2-P-N3 99.13(6) 
N1-P-N2 97.22(6) 
  
Angle sum (o) 
N1 353.89 
N2 339.90 
N3 359.50 
P 
N3 
N1 
N2 
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Despite these relatively small differences in the geometrical arrangement, the PTA ligand L1 
shows a very distinct catalytic behaviour as compared to the Feringa phosphoramidite ligand 
(Chapter 3.2.) 
 
 
Figure 22: Superimposition of the crystal structures of the Feringa ligand (11) and L1 
 
- 11 
- L1 
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3.1.4 Modular synthesis of PTA based on the 1,2-cyclohexyl-diamine moiety 
 
3.1.4.1 Ligand synthesis via Route B 
 
As discussed in Chapter 3.1.3.2., Route B is best suited for the variation of the diamine side of 
the PTA ligands. The phosphorous-amino-dichloride precursors (R,R)-21 and (S,S)-21 have 
been reacted with a variety of (R,R)-1,2-diamino-cyclohexane derivatives via Route B 
resulting in novel cyclohexyl diamine based PTAs. The differently substituted diamines were 
prepared according to literature procedures and are depicted in Figure 19 (for references see 
Experimental part). 
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Figure 23: (R,R)-1,2-cyclohexyl-diamine derivatives for the preparation of novel PTAs via Route B 
 
Diamine 22 has been choosen because of the tosyl substituents which are both sterically 
demanding and electron withdrawing. The change to benzyl substituents (23) would result in 
ligands with very similar steric bulk on the diamine side, but different electronic properties. 
Using diamine 24 which bears allyl functionalities, PTA could be obtained for further 
modification at the terminal double bonds. Dicarbamate 25 is selected as a building block 
having small but electron withdrawing substituents and diamine 26 bearing methyl groups as 
small and electron donating substituents. 
Diamines 22 and 26 could be in one step converted into the corresponding PTA ligands. In the 
case of 26, DMAP was used for the ligand synthesis, but it turned out not to be sufficient for 
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22 (Table 2, Entry 5). Surprisingly, no clean ligand formation could be observed starting from 
23, 24, and 25: Benzyl, allyl, and carbamate substituted cyclohexyl diamines gave complex 
mixtures of phosphorous containing species (Scheme 23 and Table 2). 
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Scheme 23:  Synthesis of (R,R)-1,2-cyclohexyl diamine based PTAs via Route B  
 
This way ligands L3-L6 with a common chiral bis-(α-methyl-benzyl)-amine moiety have 
been prepared, bearing both electron donating methyl groups (L5 and L6) and electron 
withdrawing and sterically more demanding tosyl substituens (L3 and L4) on the diamine 
backbone. The air and moisture stability strongly depends on the nature of the substituents on 
the diamine moiety: Ligands L5 and L6 are oxygen and water sensitive, whereas L3 and L4 
can be handled in air (Scheme 24). 
 
Table 2: Preparation of PTAs via Route B 
Entry Ligand Diamine 21 Base Yield % 
31P NMR 
δ (ppm) 
1 L3 22 R,R BuLi 39 99.5a 
2 L4 22 S,S BuLi 45 96.6 
3 L5 26 R,R DMAP 75 114.6 
4 L6 26 S,S DMAP 83 110.5 
5 - 22 R,R DMAP - complex mixture 
6 - 23 R,R BuLi - complex mixture 
7 - 24 R,R BuLi - complex mixture 
8 - 25 R,R BuLi - complex mixture 
                              a
 Ligand L3 was also independently reported in [46] 
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Scheme 24: Synthesis of novel PTA via Route B   
 
 
3.1.4.2 Modular synthesis of cyclohexyldiamine based PTA via Route A 
 
As it has been shown, the tosyl substituent on the cyclohexyl diamine sharply increases the 
ligand stability. For this reason, this backbone was chosen for the variation of the monoamine 
side via Route A. To this aim, chloro-diaminophosphine 27 has been prepared from 22 with an 
excess of PCl3 in the presence of BuLi (DMAP was not sufficient for the reaction). After 
removal of the unreacted PCl3 and the formed LiCl, the product was obtained as white solid 
which is very sensitive towards air and moisture. Therefore, it was reacted in situ with various 
monoamines under different conditions (Scheme 25). In Figure 23 all isoltated ligands based 
on (R,R)-1,2-cyclohexyl diamine backbone are depicted. 
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Scheme 25: Modular synthesis of cyclohexyl diamine based PTAs 
 
In the case of L7-L9 the secondary amine was used in two fold excess acting also as the 
hydrochloride acceptor (Table 3, Entry 1-3). For the preparation of more expensive L10, 
DMAP was chosen as base, while nBuLi was employed for the synthesis of ligands L11-L12. 
Surprisingly, no ligand formation could be observed using dibenzylamine and DMAP as the 
base (Table 3, Entry 5). All ligands are stable towards air and moisture, they allow 
purification by filtration over a short pad of alumina and can be crystallised from 
THF/pentane.  
 
 
Table 3: (R,R)-1,2-cyclohexyl diamine based ligands prepared via Route A 
Entry Ligand Amine Base (1 eq) Yield % 
31P NMR 
δ (ppm) 
1 L7 Piperidine Piperidine 60 95.0 
2 L8 Pirrolidine Pirrolidine 61 97.1 
3 L9 Dibutylamine Dibutylamine 47 100.4 
4 L10 (R)-N-methyl-1-phenylethylamine DMAP 70 99.5 
5 --- Dibenzylamine DMAP --- --- 
6 L11 Diphenylamine BuLi 65 89.1 
7 L12 Pyrrol BuLi 72 84.8 
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Figure 23: The (R,R)-1,2-cyclohexyl-diamine based PTA ligand family 
 
 
3.1.4.3 Coordination properties of ligands based on the cyclohexyl-diamine backbone  
  
The coordination ability of the PTA was tested by generation of typical rhodium complexes 
used for catalytic purposes. Rhodium complexes of general formula trans[RhCl(CO)L2] could 
be readily prepared starting from [RhCl(CO)2]2 and the ligands L7-L9 and L12 in 
dichloromethane. The chemical shifts and rhodium-phosphorous coupling constants are 
summarised in Table 4. Also, CO stretching frequencies have been determined for two 
complexes bearing electronically different monoamine parts. As discussed in Chapter 2.1.3, 
PTAs consisting of structurally similar, but electronically different monoamines (pyrrolidine 
vs pyrrol) show different basicity of the phosphorous atom. The basicity of tris-pyrrolidino 
phosphine is comparable to that of common trialkylphosphines35 (ν(CO)=1952 cm-1); whereas 
tris-pyrrolo phosphine possesses strong π-acidic properties, comparable with those of 
phosphites (ν(CO)=2024 cm-1).36 Therefore we have selected ligands L8 and L12 both 
containing the same diamine backbone, but pyrrolidine and pyrrol as monoamine counterparts 
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and compared the CO stretching values for the prepared Rh complexes. Interestingly, there is 
practically no difference in the π-acidity of the both ligands. The CO stretching values of 
2021 cm-1 (Table 4, Entry 1) and 2018 cm-1 (Table 4, Entry 4) are very similar to the one 
obtained with the achiral tris(pyrrolo)phosphine and compare to those obtained with 
phosphites. This means that in this particular case, changing the electronic properties on the 
monoamine part of the structure doesn’t have a significant influence on the π-acidity of the 
ligand.The reason for this observation might be that the diamine backbone itself is strongly 
electron withdrawing and dominates the electronic structure. 
 
Table 4: NMR and IR data of trans[RhCl(CO)L2] for different PTAs 
Entry Ligand 
Free ligand 
31 P NMR δ (ppm) 
trans[RhCl(CO)L2] 
31 P NMR δ (ppm) 
JRh-P 
(Hz) 
ν(CO) 
(cm-1) 
1 L7 95.0 110.1 225.5 2021 
2 L8 97.1 115.5  230.1 n.d. 
3 L9 100.4 117.1 237.5 n.d. 
4 L12 84.8 97.7 210.4 2018 
 
Interestingly, no Rh complex formation could be observed with L4. Further investigation of 
the coordination abilities of L4 showed that the ligand appears to be generally inert towards a 
number of usual metal precursors (Scheme 26). Similarly to the reaction with [RhCl(CO)2]2, 
the coordination of L4 with [Rh(COD)2]BF4 , [Rh(acac)(CO)2] and [Rh(norbornadiene)acac] 
failed. Furthermore, [(Cp)Pd(allyl)] and [Ni(allyl)Cl]2 were tested for a possible coordination, 
however in each case only the free ligand signal could be detected in 31P NMR.  
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Scheme 26: Attempts for complex formation with L4 
 
 
3.1.4.4 Crystal structure analysis of L4  
 
As the crystal structure of ligand L4 reveals (Figure 24 and 25) the unusual coordination 
inability of this ligand could be explained mostly by steric reasons. In all possible 
conformations, either a methyl group or a phenyl group will point in the space where the lone 
pair resides. This may hinder coordination.  
All three angles around the phosphorous are different: a rather small value of 86.0 for N1-P-
N2 can be measured for the phosphorous heterocycle, followed by 99.46 for N2-P-N3 and 
109.46 for N1-P-N3. Two of the nitrogens are nearly planar: the exocyclic N3 with an angle 
sum of 359.7 o around the nitrogen, followed by N1 with 354.9 o and N2 with 348.3 o. The 
exocyclic P-N3 bond is considerably shorter (1.664 Å) than the two P-N bonds which are part 
of the heterocyclic ring (1.766 Å for P-N2 and 1.778 Å for P-N1). 
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Figure 24: Molecular structure of L4 in the solid state as revealed by single crystal X-Ray diffraction: 
side view 
 
 
Figure 25: Molecular structure of L4 in the solid state as revealed by single crystal X-Ray diffraction: 
“lone pair” view 
Bond distance (Ǻ) 
P-N3 1.6642(17) 
P-N1 1.7779(18) 
P-N2 1.7661(18) 
    
Angle (o) 
N1-P-N3 109.49(9) 
N2-P-N3 99.46(8) 
N1-P-N2 86.00(8) 
    
Angle sum (o) 
N1 354.90 
N2 348.27 
N3 359.67 
P 
N1 
N2 
N3 
P 
N3 
N2 
N1 
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The two tosyl groups point in the same direction and are nearly perpendicular to the plane 
defined by the cyclohexyl ring and are close to each other (3.94 Å).  
Considering a plane, which passes through the P-N3 axis and the centre of the cyclohexyl ring, 
two basic features can be pointed out. First, such a plane would be roughly an element of 
symmetry for the “upper part” of the molecule, which basically means that the possible C2 
symmetry of the diamine backbone is broken. Secondly, both phenyl groups of the chiral 
secondary amine moiety reside on the same side of this plane, indicating a dissymmetric 
arrangement of the “lower part”of the molecule, similarly to that observed in the structure of 
L1 (Chapter 3.1.3.4).  
 
3.1.4.5 Crystal structure analysis of L9 
 
The crystal structure of L9 shows that the monoamine side is less “crowded” than in the case 
of L4 (Figure 26 and 27): There is no branching at the carbon next to phosphorous. Thus, the 
alkyl chains can turn away from the lone pair direction and allow for coordination. Similarly 
to the crystal structure of L4, the N1-P-N2 angle is the smallest with 86.63 o, followed by N1-
P-N3 (107.71o) and N2-P-N3 (102.19o). The exocyclic P-N3 bond is the shortest with 1.649 Ǻ. 
The two P-N bonds in the heterocycle are almost similar to each other but considerably longer 
(P-N1: 1.758 Ǻ; P-N2: 1.771 Ǻ). In contrast to L4, N1 which is part of the phosphorous 
heterocycle is the closest to the trigonal planar geometry, with an angle sum of 359.8 o around 
the nitrogen, followed by the exocyclic N3 with 357.8 o and N2 with 351.3 o. 
One of the considerations for the introduction of sterically demanding tosyl groups on the 
diamine backbone was to elucidate a possible transfer of chiral information coming from the 
cyclohexyl-diamine backbone closer to the central atom. In the crystal structure of L9 we can 
see that the two tosyl groups point into the same direction (Figure 26), as discussed in the 
case of the crystal structure of L4. Thus, these structural elements would not generate a chiral 
array around a metal center upon coordination at the phosphorous lone pair. 
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Figure 26: Molecular structure of L9 in the solid state as revealed by single crystal X-Ray diffraction: 
“lone pair” view 
Bond distance (Ǻ) 
P-N3 1.649(2) 
P-N1 1.758(2) 
P-N2 1.771(2) 
  
Angle (o) 
N1-P-N3 107.71 
N2-P-N3 102.19 
N1-P-N2 86.63 
    
Angle sum (o) 
N1 359.8 
N2 351.3 
N3 357.8 
P 
N1 N2 
N3 
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Figure 27: Molecular structure of L9 in the solid state as revealed by single crystal X-Ray diffraction: 
side view 
 
The preferred conformation of L9 in solution is likely to be similar to that in the solid state as 
derived on the basis of NOESY NMR measurements. The aromatic as well as aliphatic 
protons of the two tosyl substituents have different chemical shifts, already indicating a non-
C2 symmetric structure. As it is shown in Figure 28, two aromatic signals at 6.78 ppm (A1) 
and 7.76 ppm (A2) respectively belong to the tosyl ring A and two at 6.96 ppm (B1) and 8.03 
ppm (B2) to tosyl ring B. Signals A1 and B1 as well as A2 and B2 show NOESY correlations 
with each other indicating that the two tosyl rings are near to each other which is only 
possible, when the conformation in solution is similar to that observed in the solid state. 
A similar behaviour of tosyl-cyclohexyl diamines has been reported by Heumann at. al. who 
describe that in non-racemic (R,R)-dialkyl-1,2-diaminocyclohexane palladium dichloride 
complexes ligand does not adapt a C2-symmetric conformation.116  
P 
N3 
N1 
N2 
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Figure 28: NOESY NMR spectrum of L9 in CDCl3 
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3.1.5. Modular synthesis of novel (S)-N-phenyl-2-aminomethyl-pyrrolidine 
based PTA 
 
3.1.5.1 Ligand synthesis via Route B 
Commercially available (S)-N-phenyl-2-aminomethyl-pyrrolidine (28) easily reacts with the 
diamino-phosphorous-dichloride (R,R)-21 in the presence of 2 equivalents of DMAP at room 
temperature resulting in a mixture of two diastereomeric ligands (M1) with opposite absolute 
configuration on the phosphorous. The diastereomeric mixture M1 consists of ligands L13a 
and L13b in a ratio of 1 : 1.1 (Scheme 27). 
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Scheme 27: Synthesis of diastereomeric mixture M1 via Route B  
 
Applying aminophosphorous-dichloride (S,S)-21 for the synthesis, the diastereomeric mixture 
M2 was obtained, which contains ligands L14a and L14b in the ratio of 1 : 3 (Scheme 28). 
(Table 5) 
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Scheme 28: Synthesis of diastereomeric mixture M2 via Route B  
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Table 5: Chemical shifts and compositon of the diastereomeric mixtures M1 and M2 
Diastereomeric 
mixture 
Composition  Ligand configurationa 31P NMR 
δ (ppm) 
Ratio Yield 
(%) 
M1 L13a : L13b S,R,R,SP : S,R,R,RP 105.8 : 90.2 1:1.1 93 
M2 L14a : L14b S,S,S,SP : S,S,S,RP 108.0 : 86.5 1:3 95 
a
 The configuration of the ligands is given as follows: 1. Configuration of the pyrrolidine carbon, 2. 
and 3. configuration of the carbons on the chiral secondary amine part, 4. configuration at the 
phosphorous.  
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Figure 29: 31P NMR spectra of diastereomeric mixtures M1 and M2  
 
The absolute configurations at the phosphorous were assigned first on the basis of the 
characteristic coupling constants between the phosphorous and C1 pyrrolidin carbon (Figure 
30) and confirmed by crystal structure analysis as described below in Chapter 3.1.5.2. 
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There is a correlation between the 2JC-P values and the dihedral angle between the 
phosphorous lone pair and the C1 pyrrolidine carbon. If they are oriented syn to each other, the 
coupling constant value corresponds to ~40 Hz. In the anti case it is close to zero.48,117  
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Figure 30: Syn and anti diastereomers of ligand L13  
 
3.1.5.2 Separation of the diastereomers via borane complex formation 
Despite several attempts, it was not possible to separate the diastereomeric ligands L13a 
(S,R,R,SP) and L13b (S,R,R,RP) contained in the M1 mixture by column chromatography. 
However, upon conversion of the oily materials into their solid borane adducts, we succeeded 
to selectively crystallise the L13a.BH3 diastereomer. The free L13a was liberated with an 
excess of diethylamine at room temperature (Scheme 29).  
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Scheme 29: Separation of diastereomers via crystallisation of borane adducts 
 
3.1.5.3 Crystal structure analysis of L13a.BH3  
Crystals suitable for X-ray analysis were obtained by slow diffusion of pentane into a CDCl3 
solution of the pure S,R,R,Sp·BH3 diastereomer and the absolute configuration at the 
phosphorous was confirmed as S. 
The nitrogen atoms N1 and N2 are almost planar (angle sum around the nitrogen: 358.1 o and 
356 o respectively), indicating low basicity and delocalisation of the electrons on the 
nitrogens, whereas N3 embedded in the pyrrolidine ring is slightly pyramidal (S-configuration, 
angle sum 349.9°). The P-N bond lengths P,N1 and P,N3 are identical within experimental 
error and P,N2 is slightly bigger (1.653 Ǻ, 1.658 Ǻ, 1.695 Ǻ, respectively). The angle N2-P-N3 
belonging to the heterocycle is the smallest with 92.8 o, the other two show very similar 
values: 110.4 o for N1-P-N2 and 111.6 o for N1-P-N3. 
The secondary amine part has a similar arrangement to the one observed in L1 (Chapter 
3.1.3.4) and L3 (Chapter 3.1.4.4): the two methyl groups of the α-benzylamine moieties point 
in the same direction. Moreover, one phenyl group of the α-benzylamine moiety and the 
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phenyl group of the diazaphospholidine part are close enough (~4 A) to each other for a 
possible extended π-π interaction (Figure 28).118 
 
  
Figure 31: Molecular structure of L13a·BH3 in the solid state as revealed by single crystal X-Ray 
diffraction 
 
Figure 32: Molecular structure of L13a·BH3 in the solid state as revealed 
by single crystal X-Ray diffraction: side view 
 
 
Bond distance (Ǻ) 
P-B 1.910(6) 
P-N1 1.653(4) 
P-N2 1.695(4) 
P-N3 1.658(4) 
Angle (o) 
N1-P-N3 111.6(2) 
N1-P-N2 110.43(18) 
N2-P-N3 92.8(2) 
  
Angle sum (o) 
N1 358.1  
N2 356.0  
N3 349.9 
P 
B 
N1 
N2 
N3 
P 
B 
N1 
N2 
N3 
4.53 Ǻ
 
3.38 Ǻ
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3.1.5.4 Separation of the diastereomers via Rhodium complex formation 
Another possibility for the separation of diasteromeric ligands relies on their competitive 
complexation with a suitable metal precursor. If one diastereomer selectively reacts with an 
appropriate metal precursor, the solubility difference between the “free” diastereomer and the 
“complexed” one should allow for an easy separation. This strategy was successfully applied 
for M1 (containing ligands L13a and L13b) using [Rh(COD)2]BF4. The reaction of M1 with 
0.26 eq metal precursor (corresponds to a ratio of 2:1 forL13b: Rh) in dichloromethane, led to 
Rh complex formation exclusively with the S,R,R,Rp diastereomer (L13b), which could be 
precipitated with pentane. After filtration, the pure S,R,R,Sp diastereomer (L13a) was 
quantitatively recovered from the pentane phase (Scheme 28). 
 
5060708090100110120130140
102030405060708090100110120130140150160
-100102030405060708090100110120130140150160170
[Rh(COD)2]BF4 + 2 (L13a + L13b) 2 L13a[Rh(COD)(L13b)2]BF4 +
[Rh(COD)(L13b)2]BF4
L13a
L13a
L13b
 
Scheme 30: Separation of the diastereomeric ligands L13a and L13b contained in M1 via Rhodium 
complex formation 
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3.1.5.5 Ligand synthesis via Route B and determination of the optical purity of diamines 
 (S)-N-phenyl-2-aminomethyl-pyrrolidine (28) is commercially available, but quite expensive. 
Alternatively, it can be obtained by methods described in the literature.30 The reported 
synthesis starts from L-glutamic acid (29) which is reacted with an excess of aniline at reflux 
temperature to give lactam 30. Then, this compound is reduced to the desired product 28 with 
LiAlH4 (Scheme 31). 
HO OH
O O
NH2
NH2
N
H
* NH
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*
NH
86%
29 30 28
45%
 
Scheme 31: Synthesis of (S)-N-phenyl-2-aminomethyl-pyrrolidine (28) starting from glutamic acid 
(29) 
 
When the product obtained following the described procedure is reacted with (R,R)-21, two 
additional signals at 109 ppm and 86 ppm appear besides the confirmed ligand signals (106 
ppm: L13a (S,R,R,Sp) and 90 ppm: L13b (S,R,R,Rp)) (Figure 30).These smaller peaks could 
be attributed to two other diastereomers of the ligand: R,R,R,Sp and R,R,R,Rp, formed from 
the R configurated amine impurity. This is in agreement with the fact that the reaction of the 
optically pure, commercially available diamine with (S,S)-21 affords two diastereomers at 109 
(L14a S,S,S,Sp) and 86 ppm (L14b S,S,S,Rp) having identical chemical shifts as the two 
diastereomeric impurities, as these compounds are enantiomers to each other (Figure 29).  
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Figure 33: Diastereomers L14a and L14b contained in mixture M2 and their corresponding 
enantiomers 
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Figure 34: Determination of the optical purity of diamine 28 via ligand formation 
 
We supposed that the racemisation in the amine is most likely to occur in the first step of the 
synthesis, where an excess of aniline and high temperatures are used (190 oC). Thus, the 
synthesis of 30 was carried out again reducing the amount of aniline to 1 equivalent and 
decreasing the temperature to 160 oC (Table 6, Entry 2). The reduction of 30 to 28 was then 
performed the same way as described in the literature. To prove the optical purity of this new 
batch of 28, it has been reacted again with precursor (R,R)-21 resulting in only two desired 
ligand signals at 106 and 90 ppm. The optimised synthetic procedure can be upscaled for 40 g 
starting material, in this case, however, 2 equivalents of aniline should be used (Table 6, Entry 
4). 
 73 
Table 6: Experimental conditions for the preparation of 28 
29 
g 
Aniline 
eq 
T 
oC 
Diastereomeric purity 
10 10 190 90 % 
10 1 160 >99% 
40 2 160 >99% 
 
With this information in hand, the ligand synthesis procedure itself becomes a method for the 
determination of the optical purity of diamine 28, which can be quantified by integration of 
the phosphorous signals (optical purity = (R,R,R,Rp+ R,R,R,Sp)/( S,R,R,Rp + S,R,R,Sp) ). 
In a more general view, compounds (R,R)-21 and (S,S)-21 could be used as derivatising 
agents for the determaination of the optical purity of diamines, diols or aminoalcohols. This 
would be a complementary method to those developed by Feringa and Kee (Chapter 2.1.2) for 
the determination of the optical purity of monoamines, alcohols and thiols.31,32,33  
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Scheme 32: Methods for the determination of the optical purity of chiral protic compounds  
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3.1.5.6 Ligand synthesis via Route A 
 
Route A was selected as the method of choice for the generation of ligands with different 
monoamine components. Compound 31 was synthesised following literature procedures, 
which claimed that the reaction of 28 with PCl3 would proceed with complete 
stereoselection.48  
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NH PCl3
NEt3 N
N
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28 31
 
Scheme 33: Preparation of 31 as described in the literature 
 
In our hands, however, the desired phosphorous-diamino-chloride was repeatedly obtained as 
a mixture of two diastereomers in a ratio of 3.5:1 as indicated by 31P NMR (δ 153.9 ppm and 
146.2 ppm). Moreover, compound 31 gave rise to broad signals both in 1H and 13C NMR. 
Since the racemisation of the starting enantiomerically pure 28 under the reaction conditions 
can be excluded, the two diastereomers should be epimers at the phosphorous. Thus, a 
detailed NMR study was carried out to prove whether an equilibrium between these two 
diastereomers is present. 
 
 
3.1.5.7 Epimerisation of the diamino-phosphorous chloride 29 
 
The EXSY NMR measurement clearly shows that the two epimers with chemical shifts at 
153.9 ppm and 146.2 ppm are in equilibrium with each other (Figure 35). We have assigned 
the conformation of 31a, belonging to the signal with chemical shift at 153.9 ppm, as anti 
(absolute configuration RP) and the conformation of 31b as syn (absolute configuration SP) 
based on 13 C NMR measurement (see Experimental). The rate of exchange was also 
determined by EXSY-NMR measurements carried out with different mixing times, followed 
by calculation. (k1 = 44.0 s-1; k2 = 13.8 s-1)  
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Scheme 34: Equilibrium between the two epimers of 31 
 
 
Figure 35: EXSY NMR spectrum of 31 
 
Various temperature NMR measurements were also carried out from -30 oC till 40 oC in 
CDCl3 (Figure 36). By decreasing temperatures the signals become sharper, while with 
increasing temperatures broadening of the peaks can be observed. The coalescence 
temperature could not be reached even at 70 oC in deuterated toluene. 
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Figure 36: VT NMR spectra of 31 in CDCl3 from -40 oC to 40 oC 
 
 
The fact, that the peaks are broader in polar solvents at the same temperature suggests an SN1 
process for the exchange. 119  
It has been also observed that the addition of triethylamine leads to coalescence of the two 
signals at room temperature indicating that the presence of base accelerates the epimerisation 
process (Figure 37). The explanation for the discrepancy of our results with the claims in the 
literature 44 could be that in the literature study triethylamine, which is used for the reaction, 
remained in the final product after purification. In this case, only one broad signal would be 
observed. Indeed, the 31P NMR shift described in reference 44 for 31 (153.6 ppm) 
corresponds to the chemical shift on Figure 37 measured after addition of 0.5 ml 
triethylamine.  
Thus one can conclude that ligand 31 exists as a mixture of diastereomers resulting from the 
chirality at the phosphorous donor atom. At room temperature, the two diastereomers 
interconvert in a process that is slow on the 31P NMR timescale in non polar solvents. The 
addition of free amine sharply accelerates the exchange process. 
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Figure 37: Room temperature 31 P NMR spectra of 31 after addition of triethylamine 
 
 
3.1.5.8 Modular ligand synthesis via Route A 
 
The reaction of 31 with a range of secondary amines affords ligands L13a-L23 (Table 7, 
Entry 1-11), with high diastereomeric purity in favour of the syn epimers, suggesting that a 
dynamic kinetic resolution takes place (Scheme 35). It is interesting to note, that in all cases, 
predominantly the syn diastereomer of the ligands is formed while the major epimer of the 
starting phosphorous chloride precursor (31a) has anti configuration. Ligands L13a-L23 
show sharp signals in 1H, 13C and 31P NMR spectra and no epimerisation could be observed, 
as an indication of a configurationally rigid phosphorous in the PTA ligands. 1 
An excess of the secondary amine was used for the preparation of ligands L15-L19 acting 
both as building block and hydrochloride acceptor (Table 7, Entry 3-7). Alternative bases 
were used for less basic or more expensive amines: DMAP was chosen as the hydrochloride 
acceptor for the synthesis of ligands L20-L21 (Table 7, Entry 8-9) whereas deprotonation of 
the corresponding amines with nBuLi was employed for the synthesis of ligands L13-L14 and 
L22-L23 (Table 7, Entry 1-2 and Entry 10-11).  
 
                                                 
1
 The conformation syn and anti is defined based on the relative positions of the phosphorous lone pair and the 
carbon neighbouring with the nitrogen in the pyrrolidine ring. If they are oriented syn to each other, the 2JC-P 
value corresponds to ~40 Hz. In the anti case it is nearly zero. This way the absolute configuration of the 
phosphorous atom can be determined by 13C NMR spectroscopy. We prefer to use the terms syn and anti instead 
of R and S, as the stereochemical desriptors for the chirality at the phosphorous can be inverted (Cahn-Ingold-
Prelog rules) although the spatial arrangement around the phosphorous remains the same. 
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Scheme 35: Modular ligand synthesis via Route A  
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Figure 38: PTA ligand library based on the (S)-N-phenyl-2-aminomethyl-pyrrolidine backbone 
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All ligands were purified by filtration over a short pad of alumina. This purification method 
allows for the removal of the hydrochloride by-product and of starting amine if present in 
one-step.  
 
Table 7 Diastereomeric purity of (S)-N phenyl-2-aminomethyl-pyrrolidine based PTA  
Entry R2NH Base (1 eq) Ligand d.r syn:anti 
31P NMR 
δ (ppm) 
Config. 
syn 
1 (R,R)-bis(α-methyl benzyl)-amine BuLi L13a 20:1 105.8 : 90.2 S,R,R,SP
a
 
2 (S,S)-bis(α-methyl benzyl)-amine BuLi L14a 15:1 109.0 : 86.5 S,S,S,SP 
3 Piperidine Piperidine L15b 45 : 1 114.7 : 95.7 S,RP 
4 Pyrrolidine Pyrrolidine L16 80:1 107.3 : 91.7 S,RP 
5 Morpholine Morpholine L17 90:1 114.5 : 95.0 S,RP 
6 Diisopropylamine Diisopropylamine L18 - 107.0 S,SPa 
7 Dibutylamine Dibutylamine L19 47:1 118.2 : 97.6 S,RP 
8 [R]-(-)(α-methyl benzyl)-amine DMAP L20 115:1 118.5 : 97.8 S,R,RP
a
 
9 Dibenzylamine DMAP L21 68:1 118.8 : 96.6 S,RP 
10 Diphenylamine BuLi L22 100:1 103.2 : 90.6 S,RP 
11 Pyrrol BuLi L23 15:1 100.8 : 89.1 S,RP 
a
 absolute configuration on the phosphorous determined by crystal structure measurement 
b Ligand L15 was independently reported in [48] 
 
In contrast to Route B where using phosphorous dichloride intermediates (S,S)-21 and (R,R)-
21 resulted in diasteromeric mixtures with significant amounts of anti epimers (Page 62, 
Table 5), these were barely detectable when applying Route A (Table 7, Entry 1 and 2). This 
represents an example of the non-equivalence of the two synthetic routes and shows, that it is 
possible to control the diastereomeric ratio of the final product by choosing the right synthetic 
way (Route A vs Route B). 
Geometry optimisations by DFT methods at the B3LYP/6-31G(d) level for syn (RP) and anti 
(SP) diastereomers of ligands L16 support the almost exclusive formation of the syn 
diastereomers. The calculated energy difference between the two diastereomers results in 3.42 
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kcal/mol in favour of the syn diastereomer (Figure 39). In all the ligands prepared through 
Route A the syn-diastereomers were preferred.   
 
Figure 39: Calculated structures of Sp (syn) and Rp (anti)diastereomers of L16  
 
 
3.1.5.9. Crystal structure analysis of ligands L18 and L20 
 
Based on single crystal structure analysis, the absolute configurations at phosphorous were 
assigned as SP for L18 and RP for L20. It is important to note that the stereochemical 
desriptors for the chirality at the phosphorous are inverted (Cahn-Ingold-Prelog rules) 
although the spatial arrangement (syn) around the phosphorous remains the same. 
The exo-cyclic P-N1-bonds was found to be considerably shorter than the P-N bonds within 
the phosphorous heterocycle: 1.678 for L18 and 1.671 for L20, followed by the P-N3 bonds 
with 1.711 Ǻ for L18 and 1.708 for L20. Finally, the P-N2 bonds are the longest with 1.738 Ǻ 
and 1.739 Ǻ for L18 and L20 respectively. In both structures, the nitrogen atoms N1 and N2 
are almost planar (angle sum around the nitrogen: 358.1 o and 356 o), indicating low basicity 
and delocalisation of the electrons on the nitrogens. The nitrogens N3 embedded in the 
pyrrolidine ring are slightly pyramidal (S-configuration, sum of all angles 349.9° for L18 and 
341.24 o for L20). Principal bond lengths and angles for L18 and L20 are in close accordance 
with the corresponding data found in the crystal structure of L13.BH3 (Chapter 3.1.5.3).  
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Figure 40: Molecular structure of L18 in the solid state  
as revealed by single crystal X-Ray diffraction 
 
 
 
 
 
Figure 41: Molecular structure of L20 in the solid state as revealed by single crystal X-Ray diffraction 
  
Bond distance (Ǻ) 
P-N1 1.678 
P-N3 1.711 
P-N2 1.738 
  
Angle (o) 
N1-P-N3 108.87 
N1-P-N2 100.59 
N2-P-N3 90.97 
  
Angle sum (o) 
N2 359.21 
N3 340.46 
N1 359.17 
Bond distance (Ǻ) 
P-N1 1.671 
P-N3 1.708 
P-N2 1.739 
    
Angle (o) 
N1-P-N3 106.44 
N1-P-N2 103.57 
N2-P-N3 89.84 
  
Angle sum (o) 
N2 355.17 
N3 341.24 
N1 359.26 
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N3 
N2 
N3 
N2 
N1 P 
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3.2. Asymmetric catalysis with novel PTAs 
 
In this chapter, the application of the newly synthesised PTAs in the asymmetric catalysis is 
presented. Reactions have been selected where monodentate phosphorous ligands and 
especially phosphoramidites were already successfully used. After exploring different PTA 
structures in the asymmetric Rh-catalysed hydrogenation of dimethyl itaconate with little 
success (Chapter 3.2.1), we focused on the copper catalysed Michael addition of diethyl zink 
to cyclohexenone as suitable benchmark reaction (Chapter 3.2.2). Finally, selected PTAs were 
successfully applied in the Ni-catalysed hydrovinylation of styrene (Chapter 3.2.3) yielding 
promising selectivities and activities. When appropriate, relevant results obtained with PTAs 
will be compared with the results achieved with the analogous phosphoramidites in the 
following sections. 
 
3.2.1 Asymmetric hydrogenation  
 
As discussed in the introduction, monodentate phosphorous ligands, both with chirality in the 
backbone and on the phosphorous have been successfully applied in the Rh-catalysed 
asymmetric hydrogenation of unsaturated amino acids and standard substrates like dimethyl-
itaconate.120 Therefore, hydrogenation of dimethyl-itaconate has been carried out as a first test 
reaction with some of the novel phosphorous triamides with different structural features 
(Scheme 36). 
 
MeOOC COOMe MeOOC COOMe
*
H2, CH2Cl2
[Rh] / 2 eq. PTA
32 33
 
  
Scheme 36: Rhodium catalysed asymmetric hydrogenation of dimethyl itaconate 
 
All reactions were performed at room temperature in dichloromethane for 18 h under an 
initial H2 pressure of 30 bar using in situ catalysis with a ligand:[Rh] ratio of 2:1 and a 
substrate to [Rh] ratio of 100:1.121 Two different Rh precursors have been used for the in situ 
generation of the cationic Rh complexes. While the 2-aminomethyl-pyrrolidine based PTAs 
reacted smoothly with [Rh(COD)2]BF4 , for the cyclohexyldiamine based PTAs, L3 and L7 a 
different precursor has been choosen. In this case, the desired [Rh(COD)L2]BF4 complexes 
were prepared by reaction of [Rh(COD)solv2]BF4 obtained by protonation of [Rh(COD)acac] 
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with HBF4.The formation of the Rh-complexes was confirmed by 31P NMR measurement 
with the observation of a downfield coordination shift (~10 ppm) accompanied by the 
appearance of 31P-103Rh coupling.(~200 Hz) The hydrogenation results are depicted in Figure 
42. Only low activities and very poor enantioselectivities could be obtained almost with all 
the tested ligands.  
 
Figure 42.  Asymmetric hydrogenation of dimethyl itaconate with various PTAs 
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The enantioseletivities remained below 5% with all ligands based on the 2-aminomethyl-
pyrrolidine backbone with the only exception of the diastereomeric mixture M2 (containing 
ligands L14a and L14b), which led to a moderate enantioselectivity of 28%. In contrast, M1 
did not provide the same level of enantioselectivity. Low conversions and almost racemic 
products were obtained with L15, L16 and L18. Also, the cyclohexyl diamine based PTA 
(L5) gave only 10 % conversion and very low enantioselectivity. In contrast, full conversion 
of 32 and 10% enantioselectivity was obtained with ligand L7, bearing tosyl substituents 
instead of methyls, representing the most successful PTA structure in terms of conversion, 
among the tested ligands. 
The reason for the poor performance of PTAs in the asymmetric hydrogenation is yet 
unknown and in agreement with the findings of Reetz and Oka.45 They observed no 
0
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conversion in the hydrogenation of dimethyl-itaconate using a PTA based on the binaphthyl-
diamine backbone. 
 
3.2.2 Copper catalysed Michael addition 
 
Next, we focused our attention on the Cu-catalysed conjugate addition of diethyl-zink to 
cyclohexenone (Scheme 37). 
 
O
[Cu] / 2 eq Ligand
O
+ ZnEt2 *
34 35
 
 
Scheme 37: Michael addition of diethyl-zink to cyclehexenone 
 
 
The QUIPHOS ligand (See Chapter 2.1.1, Figure 3.), which is structurally the most similar 
ligand to our pyrrolidine backbone based PTA (L13-L23), was tested using different Cu 
sources and solvents by Buono.122 CuI showed to be the best precursor giving 22% ee in 
toluene and 53% ee in dichloromethane within 12 h. The effect of water and Zn(OH)2 as 
additive was also investigated. The best enantioselectivity of 63% was achieved with ZnOH 
as additive at 80% conversion. Furthermore, as already discussed in Chapter 2.2., the Feringa 
ligand gave excellent enantioselectivities up to 98% ee.123 In the course of our investigations, 
the group of Gennari applied electron poor PTAs in this benchmark reaction. Most of the 
PTAs performed poorly with the notable exception of the bis-mesylated-binaphthyl-dimethyl 
PTA, which led to an ee of 78%.46 
 
 
3.2.2.1. Ligands based on the binaphthyl-diamine backbone 
 
The outcome of the Cu-catalysed Michael addition is very much dependent on the copper 
source, type of solvent and temperature.124 L1 was first tested at -20 oC in toluene, using 
different copper sources. The results are summarized in Table 8. High conversion and low 
enantioselectivity of 28% was obtained using [(CuOTf)2·C6H6] as Cu-precursor (Entry 1). The 
same level of enantioselectivity was achieved with [Cu(CH3CN)4][PF6] but a dramatic drop of 
activity was observed (Entry 2). [Cu(OTf)2] turned out to be the best copper source resulting 
in 53% enantioselectivity albeit with moderate conversion after 1 h reaction time (Entry 3). 
Hence, all following experiments were conducted using [Cu(OTf)2] as the Cu source. Under 
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the same condition as in Entry 3 but using LiCl as an additive, the conversion could be 
slightly improved at the expenses of the enantioselectivity (Entry 4). In contrast, full 
conversion and an enantioselectivity of 55% was achieved by prolonging the reaction time to 
5 h (Entry 5). Full conversion of 34 was also obtained within 1 h by raising the reaction 
temperature to 0  C with slightly lower enantioselectivity (Entry 6). 
 
Table 8. Cu-catalysed addition of ZnEt2 to cyclohexenone with binaphthyl-diamine based PTAs.a 
a
 Reaction conditions: toluene, substrate = 0.1mmol, [Cu] 5 mol%, ligand 10 mol%. 
Reaction conditions: 0.003 mmol [Cu], 0.005 mmol ligand, 0.1 mmol substrate 
b
 LiCl as an additive 
 
Interestingly, ligand L2 afforded 35 quantitatively with almost identical enantioselectivity as 
the diastereomeric ligand L1 although with opposite absolute configuration (Entry 7). This 
result indicates that the enantioinduction is dominated by the monoamine moiety of the ligand 
and matching/mismatching effects between the central and the axial chirality appear to be 
negligible. Again, full conversion within one hour could be achieved in the presence of L2 
carrying out the reaction at 0   C with only small decrease of the enantioselectivity (Entry 8). 
The results achieved with L1 and L2 are inferior to those obtained with the analogous 
phosphoramidite (Feringa ligand), but are in line with those reported by Gennari with the bis-
mesylated-binaphthyl diamine based phosphorous triamides. 
 
Entry Ligand Precursor 
T 
[°C] 
t [h] 
Conv. 
[%] 
ee [%] 
1 
  
(CuOTf)2·C6H6 -20 1 90 28 (S) 
2  [Cu(CH3CN)4][PF6] -20 1 5 32 (S) 
3 [Cu(OTf)2] -20 1 60 54 (S) 
4b 
L1 
[Cu(OTf)2] -20 1 70 26 (S) 
5 
N
N
Me
Me
P N
Ph
Ph
 
 [Cu(OTf)2] -20 5 >99 55 (S) 
6   [Cu(OTf)2] 0 1 >99 49 (S) 
 
7 
 
[Cu(OTf)2] 
 
-20 
 
5 
 
>99 
 
53 (R) 
8 
N
N
Me
Me
P N
Ph
Ph
L2 
[Cu(OTf)2] 0 1 >99 50 (R) 
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3.2.2.2 Ligands based on the cyclohexyl diamine backbone 
 
This class of PTA was tested under the optimised conditions used for L1 and L2 (toluene, 
-20 o C and 5 h) as well as at lower temperature (-35 oC) combined with longer reaction time 
(12 h). The results are summarised in Table 9. Almost in all cases, full conversion could be 
attained within 5 hours. Ligand L5 bearing sterically less demanding methyl groups on the 
cyclohexyl moiety and sterically demanding chiral secondary amines on the monoamine site 
gave full conversion and the highest enantioselectivity (ee 50%) for this class of PTAs (Entry 
1). Ligand L6 with inverted chirality at the monoamine moiety resulted in a reduced 
enantioselectivity of 35% ee (Entry 2). A difference can be pointed out between the 
diastereomeric pairs L1/L2 and L5/L6: ligands L1/L2 led to the same absolute level of 
enantioselectivity with opposite product chirality while L5/L6 afforded both preferentially S-
35 although with different enantiopurity. Hence, for L1/L2 the chiral monoamine appears to 
be largely responsible for the enantioselectivity, whereas for the pair L5/L6 the chiral diamine 
part of the ligand seems to exert the enantiocontrol. Ligands L3 and L4, structurally related to 
L5 and L6 but bearing electron withdrawing and more bulky tosyl groups instead of methyl 
on the diamine backbone, led to almost racemic products (Entry 3 and Entry 4). This can be 
explained due to the above discussed difficulties of compounds L3 and L4 to coordinate to 
metals (Chapter 3.1.4.3). L7 containing an achiral piperidine as monoamine results in 24% 
enantioselectivity towards the R enantiomer of 35 (Entry 5). Noteworthy, a minor change in 
the PTA structure resulted in fairly different catalytic results. Exchanging the piperidin moiety 
with the sterically and electronically similar pyrrolidine (L8) the enantioselectivity decreases 
nearly to the half (Entry 6). The introduction of n-butyl substituents (L9) resulted in a 
strongly increased enantioselectivity of 49% (Entry 7). This last result is among the best of 
our tested PTAs based on the cyclohexyl diamine backbone and outperforms the similar PTAs 
prepared by Gennari (max 16% ee reported for this backbone).46 Both ligands L11 and L12 
containing diphenylamine and pyrrol as monoamines resulted in poor enantioseletivities 
(Entries 8 and 9). The enantioselectivity was slightly higher in the case of L10 bearing R-α-
methyl-benzylamine as the monoamine giving 16 % ee (Entry 10).No improvement of the 
enantioselectivity was observed carrying out the catalytic reactions at lower temperature 
(Entries 2-9). Also doubling the catalyst loading as well as using a ligand to [Cu] ratio of four 
for L7 did not have a beneficial effect on the enantioselectivity of the reaction. 
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Table 9: Cu-catalysed addition of ZnEt2 to cyclohexenone with cyclohexyl-diamine based PTAs.a 
Entry Ligand Conv. [%] ee [%] Conv. [%] ee [%] 
   T = -20 °C; t = 5 h T = -35 °C t = 12 h 
1 
N
N
Me
Me
P N
Ph
Ph
 
L5 99 50 (S) n.d - 
2 
N
N
Me
Me
P N
Ph
Ph
 
L6 99 35 (S) 99 35 (S) 
3 
N
N
Tos
Tos
P N
Ph
Ph
 
L3 99 4 (R) 99 5 (R) 
4 
N
N
Tos
Tos
P N
Ph
Ph
 
L4 99 8 (S) 99 8 (S) 
5 
N
N
Tos
Tos
P N
 
L7 99 24 (R) 85 18 (R) 
6 
N
N
Tos
Tos
P N
 
L8 99 12 (R) 90 11 (R) 
7 
N
N
Tos
Tos
P N
nBu
nBu
 
L9 99 49 (R) 99 44 (R) 
8 
N
N
Tos
Tos
P N
Ph
Ph
 
L11 99 17 (R) 75 9 (R) 
9 
N
N
Tos
Tos
P N
 
L12 99 8 (R) 99 2 (R) 
10 
N
N
Tos
Tos
P N
Ph
 
L 10 n.d. - 90 16 (R) 
a
 Reaction conditions: toluene, t = 5 h, substrate = 0.1mmol, [Cu(OTf)2]5 mol%, ligand 10 mol%. 
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3.2.2.3 Ligands based on (S)-N-phenyl-2-aminomethyl-pyrrolidine backbone 
 
At first we adopted the same conditions used before in the case of (R)-1,2-cyclohexyl-diamine 
based PTA for the evaluation of our ligands. The results are summarised in Table 10. 
Full conversion was obtained in 5 h both at -35 oC and -20 oC with all ligands containing the 
chiral bis-(1-phenyl-ethyl)-amine moiety and no variation of the enantioselectivity was 
observed within this temperature range. Interestingly, the diastereomeric mixtures M1 
(containing L13a (S,R,R,SP) and L13b (S,R,R,RP) in ratio 1:1.1) and M2 (containing L14a 
(S,S,S,SP) and L14b (S,S,S,RP) in ratio 1:3) led both to the preferential formation of the R 
product in 23% and 38%, respectively (Entry 1 and 2). In contrast, pure L13a and L14a led to 
a product with opposite absolute configuration, although with slightly lower 
enantioselectivities (Entry 3 and 4). The switch of the absolute configuration of 35 from R to 
S by using the diastereomeric pure ligands L13a and L14a (both having S configured 
phosphorous cental atoms) indicate that the impact of the chiral information at the donor atom 
is larger than the one of the secondary amine moiety. Attempts to isolate the pure R-
configured diastereomers L13b and L14b from M1 and M2 either as free ligands or as a 
copper complex were not successful. The use of an excess of the ligand mixtures in order to 
adjust the ratio of the R-configured diastereomer to [Cu] to 2:1 did not improve the 
enantioselectivity. Enantioselectivity (33%) in a similar range was obtained with ligand L23 
bearing the achiral pyrrol secondary amine moiety (Entry 13). Ligands L15, L16 and L17 
bearing piperidine, pyrrolidine and morpholine moieties turned out to lead to very similar 
conversions and enantioselectivities at -35 oC (conv. 46-48%; ee 6-8%; Entries 5-7). 
Surprisingly, ligands L15 and L16 resulted in much higher conversion at -20 °C. Ligands 
L18, L19 and L21 incorporating a di-nbutyl-, di-ipropyl and di-benzyl-amino moieties, 
respectively, led to similar high conversions and modest enantioselectivities (Entries 8, 9 and 
11). Very low enantioselectivity was achieved with ligand L20 bearing the chiral α-methyl-
benzylamino monoamine structure.  
The best performance for this ligand class was obtained with the diphenylamino substituted 
ligand L22 with 50% enantioselectivity both at -20 and -35 °C at full conversion. This 
enantioselectivity value is higher than that achieved with the related QUIPHOS under the 
same conditions.122  
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Table 10:Cu-catalysed addition of ZnEt2 to cyclohexenone with (S)-N-phenyl-2-aminomethyl-
pyrrolidine based PTAs.a 
Conv. [%] ee [%] Conv. [%] ee [%] 
Entry Ligand 
T = -35 °C; t = 12 h  T = -20 °C; t = 5 h 
1 
Ph
N
Ph
N
N
P
Ph
 
M1(L13a+L13b) 99 21 (R) 99 23 (R) 
2 
Ph
N
Ph
N
N
P
Ph
 
M2(L14a+L14b) 99 35 (R) 99 38 (R) 
3 
Ph
N
Ph
N
N
P
Ph
 
L13a 99 15 (S) 99 15 (S) 
4 
Ph
N
Ph
N
N
P
Ph
 
L14a 99 33 (S) 99 35 (S) 
5 NN
N
P
Ph
 
L15 48 6 (S) 88 21 (S) 
6 N
N
N
P
Ph
 
L16 47 8 (S) 79 15 (S) 
7 N
N
N
P
Ph
O
 
L17 46 7 (S) - - 
8 N
N
N
P
Ph
iPr
iPr
 
L18 93 21 (S) 88 20 (S) 
9 N
N
N
P
Ph
nBu
nBu
 
L19 - - 89 19 (S) 
10 N
N
N
P
Ph
Ph
 
L20 42 3 (S) 92 6 (S) 
11 N
N
N
P
Ph
Ph
Ph
 
L21 96 15 (S) 92 24 (S) 
12 N
N
N
P
Ph
Ph
Ph
 
L22 99 50 (S) 99 51 (S) 
13 N
N
N
P
Ph
 
L23 99 34 (S) 88 34 (S) 
a
 Reaction conditions: toluene, substrate = 0.1 mmol, [Cu(OTf)2]5 mol%, ligand 10 mol%. 
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The most promising ligands have been tested under the conditions introduced by Buono.122b 
The results are summarized in Table 11. Diastereomeric mixture M2 performed better using 
CuI as the copper precursor instead of Cu(OTf)2 and carrying out the catalysis in 
dichloromethane instead of toluene (Table 11, Entry 1 vs Table 10, Entry 2). The 
enantioselectivity could be improved under these conditions to 60%. The addition of water as 
an additive resulted in racemic 35 probably because of the water sensitivity of the ligand. In 
the case of L22, the enantioselectivity could be slightly ameliorated from 50 to 55% using 
CuI in dichloromethane and up to 58% ee adding water (0.5 equivalent with respect to the 
substrate).  
 
Table 11: Cu-catalysed addition of ZnEt2 to cyclohexenone under optimised conditions.a 
Entry Ligand Additive Conv. [%] ee [%] 
1 --- 99 60 (R) 
2 
Ph
N
Ph
N
N
P
Ph
 
M2 
(L14a+L14b) H2O 99 rac 
3 --- 99 53 (S) 
4 
N
N
N
P
Ph
Ph
Ph
 
L22 
H2O 99 58 (S) 
a
 Reaction conditions: CH2Cl2, t = 12 h, T = -20 °C, substrate = 0.1mmol, 5 mol% CuI, 10 mol% 
ligand.  
 
 
3.2.2.4 Short summary 
 
The pyrrolidine backbone based ligands L22 and M2, result in higher enantioselectivities (50 
to 60 % respectively) than the structurally related phosphorous diamidite (QUIPHOS) and are 
promising. It can also be assumed, that the pure L14b ligand should give even higher 
enantioselectivities. However to isolate this PTA from diastereomeric mixture M2 either as 
free ligand or as copper complex was not possible.An enantioselectivity in a similar range 
(50%) was obtained with the 1,2-dimethyl-cyclohexyl diamine based ligand L5. With the 
“Feringa analogue” PTAs L1 and L2 enantioselectivities of 32% could be achieved which is 
far below the performance of the benchmark phosphoramidite 11.  
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3.2.3.1 Asymmetric hydrovinylation of styrene with phosphorous triamides 
 
 
CH2Cl2
C2H4 [Ni] +Oligomers
3-Phenyl-1-butene E and Z 2-Phenyl-
2-butene
[Ni(allyl)Br]2/L
NaBARF *
+
36 37 38
 
 
Scheme 38: Nickel catalysed asymmetric hydrovinylation of styrene 
 
As discussed in the introduction, the state of the art for the hydrovinylation (Scheme 35) is 
defined by the Wilke125 and the Feringa126 ligands, which provide high chemo- and 
enantioselectivities. Although the two ligands may appear rather different at a first glance, the 
superimpositions of the solid state structures show important structural similarities.112 In 
particular, the ligand regions involved in the coordination to the Nickel center are closely 
related, both including a 1-phenyl-ethyl-amine moiety. These structural analogies and similar 
results in catalysis suggest that the two ligands may operate in essentially the same way. 
PTAs L1 and L2 are directly related to the Feringa phosphoramidite. Moreover, as shown in 
Chapter 3.1.3.2, they possess a more rigid nature as the rotation around the P-N bond is frozen 
even at room temperature. In addition to L1 and L2, the PTAs M1, M2 and L20 also posess 
structural motifs present in the Feringa as well as in the Wilke ligand. (Figure 43) 
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Figure 43:Established ligands for hydrovinylation compared with some PTAs: structural analogies are 
highlighted in blue. 
 
These and some other PTAs were applied in the hydrovinylation of styrene using 
[Ni(allyl)Br]2 as precursor with NaBARF as activator at different temperatures ranging from 
-50 to 0 oC. The same catalyst loading of 0.17 mol% was used in all experiments in order to 
compare the relative activity. Selected results are summarised in Table 12.  
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Differently from the very active catalytic system including the parent Feringa ligand, in the 
presence of the PTAs L1 or L2 no conversion was observed after 3 h carrying out the reaction 
at -50 oC. At -15 oC, however, 82 % conversion was achieved within 3 hours with L1 and the 
desired 3-phenyl-1-butene was obtained with high chemoselectivity and an enantioselectivity 
of 32 % (Entry 1). Ligand L2 turned out to be less active and gave a conversion of 50 % 
under the same conditions. Chemo- and enantioselectivity remained at the same level as with 
the diastereomer L1 (Entry 2). It is interesting to note that diastereomers L1 and L2 act as 
enantiomers in the hydrovinylation as they favour the formation of products with almost 
identical enantioselectivity but opposite configuration. Except for the slightly different 
activity, no diastereomeric match-mismatch effects are present and the enantioselectivity is 
determined by the chirality of the bis-(1-phenyl-ethyl)-amine moiety. A similar behaviour of 
the pair L1/L2 has been observed also in the Cu-catalysed Michael addition (Chapter 3.2.2.1).  
Surprisingly, ligands L13a and L14a and the diastereomeric mixtures M1 (containing L13a 
and L13b) and M2 (containing L14a and L14b) based on the (S)-N-2-aminomethyl-
pyrrolidine backbone and bearing the bis-(1-phenyl-ethyl)-amine moiety as the secondary 
amine counterpart showed no activity at all even at 0 oC. In contrast, the less crowded L20 
having only one 1-phenyl-ethyl group and a methyl on the monoamine backbone could be 
successfully used in the hydrovinylation of styrene. A conversion of 50% was achieved within 
3 h at -15 °C with a chemoselectivity of 86% and enantioselectivity of 60% (Entry 3). 
Remarkably, the chemo- and enantioselectivity remains on the same level by almost full 
conversion of styrene even at 0 oC (Entry 4).  
For comparison, we have tested L16 and L22 which contain a non-chiral monoamine 
backbone. The pyrrolidine monoamine containing ligand L16 provided good conversion of 
36, good chemoselectivity and low enantioselectivity (Entry 4). The diphenyl substituted 
ligand L22 was active even at -50 o C giving 68% conversion within 3 hours with 85% 
selectivity towards the desired product and an enantioselectivity of 33% (Entry 5). At -15 oC 
within 2 hours and at 0 oC within one hour almost all the starting material was consumed and 
a high degree of isomerisation of 37 to 38 took place. As a result, the enantioselectivity 
reached a very high level of 92 and 99%, respectively, and is inversely proportional to the 
amount of 3-phenyl-1-butene left in the reaction mixture (Entry 8 and Entry 9). The fact that 
the enantioselectivity increases with decreasing amount of 37 (Entry 8 and Entry 9) indicates 
that one enantiomer of 37 is isomerised more rapidly towards the non chiral isomer 38. The 
consecutive isomerisation coupled with kinetic resolution is described also with the Wilke 
ligand127 and is very common for Pd-based catalysts.128 
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Some PTAs based on the cyclohexyl diamine moiety were also investigated in this reaction. 
Ligand L8 gave almost no conversion at -50 oC and polymerisation products at -15 oC. Ligand 
L10 containing the 1-phenyl-ethyl group and a methyl as monoamine part turned out to be not 
suitable for this reaction. The ligand L5 based on the bis-methyl-cyclohexyl diamine 
backbone and on the bis(1-phenyl-ethyl)-amine moiety formed a rather active and 
chemoselective but poorly enantioselective catalyst. As the other diastereomer L6 was not 
tested in the hydrovinylation, is not possible to evaluate potential match-mismatch effect at 
present. 
 
 
3.2.3.2 Short summary 
The first time, PTA ligands have been applied in the asymmetric hydrovinylation with 
promising results. High selectivities, comparable to those achived with the parent 
phosphoramidite 11 were attained with ligands L1 and L2, albeit with lower ee values. Both 
good selectivity and enantioselectivity was achieved with the pyrolidine backbone based L20 
even at relatively high reaction temperature of 0 oC.  
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Table 12: Hydrovinylation of styrene with various PTAsa 
Entry Ligand 
T 
[°C] 
t 
[h] 
 Conv. 
[%] 
Sel. 37 
[%] 
Sel. 38 
[%] 
Sel. olig. 
[%] 
Ee 7 
[%] 
 
N
N
Me
Me
P N
Ph
Ph
 
L1 -15 3 82 95 0.4 0.8 32(S) 
 
N
N
Me
Me
P N
Ph
Ph
 
L2 -15 3 50 98 0.5 0.9 33 (R) 
2b N
N
N
P
Ph
Ph
 
L20 -15 3 50 86 9 5 60 (S) 
3 N
N
N
P
Ph
Ph
 
L20    0 3 98 79 14 7 63 (S) 
4 N
N
N
P
Ph
 
L16 -15 3 80 84 5 11 26 (S) 
5 N
N
N
P
Ph
Ph
Ph
 
L22 -50 3 68 85 13 2 33 (S) 
6 N
N
N
P
Ph
Ph
Ph
 
L22 -15 2 99 24 65 10 92 (S) 
7 N
N
N
P
Ph
Ph
Ph
 
L22    0 1 98 2 86 11 99 (S) 
8 
N
N
Tos
Tos
P N
 
L8 -15 3 89 31 0.5 65 8 (R) 
9 
N
N
Me
Me
P N
Ph
Ph
 
L5 -15 3 80 84 4 1 11 (R) 
a Reaction conditions: CH2Cl2, styrene = 0.1mmol, ethylene 1 bar, 0.17 mol% [Ni(allyl)Br]2, ligand 
0.32 mol%., NaBARF 0.32 mol%. 
b
 no activity at -50 °C.  
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Chapter 4. Conclusions and Outlook 
 
 
 
A systematic set of 25 different novel chiral phosphorous triamides, based on three different 
chiral diamine backbones has been prepared through a convenient modular synthetic 
approach. The study significantly increases the knowledge about the synthesis, purification, 
stability and structural features of these compounds. It has been demonstrated, that it is of 
fundamental importance to carefully optimize the preparation by choosing not only the best 
synthetic route but also the most suited base for the deprotonation of the starting materials. 
The suitable synthetic approaches, which are generally depicted in Scheme 39, are 
summarised in Table 13 for each ligand. 
 
 
PCl3
Route B
Route A
Diamine
Diamine
BuLi
Base
Monoamine
Monoamine
BuLi
Base
P
N
N
Cl
PN
Cl
ClR
R
stability, 
isolation
Diamine
Diamine
BuLi
Base
Monoamine
Monoamine
BuLi
Base
A1 A2
B1 B2
P
N
N
N
R
R
R
R
P
N
N
N
R
R
R
R
 
Scheme 39: General picture of the possible synthetic approaches for preparation of PTAs 
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Table 13: Summary of the reaction conditions for preparation of the PTA ligand library 
Ligand code Step 1 Step 2 
Ligand stability 
towards air/moisture 
L1 B1base B2BuLi yes 
L2 B1base B2BuLi yes 
L3 B1base B2BuLi no 
L4 B1base B2BuLi no 
L5 B1base B2base yes 
L6 B1base B2base yes 
L7 A1BuLi A2amine no 
L8 A1BuLi A2amine no 
L9 A1BuLi A2amine no 
L10 A1BuLi A2base no 
L11 A1BuLi A2BuLi no 
L12 A1BuLi A2BuLi no 
L13a A1base A2BuLi yes 
L14a A1base A2BuLi yes 
L15 A1base A2amine yes 
L16 A1base A2amine yes 
L17 A1base A2amine yes 
L18 A1base A2amine yes 
L19 A1base A2amine yes 
L20 A1base A2base yes 
L21 A1base A2base yes 
L22 A1base A2BuLi yes 
L23 A1base A2BuLi yes 
M1 (L13a + L13b) B1base B2base yes 
M2 (L14a + L14b) B1base B2base yes 
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The prepared ligand library has been evaluated in three different asymmetric catalytic 
transformations: Rh catalysed hydrogenation of dimethyl ithaconate (RhH), Cu catalysed 
Michael-addition of diethyl zink to cyclohexenone (CuM) and Ni catalysed 
hydrovinylation of styrene (NiHv). In general, these ligands behave significantly different 
from the related phosphites or phosphoramidites. All tested structurally very different 
PTAs show poor performance in the RhH. More promising results were obtained with 
catalysts based on Cu and Ni. The following main conclusions for PTAs based on the 
different backbones can be derived from this study: 
•  Ligands L1-L2 based on the axially chiral (R)-2,2´-bis(methylamino)-1,1´-binaphthyl 
are structural analogues to the Feringa ligand (11). In contrast to the parent 
phosphoramidite, the rotation around the P-N axis is frozen at room temperature 
therefore the PTAs possess a much more rigid structure and loose the possibility to 
adopt a C2 symmetric conformation. In the CuM and NiHv, where 11 represents a 
benchmark ligand, the performance of L1 and L2 in terms of activity and 
enantioselectivity is moderate at best. However, excellent regioselectivities of 95% 
and 98% could be achieved in the NiHv with L1 and L2 respectively. 
• A significant difference in stability can be pointed out among PTAs based on the 
(R,R)-1,2-cyclohexyl diamine backbone (L3-L12). Ligands L5 and L6 bearing methyl 
groups on the diamine backbone turn out to be extremely senstitve towards air and 
moisture, whereas ligands L3-L4 and L7-L12 bearing the electron withdrawing the 
tosyl substituents can be handled on air and stored on the bench.  
•  A good enantioselectivity of 50% could be achieved with L5 and L9 in the CuM 
representing the highest enantioselectivity among known PTA based on the 
cyclohexyl-diamine backbone.  
• Single crystal X-Ray measurements in the solid state and NOESY NMR measurement 
in solution for the tosyl substituted L4 and L9 indicate, that the chiral (R,R)-1,2-
cyclohexyl-diamine backbone does no longer adopt a C2-symmetric conformation 
upon ligand formation.  
• Ligands L13a-L23 based on the C1 symmetric pyrrolidin-2-yl-methylamine contain 
an additional stereocentre on the donor atom and can be prepared via Route A with 
high diastereomeric purity in favour of the syn epimers.  
• The diastereomeric purity of the product can be controlled by the variation of the 
synthetic route depending on the starting phosphorous chloride precursor as 
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demonstrated for L13a and L14a vs their diastereomeric mixtures M1 and M2. The 
syn and anti diastereomers contained in M1 can be separated by crystallisation and 
selective metal complex formation. 
• Good enantiosleectivities of 60 % and 55% could be achieved with L22 and M2 in the 
CuM. 
• Promising results have been obtained with L20 in the NiHv reaching 60% ee together 
with good regioselectivity even at relatively high temperature (0 oC).  
 
In general, these results demonstrate that chiral PTAs are accessible and can provide 
significant levels of enantioselectivity in asymmetric catalysis.Their binding characteristics 
are however, very different from classical phosphorous ligands and their potential in 
enantioselective catalysis is not yet fully explored. Based on the results of the present study, 
catalytic reactions involving d9 and d10 metals (e.g Pt, Ag, Au) might be promising candidates 
for future investigation. 
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Chapter 5. Experimental 
   
5.1. General Methods, Solvents and Reagents 
5.1.1. Inert Gas Conditions 
 
All reactions involving air-sensitive chemicals were performed under Argon atmosphere 
using standard Schlenk techniques. Glassware was heated in vacuo and subsequently purged 
with Argon. The addition of reagents and solvents was carried out with polypropylene 
syringes equipped with V2A steel needles under Argon stream.  
5.1.2. Solvents 
 
The following solvents were dried and purified by distillation under Argon according to 
standard procedures (Table 14). All solvents for column chromatography, recrystallization 
and reaction workup were distilled prior to use. Furthermore, deuterated solvents were 
transferred into Schlenk under argon stream and stored over molecular sieves. The water 
amount of the solvents was controlled by Karl-Fisher titration.  
 
Table 14. Purification conditions for solvents 
Entry Solvent Conditions 
1 Tetrahydrofurane heated under reflux over sodium/benzophenone  
2 Diethylether heated under reflux over sodium/benzophenone  
3 Toluene heated under reflux over sodium/benzophenone   
4 Benzene heated under reflux over sodium/benzophenone  
5 Chloroform heated under reflux over calcium hydride  
6 Dichloromethane heated under reflux over calcium hydride 
7 Pentane heated under reflux over calcium hydride 
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5.1.3 Reagents 
 
The commercially available reagents were obtained from various suppliers and in different 
qualities (Table 15). 
 
Table 15: Reagents used for the synthesis 
Reagent Supplier Quality 
Piperidine  Aldrich 99.5 % (Sure/Seal) 
Pyrrolidine Aldrich 99.5 % (Sure/Seal) 
Diisopropylamine Aldrich 99.5 % 
Dibutylamine Aldrich 98 % 
Diethylamine Aldrich 99.5 % (Sure/Seal) 
Dibenzylamine Aldrich 97 % 
Diphenylamine Aldrich 99 % 
Morpholine Aldrich 99.5 % (Sure/Seal) 
Pyrrol Aldrich 98 % 
Aniline Aldrich 99 % 
Hünigs base Aldrich 99 % 
Triethylamine Aldrich 99.5 % 
Pyridine Aldrich 99 % 
Dimethylaminopyridine Fluka > 99.0 % 
(R)-1,1´-Binaphthyl-2,2´-diamine Aldrich and Strem 99 % 
(1R,2R)-1,2-Diaminocyclohexane L-
tartarate Aldrich 99 % 
(1R,2R)-1,2-Diaminocyclohexane Aldrich 98 % 
Bis-(R,R)-( α-methylbenzyl)amine Aldrich 99 % 
Bis-(S,S)-( α-methylbenzyl)amine Aldrich 99 % 
(R)- N, α-Dimethylbenzylamine Aldrich 98 % 
L-Glutamic acid Aldrich 99 % 
Tris(dimethylamino)phosphine Strem 98 % 
Phosphoryl chloride Aldrich 99 % 
Acetyl chloride Acros 98 % 
Ethyl chloroformate Acros 97 % 
TMS triflate Aldrich 97 % 
Tosyl chloride Aldrich 98 % 
Trifluoromethynesulfonyl chloride Avocado 99 % 
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Benzyl bromide Aldrich 98 % 
Allyl chloride Aldrich 99.5 % 
Borane in THF Aldrich 99.5 % 
LiAlH4 Fluka 95 % 
Styrene Aldrich 99 % 
Ethylbenzene Aldrich 99 % 
Cyclohexenone Aldrich 95 % 
Dimethyl itaconate Fluka 99% 
Potassium iodide Aldrich 99 % 
Copper (I) iodide Aldrich 98 % 
Copper (I) trifluoromethanesulfonate Aldrich 99.99 % 
Copper (II) trifluoromethanesulfonate Aldrich 98 % 
Diethylzink (1M solution in hexane) Fluka 99% 
Butyl-lithium (1M solution in hexane) Aldrich 99% 
[Rh(CO)2Cl]2 Strem 98% 
[Rh(COD)2]BF4 Aldrich 99% 
 
 
5.1.4 Further purification of reagents 
 
Amines (triethylamine, Hünigs base, diisopropylamine, dibutylamine, dibenzylamine, 
pyridine, aniline) as well as benzyl-bromide, vinyl-chloride and acetyl-chloride were distilled 
under reduced pressure and stored under argon. PCl3 was refluxed for 3 hours and distilled 
under reduced pressure. Styrene and ethylbenzene were distilled under reduced pressure and 
stored in dark at -30 oC under argon atmosphere above molecular sieves. Dimethyl-itaconate 
and DMAP were powdered and dried in vacuo overnight. Cyclohexenone was stored in dark 
above molecular sieves. The concentration of BuLi was determined by titration with 
phenantroline prior to use. All other reagents were used as received, without further treatment. 
 
5.1.5 Thin Layer Chromatography 
 
For Thin Layer Chromatography (TLC), POLYGRAM SIL G/UV254 plates from Macherey 
and Nagel with a silica layer of 0.2 mm and POLYGRAM ALOX G/UV254 with an alumina 
layer of 0.2 mm were used. Visualization was realized through UV or iodine treatment. 
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5.1.6 Column Chromatography and filtration 
 
For ligand synthesis neutral alumina was used, from Fluka with Brockman activity 1. It was 
transferred to a 1 l Schlenk flask and dried in vacuo overnight at room temperature. For 
further column chromatography, KIESELGEL 60 from Merck with a particle size in the range 
of 0.040 – 0.063 mm was used as received. Celite was purchased form Aldrich and dried in 
vacuo overnight at 80 oC. PFTE syringe filter pads (0.45 µm) were purchased from Roth.  
 
5.1.7 NMR Spectroscopy 
 
1H-, 13C-, 31P- NMR spectra were recorded on Bruker DPX 300 and AV 600 spectrometers. 
The operating frequencies of these spectrometers for NMR measurements are 300.1 MHz for 
1H, 75.5 MHz for 13C, 121.5 MHz for 31P at DPX 300 spectrometer and 600.1 MHz for 1H, 
150.9 MHz for 13C, 242.9 MHz for 31P at the AV 600 spectrometer. 
 For 1H- and 13C {1H } NMR spectroscopy, the chemical shifts (δ) are given in ppm using the 
residual solvent signals as internal standard. For 31P-NMR spectroscopy the chemical shift 
values δ are given in ppm relative to 85% phosphoric acid as external standard. The 
multiplicity of the signals was assigned assuming spectra of first order. The coupling constant 
J is given in Hertz. For the description of the multiplicity of the signal following 
abbreviations are used: s = singulet, d = doublet, t = triplet, q = quadruplet, qi=quintet, m = 
multiplet, br = broad. Unless indicated otherwise, the spectra are recorded at room 
temperature.The assignement of the ligand chemical shifts was carried out on the basis of two 
dimensional NMR spectra (31P-1H-HMBC, 1H-1H COSY, HMBC, HSQC, NOESY ) 
 
5.1.8 IR Spectroscopy  
IR spectra were recorded with a Perkin-Elmer spectrometer (PE 1720X, PE 1760 FT). The 
measurements were carried out on KBr tabletts for solids. The positions of the absorption 
signals are listed in cm−1.  
5.1.9 Mass Spectroscopy 
Mass spectroscopic and High-resolution MS measurements were performed on a Finnigan-
MAT 95 spectrometer. For high-resolution MS, the mass of the molecule ion is given.  
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5.2 Chemicals prepared according to literature procedures 
 
The following chemicals (Table 16) were prepared according to literature procedures, and 
readily characterised by NMR spectroscopy. The analytical data are in agreement with those 
indicated in the literature. 
 
Table 16: Chemicals prepared according to literature procedures 
Substance Reference 
(R)-2,2´-bis(ethoxycarbonylamino)-1,1´-
binaphthyl 
M. Shi, C-J. Wang, Tet.Asymm. 2002, 13, 
2161-2166 
(R)-2,2´-bis(acetyl)-1,1´-binaphthyl H. Hashimoto et al., Bull. Chem. Soc. 1984, 
57, 2171;  
(R)-2,2´-bis(methylamino)-1,1´-binaphthyl M. Shi, C-J. Wang, Tet.Asymm. 2002, 13, 
2161-2166 
(R)-2,2´-bis(ethylamino)-1,1´-binaphthyl H. Hashimoto et al., Bull. Chem. Soc. 1984, 
57, 2171;  
(1R,2R)-(Ethoxycarbonylaminocyclohexyl) 
carbamic acid ethylester 
A. Alexakis et al. Tet.Asymm. 2001, 12, 1171-
1178 
(1R,2R)-N,N´-Dimethylcyclohexane-1,2-
diamine 
Y. L, Bennani, S. Hanessian, Tetrahedron, 
1996, 44, 13837 
(1R,2R)-cyclohexane-1,2-di-4-
methylbenzenesulfonamide 
Watkinson et al. Dalton Transaction, 2003, 
2043-2052 
(1R,2R)-N,N´-Diallylcyclohexane-1,2-diamine Alexakis et al.Tet.Asymm. 2001, 12, 1171-
1178 
(1R,2R)-N,N´-Dibenzylcyclohexane-1,2-
diamine  
Alexakis et al.Tet.Asymm. 2001, 12, 1171-
1178 
[CpPd(allyl)] Inorg. Synth., 1990, 28, 342-345 
 
 
Samples of NaBARF, [Ni(allyl)(COD)][SbF4], [Rh(acac)CO2] and [Ni(allyl)Br]2 were kindly 
provided by Christiane Diez-Holz, Dirk Reinartz and Christian Böing. 
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5.3 Syntheses 
 
5.3.1 Precursor synthesis  
 
5.3.1.1 [(R,R)-Bis(α-methylbenzyl)amino]phosphorous-dichloride: (R,R)-21 
(R,R)-bis(α-methyl-benzyl)-amine (1 g, 4.4 mmol) and DMAP (0.6 g, 4.9 mmol) were 
dissolved in 3 ml dry toluene and the mixture was stirred for 10 minutes. The mixture was 
cooled down with an ice bath to 0 oC and subsequently neat PCl3 (2.3 ml, 3 g, 22 mmol) was 
introduced via syringe under vigorous stirring. Formation of a white precipitate was observed 
immediately. The mixture was heated to 70 oC overnight, then the solvent and excess of PCl3 
were removed in vacuo. To the solid residue 15 ml pentane was added and the suspension was 
vigorously stirred for 30 minutes, followed by a filtration over dried cellite. The extraction 
and filtration procedure was repeated 3 times with 10 ml pentane. After removal of the 
solvent, the product was obtained as transparent viscous oil, which is sensitive towards air and 
moisture: 1.37 g (95% yield).The compound can be stored under argon atmosphere at -30 oC 
for several months. 
 
N
P
ClCl
1
2
3
4
5
 
 
31P {1H}NMR (C6D6): δ= 165.9 ppm 
 
1H NMR (300 MHz, CDCl3): δ= 1.87 (d, 3J=7.1 Hz, 6H, H-1); 5.04 (m, 2H, H-2); 7.20 (m, 4H, 
Harom); 7.27 (m, 6H, Harom) ppm 
 
13C {1H}NMR (300 MHz, CDCl3): δ= 21.1 (d, 3JC-P=13 Hz, C-1); 55.6 (d, 3JC-P=13 Hz, C-2); 
127.4 (C-5); 127.8 (d, 4JC-P=3 Hz, C-3); 128.1 (C-4); 140.6 (d, 3JC-P=3 Hz, Cq) ppm 
 
5.3.1.2 [(S,S)-Bis(α-methylbenzyl)amino]phosphorous-dichloride: (S,S)-21 
 
The same procedure was applied as for the preparation of (R,R)-21. (S,S)-bis(α-methyl-
benzyl)-amine was used instead of (R,R)-bis(α-methyl-benzyl)-amine. 
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N
P
ClCl
1
2
3
4
5
 
 
31P {1H}NMR (C6D6): δ= 165.9 ppm 
 
1H NMR (300 MHz, CDCl3): δ= 1.87 (d, 3JH1-H2=7.1 Hz, 6H, H-1); 5.04 (m, 2H, H-2); 7.20 
(m, 4H, H-3); 7.27 (m, 6H, H-4 and H-5) ppm 
 
13C {1H}NMR (300 MHz, CDCl3): δ= 21.1 (d, 3JC-P=13 Hz, C-1); 55.6 (d, 3JC-P=13 Hz, C-2); 
127.4 (C-5); 127.8 (d, 4JC-P=3 Hz, C-3); 128.1 (C-4); 140.6 (d, 3JC-P=3 Hz, Cq) 
 
5.3.1.3 [(1R,2R)-trans-1,2-bis(p-tolylsulfonyl)-cyclohexane diamino]phosphorous 
Chloride (27) 
 
(1R,2R)-N,N-bis-tosyl-cyclohexane-1,2-diamine (5 g, 11.8 mmol) was dissolved in THF (15 
ml) and stirred until the amine totally dissolved. The mixture was cooled down to -78 oC and 
3 equivalents of neat PCl3 (3.1 ml, 4.85 g, 35.4 mmol) were added via syringe. Then the 
mixture was allowed to stir at room temperature for overnight. The excess of PCl3 and solvent 
were removed in vacuo. To the remained solid, 20 ml THF was added and the white 
precipitate was filtered off through PTA filter pads. The removal of the solvent resulted white 
solid which is very sensitive towards air and moisture should be therefore applied in situ for 
further ligand synthesis: 5.65 g, 95% yield 
 
N
N
S
S
O O
O
Me
P
Me
O
Cl
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31P NMR (C6D6): δ= 135.7 ppm 
 
Due to its instability, the compound was reacted in situ and therefore no other NMR data are 
available. 
 
5.3.1.4 (S)-2-Anilinomethyl-pyrrolidine (28) 
The synthesis was carried out via a modification of the literature procedure. 30 
 
5.3.1.4.1 (S)-5-oxopyrrolidine 2-carboxanilide (30) 
In a round bottom flask, equipped with a reflux cooler, L-glutamic acid (10.00 g, 67.9 mmol) 
was suspended in 1 eq aniline (6.2 ml, 67.9 mmol) and stirred at 150 oC for three days. The 
cooler was removed and to the hot viscous brown material 100 ml methanol was added. After 
the mixture was allowed to cool down to room temperature, so that the product crystallised. 
The crystals were filtered off on a Büchner-flask in water vacuo, and washed several times 
with acetone, until the filtrate appeared colorless. The product was recrystallised from 100 ml 
methanol: 9.70 g (70 % yield) 
NH
NH
O
O
1
2
6
7
8
3 4
5
 
1H NMR (300 MHz, DMSO-d6): δ=1.92-2.05 (m, 1H, H-2); 2.07-2.42 (m, 3H, H-1 and H-2); 
4.20 (dd, 3JH-H=9.1 Hz, 3JH-H=4.9 Hz, 1H, H-3); 7.06 (t, 3JH8-H7=7.6 Hz; 1H, H-8); 7.31 (dd, 
3JH7-H6=3JH7-H8=7.6 Hz; 2H, H-7); 7.63 (d, 3JH6-H7=7.6 Hz, 2H, H-6); 7.88-7.95 (b, 1H, H-4); 
10.02-10.08 (b, 1H, H-5) ppm 
13C NMR (300 MHz, DMSO-d6): δ= 25.3 (C-2), 29.2 (C-1), 56.3 (C-3), 119.3 (C-8); 123.5 
(C-7); 128.7 (C-6); 138.8 (Carom); 171.3 (Ccarbonyl); 177.5 (Ccarbonyl) ppm 
5.3.1.4.2 Upscaling the synthesis of 30 
 
For 40.00 g starting material, 2 equivalents (50 ml) of aniline should be used. Otherwise, the 
procedure remains the same as previously described. 
35.24 g (63.5 % yield) 
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The synthesis of (S)-2-anilinomethyl pyrrolidine (28) from 30 was carried out according to the 
procedure described in the literature.26 The spectroscopic data are in agreement with those 
described in the literature.  
 
5.3.1.4.3 Determination of the optical purity of (S)-2-anilinomethyl pyrrolidine (28) 
 
To an NMR tube, equipped with a screw cap, 28 (10 mg, 0.06 mmol) was introduced with a 
Pasteur-pipette. Subsequently DMAP (14 mg, 0.12 mmol) and 0.5 ml benzene-d6 were added. 
The mixture was shaken for 5 minutes. (R,R)-21 (37.5 mg, 0.06 mmol) was dissolved in 0.5 
ml benzene-d6 and added via syringe under argon stream. 
The tube was closed, shaken and allowed to stand at room temperature for overnight. The 
optical purity of the amine is given by the integration of the 31P NMR signals (Chapter 
3.1.5.5). The presence of signals at 108.8 ppm and 86.3 ppm indicate R configurated amine 
impurity (d.r: [(S,R,R,Rp)+ (S,R,R,Sp )/ (R,R,R,Sp)+ (R,R,R,Rp)]) 
31P NMR: δ= 108.8 (L13 (R,R,R,Sp)), 105.8 (L13a (S,R,R,Rp)), 90.2 (L13b (S,R,R,Sp)), 86.3 
(L13 (R,R,R,Rp)) ppm 
 
5.3.1.5 [(S)-2-Anilinomethyl-pyrrolidino]phosphorous-chloride (31)48 
 
The synthesis of [(S)-2-Anilinomethyl-pyrrolidino]phosphorous-chloride (31) from 28 was 
carried out according to the procedure described in the literature.48  
 
 Compound 28 (1.07 g, 6.1 mmol) was dissolved in toluene (15 ml) and strirred until the 
amine totally dissolved, after triethylamine (1.7 ml, 1.23g, 12.2 mmol) was added via syringe. 
The mixture was cooled down with an ice bath and neat PCl3 (0.64 ml, 1.00 g, 7.0 mmol) was 
added via syringe. After, the mixture was heated to reflux for 10 minutes then cooled down 
again in an ice bath. The excess of PCl3 and residual solvent was carefully removed in vacuo. 
To the remained brownish solid, 30 ml toluene was added and the white precipitate was 
filtered off over celite. The crude yellow product product was obtained after removal of the 
solvent, and distilled under vacuo (4.10-3 bar, 180 oC) The product was obtained as white 
solid which is sensitive towards air and moisture: 0.72 g, (49 % yield). 
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1H NMR (600 MHz, CDCl3): δ=1.62-1.82 (b, 1H, H-3); 2.00-2.08 (m, 1H, H-2); 2.09-2.15 
(m, 1H, H-2); 2.16-2.33 (b, 1H, H-3); 3.17-3.33 (b, 1H, H-1); 3.46-3.61 (m, 2H, H-5); 3.77-
3.88 (b, 1H, H-1); 4.10-4.19 (m, 1H, H-4); 7.02 (t, 3JH8-H7=7.8 Hz, 1H, H-8); 7.11 (d, 3JH6-
H7=8.3 Hz, 2H, H-6); 7.32 (dd, 3JH7-H6=8.3 Hz, 3JH7-H8=7.8 Hz, 2H, H-7) ppm 
 
13C NMR (300 MHz, CDCl3): δ=27.8 (b, C-2); 31.3 (b, C-3); 44.4 (b, C-1); 52.6 (b, C-5); 
66.5 (b, C-4); 117.6 (b, C-6); 121.8 (b, C-8); 129.3 (s, C-7); 143.0 (d, 3JC-P=13 Hz, Cq) ppm 
 
13C NMR (600 MHz, CDCl3, 233.15 K): δ=26.9 (C-2b); 28.2 (C-2a); 30.2 (C-3b); 31.4 (C-
3a); 44.0 (C-1a); 44.9 (d, JC-P=22 Hz, C-1b); 51.4 (C-5b); 52.4 (C-5a); 64.9 (C-4b); 66.6 (d, 
JC-P=9 Hz, C-4a); 115.6 (d, JC-P=14 Hz, C-6b); 117.2 (d, JC-P=14 Hz, C-6a); 120.8 (C-8b); 
121.7 (C-8a); 129.3 (C-7a and C-7b); 142.5 (d, JC-P=11 Hz, Cq -a and Cq-b) ppm 
 
31P NMR (600 MHz, CDCl3): δ=153.9 (a) and 146.2 (b) ppm (ratio 3.5 : 1) 
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5.3.2 Ligand synthesis 
 
 
5.3.2.1 (Ra)-3,5-dimethyl-N,N-bis((S)-1-phenylethyl)-3H-dinaphtho[2,1-d:1',2'-f] [1,3,2] 
diazaphosphepin-4(5H)-amine (L1) 
 
 
(R)-2,2´-bis(methylamino)-1,1´-binaphthyl (150 mg, 0.6 mmol) was dissolved in 4 ml dry 
THF and the solution was cooled down to -78 oC in a dry ice bath. BuLi (1.6M in hexane, 
0.85 ml, 1.2 mmol, 2 eq) was added dropwise via syringe while yellow color appeared 
immediately. The solution was allowed to warm up to room temperature for 30 minutes then 
cooled down to -78 oC again. In a separate Schlenk flask, (S,S)-21 (0.196 mg, 0.6 mmol) was 
dissolved in 1 ml toluene and the solution was added dropwise to the reaction mixture through 
a rubber septum. The mixture was allowed to warm to room temperature and stirred for 
overnight, while white precipitate formed. After, the mixture was carefully filtrated over a 
short pad of alumina (ca. 5 cm, Ø=3 cm), and the solvent was removed. To the white solid 2 
ml benzene was added and the mixture was allowed to stand in the glove box for overnight, so 
that the product crystallised. The residual solution was removed with a Pasteur-pipette, and 
the white solid was washed with 1 ml of cold benzene. The product was dried in vacuo: 104 
mg, (31 % yield). The product is sensitive towards air and moisture, should be stored in cold 
under argon atmosphere. 
 
N
N
P N
CH3
CH3
 
 
31 P NMR (600 MHz; CD2Cl2): δ= 140.6 ppm 
 
1H NMR (600 MHz; CD2Cl2): δ= 1.59 (d, 3JH-H=7.0 Hz, 3H, HMe); 1.93 (d, 3JH-H=7.3 Hz, 3H, 
HMe); 1.96 (d, 3JH-P=11.3 Hz, 3H, HNMe); 3.21 (d, 3JH-P=16.1 Hz, 3H, HNMe); 4.18 (q, 3JH-H=7.0 
Hz, 1H, HCH); 4.56 (dq, 3JH-H=7.3 Hz, 3JH-P=21.3 Hz; 1H, HCH); 6.83 (d, 3JH-H=8.7 Hz, 1H, 
Hnaphtyl); 6.92 (d, 3JH-H=6.7 Hz, 2H, Hphenyl); 7.06 (t, 3JH-H=8.7 Hz, 1H, Hnaphtyl); 7.07-7.13 (m, 
5H, Hphenyl); 7.14-7.21 (m, 5H, Hphenyl and Hnaphtyl); 7.28 (t, 3JH-H=7.4 Hz, 1H, Hnaphtyl); 7.35 
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(d, 3JH-H=8.4 Hz, 1H, Hnaphtyl); 7.42 (d, 3JH-H=9.1 Hz, 1H, Hnaphtyl); 7.82 (d, 3JH-H=8.5 Hz, 2H, 
Hnaphtyl); 7.87 (m, 2H, Hnaphtyl); 7.93 (d, 3JH-H=8.8 Hz, 1H, Hnaphtyl) ppm 
 
13 C NMR (600 MHz; CD2Cl2): δ= 21.4 (CMe); 25.4 (d, 3JC-P=15 Hz, CMe); 36.5 (d, 3JC-P=26 
Hz, CNMe); 38.9 (d, 3JC-P=41 Hz, CNMe); 52.0 (d, 3JC-P=28 Hz, CCH); 54.5 (d, 3JC-P=7 Hz, CCH); 
121.1 (Cnaphtyl); 122.0 (Cnaphtyl); 124.0 (Cnaphtyl); 124.5 (Cnaphtyl); 125.7 (Cnaphtyl); 125.9 (Cphenyl); 
126.8 (Cphenyl); 127.2 (Cnaphtyl); 127.3 (Cnaphtyl); 127.5 (Cq-naphtyl); 127.6 (Cphenyl); 127.7 
(Cnaphtyl); 127.9 (Cnaphtyl); 128.0 (Cq-naphtyl); 128.1 (d, 4JC-P=2 Hz, Cnaphtyl); 128.2 (Cnaphtyl); 
128.3 (Cq-naphtyl); 128.5 (Cq-naphtyl); 128.8 (d, 4JC-P=5 Hz, Cphenyl); 128.9 (Cnaphtyl); 129.2 
(Cphenyl); 130.9 (d, 3JC-P=4 Hz, Cq-naphtyl); 133.2 (d, 3JC-P=19 Hz, Cq-naphtyl); 142.8 (Cq-phenyl); 
144.5 (d, 3JC-P=9 Hz, Cq-naphtyl); 145.2 (d, 4JC-P=3.0 Hz, Cphenyl); 147.2 (d, 3JC-P=6.3 Hz, Cq-
naphtyl) ppm 
 
HRMS: calculated: 565.2647 found: 565.2659 
 
 
5.3.2.2. (11bR)-3,5-dimethyl-N,N-bis((R)-1-phenylethyl)-3H-dinaphtho[2,1-d:1',2'-f] 
[1,3,2]diazaphosphepin-4(5H)-amine (L2) 
 
 
N
N
P N
CH3
CH3
 
 
The same procedure was applied as before in 5.5.2.1. (R,R)-21 was used instead of (S,S)-21 
for the ligand synthesis. 
Product: white solid, yield after crystallisation: 230 mg, 67%  
The product is very sensitive towards air and moisture, should be stored in cold under argon 
atmosphere. 
 
31 P NMR (600 MHz ;C6D6): δ=137.5 ppm 
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1H NMR (600 MHz; C6D6):1.14 (d, 3JH-H=6.8 Hz, 3H, HMe); 1.68 (d, 3JH-H=6.9 Hz, 3H, HMe); 
2.59 (d, JH-P=13.9 Hz, 3H, HNMe); 3.02 (d, JH-P=10.0 Hz, 3H, HNMe); 4.07 (dq, 3JH-H=6.9 Hz, 
JH-P=18.7 Hz , 1H, HCH); 4.67 (q, 3JH-H= 6.8 Hz, 1H, HCH); 6.79 (d, 3JH-H=8.9 Hz, 1H, 
Hnaphtyl); 6.84-6.90 (m, 2H, H. Hphenyl); 7.01 (t, 3JH-H=7.5 Hz, 1H, Hnaphtyl); 7.03-7.14 (m, 10H, 
Hnaphtyl + Hphenyl); 7.20 (d, 3JH-H=8.5 Hz, 1H, Hnaphtyl); 7.26 (d, 3JH-H=9.1 Hz, 1H, Hnaphtyl); 7.48 
(d, 3JH-H=7.8 Hz, 1H, Hnaphtyl); 7.57 (d, 3JH-H=8.2 Hz, 1H. Hnaphtyl); 7.71 (d, 3JH-H=8.2 Hz, 1H, 
Hnaphtyl); 7.75 (d, 3JH-H=9.1 Hz, 1H, Hnaphtyl); 7.85 (d, 3JH-H=9.1 Hz, 1H, Hnaphtyl) ppm 
 
13 C NMR (600 MHz; C6D6): δ=20.2 (CMe); 21.4 (CMe); 37.6 (d, 3JC-P=27 Hz, CNMe); 38.9 (d, 
3JC-P=42 Hz, CNMe); 53.7 (d, 3JC-P=8 Hz, CCH); 56.1 (d, 3JC-P=25 Hz, CCH); 112.1 (Cnaphtyl); 
113.4 (Cnaphtyl); 121.5 (Cnaphtyl); 122.0 (Cnaphtyl); 123.4 (Cnaphtyl); 124.1 (Cnaphtyl); 124.5 
(Cnaphtyl); 125.8 (Cnaphtyl);125.9 (Cphenyl); 126.4 (Cphenyl);126.7 (Cphenyl); 127.4; 127.6 (d, 4JC-
P=13 Hz, Cphenyl); 127.8; 128.1; 128.3 (Cphenyl); 129.0 (Cphenyl); 129.4; 129.8; 131.1 (Cq-naphtyl); 
131.5 (Cq-naphtyl); 133.2 (Cq-naphtyl); 133.5 (Cq-naphtyl); 144.1 (d, 3JC-P=9 Hz, Cq-naphtyl); 145.4 
(Cphenyl); 146.8 (Cq-phenyl); 147.2 (d, 3JC-P= 6 Hz; Cq-naphtyl) 
 
HRMS: calculated: 565.2647 found: 565.2641 
 
5.3.2.3 (3aR,7aR)-N,N-bis((R)-1-phenylethyl)-1,3-bis(phenylsulfonyl)hexahydro-1H-
benzo[d][1,3,2]diazaphosphol-2(3H)-amine (L3)  
 
(1R,2R)-N,N-bis-tosyl-cyclohexane-1,2-diamine (0.985 g, 2.3 mmol) was dissolved in 10 ml 
dry THF and the mixture was cooled down to -78 oC with a dry ice bath. BuLi (2.8 ml, 4.6 
mmol) was added dropwise with a syringe. The mixture was allowed to warm up to room 
temperature for 1h then cooled down again. (R,R)-21 (0.74g, 2.3 mmol) was added as toluene 
solution (5ml) dropwise via syringe. The mixture was stirred at room temperature for 
overnight. The formed white precipitate was filtrated through a short pad of alumina (ca. 2 
cm, Ø=3 cm). The removal of the solvent resulted in 1.41g (90% yield) white solid which is 
stable towards air and moisture. The product was recrystallised from THF/pentane (5ml/20ml) 
with 45% yield. 
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31P (600 MHz; CDCl3): δ= 99.5 ppm 
 
1H (600 MHz; CDCl3): δ= 0.65-0.73 (m, 1H, H-3); 0.84-0.94 (m, 1H, H-5); 0.97-1.07 (m, 1H, 
H-4); 1.20-1.32 (m, 1H, H-6); 1.50-1.57 (m, 1H, H-4); 1.58-1.65 (m, 1H, H-5); 1.81 (d, 3JH-
H=7.1 Hz, 6H, H-1´ and H-3´); 2.17-2.22 (m, 1H, H-1); 2.33-2.38 (m, 1H, H-3); 2.36 (s, 3H, 
H-9 or H-12); 2.54-2.59 (m, 1H, H-6); 2.55 (s, 3H, H-9 or H-12); 3.58-3.65 (m, 1H, H-2); 
4.81-4.89 (m, 2H, H-2´and H-4´); 6.97 (d, 3JH-H=7.8 Hz, 2H, H-8 or H-11); 7.13 (d, 3JH-H=6.8 
Hz, 2H, Harom); 7.15-7.20 (m, 4H, Harom); 7.24 (d, 3JH-H=7.8 Hz, 2H, H-7 or H-10); 7.27-7.31 
(m, 4H, Harom); 7.42 (d, 3JH-H=8.2 Hz, 2H, H-8 or H-11); 7.89 (d, 3JH-H=8.2 Hz, 2H, H-7 or H-
10) ppm 
  
13C (600 MHz; CDCl3): δ= 20.9 (d, 3JC-P=8 Hz, C-1´ and C-3´); 21.5 (C-9 or C-12); 21.7 (C-9 
or C-12); 23.4 (C-5); 24.2 (C-4); 28.2 (C-3); 31.3 (C-6); 56.9 (d, 3JC-P=16 Hz, C-2´and C-4´); 
63.9 (d, 3JC-P=6 Hz, C-2); 66.2 (d, 3JC-P=4 Hz, C-1); 126.4 (Carom); 126.7 (d, 4JC-P=4 Hz, C-7 
or C-10); 127.7 (Carom); 128.0 (d, 4JC-P=6 Hz, C-7 or C-10); 128.5 (Carom); 129.2 (C-8 or C-
11); 129.6 (C-8 or C-11); 134.5 (Cq-Me); 140.8 (Cq-Me); 142.1 (Carom); 142.7 (Cq-S); 143.7 
(Cq-S) ppm 
 
HRMS: calculated: 675.2354  found: 675.2352  
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5.3.2.4.(3aR,7aR)-N,N-bis((S)-1-phenylethyl)-1,3-bis(phenylsulfonyl)hexahydro-1H-
benzo[d][1,3,2]diazaphosphol-2(3H)-amine (L4) 
 
The same procedure as before in 5.5.2.3, (S,S)-21 was used instead of (R,R)-21 for the 
synthesis. 
(1R,2R)-N,N-bis-tosyl-cyclohexane-1,2-diamine: 0.922 g  
BuLi: 2.65ml  
(S,S)-21: 0.693 g 
Product: 1.43 g, 98% 
The product was recrystallised from THF/pentane (5ml/20ml) with 52 % yield. 
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31P (600 MHz; CDCl3): δ= 96.6 ppm 
 
1H (600 MHz; CDCl3): δ= 0.41-0.52 (m, 1H, H-3); 0.91-1.03 (m, 1H, H-5); 1.03-1.15 (m, 1H, 
H-4); 1.50-1.63 (m, 2H, H-4 and H-6); 1.64-1.74 (m, 1H, H-5); 1.86 (d, 3JH-H=7.1 Hz, 6H, 
1´and 3´); 1.85-1.97 (m, 1H, 3); 2.22-2.30 (m, 1H, 1); 2.39 (s, 3H, 9 or 12); 2.57 (s, 3H, 9 or 
12); 2.70-2.78 (m, 1H, 6); 3.26-3.34 (m, 1H, 2); 4.83-4.93 (m, 2H, 2´and 4´); 6.98 (d, 3JH-H 
=8.2 Hz, 2H, 8 or 11); 7.17-7.36 (m, 10H, ar); 7.28 (d, 3JH-H =8.2 Hz, 2H, 8 or 11); 7.44 (d, 
3JH-H =7.4 Hz, 4H, 7 or 10 and ar); 7.64 (d, 3JH-H =7.9 Hz, 2H, 7 or 10) ppm 
 
13C (600 MHz; CDCl3): δ= 21.1 (C-1´ and C-3´); 21.5 (C-9 or C-12); 21.6 (C-9 or C-12), 23.6 
(C-5); 24.2 (C-4); 28.3 (C-3); 31.5 (d, 3JC-P=2 Hz, C-6); 56.0 (d, 3JC-P=15 Hz, C-2´and C-4´); 
62.7 (d, 3JC-P=6 Hz, C-2); 66.9 (d, 3JC-P=5 Hz, C-1); 126.1 (d, 4JC-P=3 Hz, C-7 or C10); 127.0 
(Carom); 127.7 (Carom); 128.2 (d, 4JC-P=6 Hz, C-7 or C-10); 129.0 (Carom); 129.2 (C-8 or C-11); 
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129.3 (C-8 or C-11); 134.4 (Cq-Me); 141.0 (Cq-Me); 141.5 (Carom); 142.7 (Cq-S); 143.5 (Cq-S) 
ppm 
 
HRMS: calculated: 675.2354  found: 675.2355 
 
5.3.2.5. (3aR,7aR)-1,3-dimethyl-N,N-bis((R)-1-phenylethyl)hexahydro-1H-benzo[d] 
[1,3,2]diazaphosphol-2(3H)-amine (L5) 
 
(R,R)-N,N-Dimethyl-cyclohexane-1,2-diamine (0.500 g, 3.5 mmol) was dissolved in 5 ml 
toluene. DMAP (0.850 g, 7.7 mmol) was added and the mixture was allowed to stir for 10 
minutes. The mixture was cooled down to 0 oC with an ice bath and (R,R)-21 (1.137 g, 3.5 
mmol) was added dropwise as toluene solution (5 ml). White precipitate formation was 
observed immediately. The mixture was stirred for overnight at room temperature, after the 
formed precipitate was removed by filtration (with 2*10 ml toluene) over a short pad of 
alumina (cca 3 cm, Ø=3 cm). The product was obtained as transparent oil after the removal of 
solvent: 1.03 g, 75% yield 
The compound is sensitive towards air, moisture, heating and polar solvents (methanol, 
ethanol, DMSO). It easily decomposes upon standing even under argon atmosphere, should be 
stored in dark and cold. 
 
N
N
P N
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31P (600 MHz; CDCl3): δ= 112.8 ppm 
 
1H (600 MHz; CDCl3): δ= 1.00-1.09 (m, 1H, H-3); 1.22-1.30 (m, 1H, H-6); 1.72 (d, 3JH-H=6.9 
Hz, 6H, H-1´); 1.73-1.90 (m, 4H, H-4 and H-5); 2.03 (d, JH-P=12.0 Hz, H-7 or H-8); 2.06-2.15 
(m, 2H, H-3 and H-6); 2.25-2.30 (m, 1H, H-1); 2.74 (d, JH-P=14.1 Hz, H-7 or H-8); 3.07-3.14 
(m, 1H, H-2); 4.57-4.69 (m, 2H, H-2´); 7.20-7.34 (m, 10H, Harom) ppm 
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13C (600 MHz; CDCl3): δ= 22.2 (d, 3JC-P=7 Hz, C-1´); 24.2 (C-4 or C-5); 24.4 (C-4 or C-5); 
29.3 (C-6); 29.6 (C-3); 33.3 (C-7 or C-8); 33.5 (C-7 or C-8); 53.5 (d, 3JC-P=25 Hz, C-2´); 64.8 
(d, 3JC-P =9Hz, C-2); 68.8 (d, 3JC-P =3Hz, C-1); 126.2 (Carom); 127.6 (Carom); 128.2 (Carom); 
145.4 (Cq-arom)  
 
HRMS: calculated: 395.2490 found: 395.2491 
 
5.3.2.6.(3aR,7aR)-1,3-dimethyl-N,N-bis((S)-1-phenylethyl)hexahydro-1H-benzo [d] 
[1,3,2]diazaphosphol-2(3H)-amine (L6) 
 
The same procedure as before in 5.5.2.5, (S,S)-21 was used instead of (R,R)-21 for the 
synthesis. 
(R,R)-N,N-bis-dimethyl-cyclohexane-1,2-diamine: 0.500 g, 3.5 mmol  
DMAP: 0.850 g, 7.7 mmol 
(S,S)-21: 1.137 g, 3.5 mmol 
Product: colorless oil, 1.150 g, 83 % yield 
The compound is sensitive towards air, moisture, heating and polar solvents (methanol, 
ethanol, DMSO), easily decomposes upon standing even under argon atmosphere, should be 
therefore stored in dark and cold under inert atmosphere. 
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31P (600 MHz; CDCl3): δ= 109.7 ppm 
 
1H (600 MHz; CDCl3): δ= 1.15-1.24 (m, 1H, H-3); 1.34-1.41 (m, 1H, H-6); 1.84 (d, 3JH-H=6.8 
Hz, 6H, H-1´); 1.89-2.04 (m, 4H, H-4 and H-5); 2.16-2.26 (m, 2H, H-6 and H-3); 2.33-2.40 
(m, 1H, H-1); 2.47 (d, JH-P=18 Hz, 3H, H-7 or H-8); 2.82 (d, JH-P=15 Hz, 3H, H-7 or H-8); 
2.96-3.04 (m, 1H, H-2); 4.60-4.88 (m, 2H, H-2´); 7.34-7.52 (m, 10H, Harom) ppm 
 
13C (600 MHz; CDCl3): δ=19.9 (d, 3JC-P=7 Hz, C-1´); 24.1 (C-4 or C-5); 24.3 (C-4 or C-5); 
29.1 (C-6); 29.8 (C-3); 32.9 (C-7 or C-8); 33.2 (C-7 or C-8); 51.9 (d, 3JC-P=6 Hz, C-2´); 64.6 
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(d, 3JC-P=9 Hz, C-2); 68.7 (d, 3JC-P=4 Hz, C-1); 125.9 (Carom); 127.3 (Carom); 127.8 (Carom), 
143.2 (Cq-arom) 
 
HRMS: calculated: 395.2490 found: 395.2485 
 
 
5.3.2.7. (3aR,7aR)-1,3-bis(phenylsulfonyl)-2-(piperidin-1-yl)octahydro-1H-benzo [d] 
[1,3,2]diazaphosphole (L7) 
 
To a stirred solution of 27 (1 g, 2 mmol) in 5 ml toluene 2 equivalent of neat piperidine (0.40 
ml, 0.345 g, 4 mmol) was added via syringe. The mixture was allowed to stir for overnight at 
room temperature and the formed white precipitate was removed by filtration over neutral 
alumina (ca. 2 cm, Ø=3 cm). Then the short pad of alumina was additionally washed 3 times 
with 10 ml toluene/THF (1:1) mixture. The product (0.643 g, 60 %) was obtained after 
removal of the solvent in vacuo as white solid which is stable towards air and moisture.   
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31P (600 MHz; CDCl3): δ= 97.1 ppm  
 
1H (600 MHz; CDCl3): δ= 0.61-0.69 (m, 1H, H-3); 0.92-1.02 (m, 1H, H-4); 1.08-1.18 (m, 1H, 
H-5);1.38-1.47 (m, 1H, H-6); 1.55-1.69 (m, 8H, H-2´, H-3´, H-5 and H-4); 2.25-2.32 (m, 1H , 
H-3); 2.39 (s, 3H, H-9 or H-12); 2.38-2.45 (m, 1H, H-1); 2.47 (s, 3H, H-9 or H-12), 2.45-2.51 
(m, 1H, H-6); 3.16-3.30 (m, 4H, H-1´); 3.40-3.46 (m, 1H, H-2); 7.18 (d, 3JH-H=8.2 Hz, 2H, H-
8 or H-11); 7.34 (d, 3JH-H=7.9 Hz, 2H, H-8 or H-11); 7.58 (d, 3JH-H =8.2 Hz, 2H, H-7 or H-10); 
7.81 (d, 3JH-H=7.9 Hz, 2H, H-7 or H-10) ppm 
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13C (600 MHz; CDCl3): δ= 21.5 (C-9 or C-12); 21.6 (C-9 or C-12); 23.5 (C-5); 23.9 (C-4); 
24.5 (C-3´); 26.1 (d, 3JC-P=3 Hz, C-2´); 29.2 (C-3); 30.7 (d, 3JC-P=3 Hz, C-6); 47.3 (d, 3JC-P=18 
Hz, C-1´); 63.2 (d, 3JC-P=6 Hz, C-2); 65.3 (d, 3JC-P=5 Hz, C-1), 126.7 (d, 4JC-P=2 Hz, C-7 or C-
10); 127.7 (d, 4JC-P=6 Hz, C-7 or C-10); 129.4 (C-8 or C-11); 129.6 (C-8 or C-11); 135.7 (Cq-
CH3); 140.0 (Cq-CH3); 143.1 (Cq-S); 143.8 (Cq-S) ppm 
 
HRMS: calculated: 535.1728 found: 535.1731 
 
 
5.3.2.8. (3aR,7aR)-2-(pyrrolidin-1-yl)-1,3-ditosyloctahydro-1H-benzo [d][1,3,2] 
diazaphosphole (L8) 
 
The same procedure was used as before in 5.5.2.7, pyrrolidine was used instead of piperidine. 
27: 1g, 2 mmol 
pyrrolidine: 0.35 ml, 0.284 g, 4 mmol 
product: 0.635 g, 61 % 
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31P (600 MHz; CDCl3): δ= 95.0 ppm 
 
1H (600 MHz; CDCl3): δ= 0.82-0.91 (m, 1H, H-3); 0.95-1.12 (m, 2H, H-5 and H-4); 1.38-1.49 
(m, 1H, H-5); 1.59-1.73 (m, 1H, H-6);1.76-1.91 (m, 6H, H-2´, H-4 and H-3); 2.40 (s, 3H, H-9 
or H-12); 2.44-2.49 (m, 1H, H-1), 2.47 (s, 3H, H-9 or H-12); 2.72-2.78 (m, 1H, H-6); 3.10-
3.18 (m, 2H, H-1´); 3.22-3.33 (m, 1H, H-2); 3.35-3.42 (m, 2H, H-1´); 7.21 (d, 3JH-H=7.8 Hz, 
2H, H-8 or H-11); 7.34 (d, 3JH-H=8.1 Hz, 2H, H-8 or H-11); 7.61 (d, 3JH-H=7.8 Hz, 2H, H-7 or 
H-10); 7.78 (d, 3JH-H=8.1 Hz, 2H, H-7 or H-10) ppm 
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13C (600 MHz; CDCl3): δ= 21.5 (C-9 or C-12); 21.6 (C-9 or C-12); 23.4 (C-5); 23.9 (C-4); 
26.4 (d, 3JC-P =4 Hz, C-2´); 29.3 (C-3); 30.3 (d, 3JC-P =4 Hz, C-6); 47.6 (d, 3JC-P =15 Hz, C-
1´); 63.7 (d, 3JC-P =6 Hz, C-2); 65.4 (d, 3JC-P=5 Hz, C-1); 126.9 (C-7 or C-10); 127.6 (d, 4JC-
P=5 Hz, C-7 or C-10); 129.4 (C-8 or C-11); 129.7 (C-8 or C-11); 135.7 (Cq-CH3); 139.1 (Cq-
CH3); 143.3 (Cq-S); 143.8 (Cq-S) ppm 
 
HRMS: calculated: 521.1572  found: 521.1577 
 
 
5.3.2.9. (3aR,7aR)-N,N-dibutyl-1,3-ditosylhexahydro-1H-benzo[d][1,3,2]diazaphosphol-
2(3H)-amine  (L9) 
 
The same procedure was used as before in 5.5.2.7, dibutylamine was used instead of 
piperidine. 
27: 1g, 2 mmol 
dibutylamine: 0.67 ml, 0.517 g, 4 mmol 
product: 0.544 g, 47 % 
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31P (600 MHz; C6D6): δ= 100.4 ppm 
 
1H (600 MHz; C6D6): δ= 0.47-0.58 (m, 2H, H-3 and H-5); 0.75-0.85 (m, 1H, H-4); 0.95 (t, J=7.4 
Hz, 6H, H-4´); 1.09-1.16 (m, 1H, H-4); 1.23-1.29 (m, 1H, H-5); 1.37 (m, 4H, H-3´); 1.43-1.52 
(m, 1H, H-6); 1.77-187 (m, 4H, H-2´); 1.83 (s, 3H, H-9 or H-12); 1.88 (s, 3H, H-9 or H-12); 
2.36-2.43 (m, 1H, H-1); 2.48-2.53 (m, 1H, H-3); 2.65-2.71 (m, 1H, H-6); 3.26-3.35 (m, 2H, H-
1´); 3.42-3.51 (m, 2H, H-1´); 3.60-3.66 (m, 1H, H-2); 6.63 (d, 3JH-H =7.0 Hz, 2H, H-8 or H-11); 
 119 
6.80 (d, 3JH-H =7.6 Hz, 2H, H-8 or H-11); 7.65 (d, 3JH-H =7.0 Hz, 2H, H-7 or H-10); 7.94 (d, 3JH-H 
=7.6 Hz, 2H, H-7 or H-10) ppm 
 
13C (600 MHz; C6D6): δ= 14.2 (C-4´); 20.9 (C-3´); 21.0 (C-9 or C-12); 21.1 (C-9 or C-12); 23.8 
(C-5); 24.2 (C-4); 29.3 (C-3); 31.1 (d, 3JC-P=3 Hz, C-2´); 31.4 (d, 3JC-P=2 Hz, C-6); 47.8 (d, 3JC-
P=19 Hz, C-1´); 63.8 (d, 3JC-P=6 Hz, C-2); 66.1 (d, 3JC-P=4 Hz, C-1); 126.9 (C-7 or C-10); 128.3 
(C-7 or C-10); 129.4 (C-8 or C-11); 129.6 (C-8 or C-11); 136.6 (Cq-CH3);142.1 (Cq-CH3); 142.5 
(Cq-S); 143.3 (Cq-S) ppm 
 
HRMS: calculated: 579.2354  found: 579.2353 
 
 5.3.2.10. (3aR,7aR)-N-methyl-N-((R)-1-phenylethyl)-1,3-ditosylhexahydro-1H-benzo 
[d][1,3,2]diazaphosphol-2(3H)-amine (L10) 
 
The same procedure was used as before in 5.5.2.7, 1 eq (R)-N-methyl-1-phenylethanamine 
and 1eq DMAP was used instead of piperidine. 
27: 1g, 2 mmol 
(R)-N-methyl-1-phenylethanamine:  0.270 g, 2 mmol 
DMAP: 0.244 g, 2 mmol 
Product: 0.820 g, 70 % 
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31P (600 MHz; CDCl3): δ= 99.5 ppm 
 
 120 
1H (600 MHz; CDCl3): δ= 0.49-0.60 (m, 1H, H-3); 0.89-1.19 (m, 2H, H-5 and H-4); 1.26-1.37 
(m, 1H, H-6); 1.48-1.57 (m, 1H, H-4); 1.59-1.66 (m, 1H, H-5); 1.75 (d, 3JH-H=6.9 Hz, 3H, H-
1´); 2.38 (s, 3H, H-9 or H-12); 2.28-2.38 (m, 1H, H-1); 2.42-2.53 (m, 2H, H-3 and H-6); 2.45 
(s, 3H, H-9 or H-12); 2.51 (s, 3H, H-3´); 3.47-3.54 (m, 1H, H-2); 4.95-5.04 (m, 1H, H-2´); 
7.09-7.15 (m, 2H, H-8 or H-11); 7.21-7.30 (m, 3H, H-8 or H-11 and Harom); 7.32-7.40 (m, 2H, 
Harom); 7.49-7.56 (m, 2H, H-7 or H-10); 7.57-7.63 (m, 2H, Harom); 7.64-7.69 (m, 2H, H-7 or 
H-10) 
 
13C (600 MHz; CDCl3): δ= 17.6 (d, 3JC-P=5 Hz, C-1´); 21.5 (9 and 12), 23.5 (C-5); 24.0 (C-4); 
28.3 (d, 3JC-P= 2 Hz, C-3´); 28.5 (C-3); 30.3 (C-6); 57.9 (d, 3JC-P=42 Hz, C-2´); 62.6 (d, 3JC-P 
=7 Hz, C-2); 66.2 (d, 3JC-P=4 Hz, C-1); 126.5 (C-7 or C-10); 127.0 (Carom); 127.6 (C-7 or C-
10); 127.8 (Carom); 128.1 (Carom); 129.4 (C-8 or C-11); 129.6 (C-8 or C-11) ;136.0 (Cq-CH3); 
137.3 (Cq-arom); 140.5 (Cq-CH3); 143.2 (Cq-S); 143.6 (Cq-S) ppm 
 
HRMS: calculated: 585.1885  found: 585.1882 
 
5.3.2.11. (3aR,7aR)-N,N-diphenyl-1,3-ditosylhexahydro-1H-benzo[d][1,3,2]diazaphosphol-
2(3H)-amine (L11) 
 
Diphenylamine (0.347 g, 2 mmol) was dissolved in THF (5 ml) and the solution was cooled 
down to -78 oC. BuLi (1.25 ml (1.6 M in hexane), 2 mmol) was added dropwise and the 
solution was stirred for 30 minutes. 27 (1 g, 2 mmol) was added dropwise as a THF (10 ml) 
solution then mixture was allowed to warm up to room temperature and was stirred overnight. 
The white precipitate was filtered off through a short pad of alumina (ca. 2 cm, Ø=3 cm) and 
washed 3 times with 10 ml toluene/THF (1:1) mixture. The product was received after 
removal of solvent in vacuo as a white solid which is stable towards air and moisture: 0.806 g, 
(65% yield). 
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31P NMR: (600 MHz; CDCl3): δ= 89.1 ppm 
 
1H NMR (600 MHz; CDCl3): δ= 0.31-0.43 (m, 1H, H-3); 0.56-0.67 (m, 1H, H-5); 0.67-0.78 
(m, 1H, H-4); 0.80-0.92 (m, 1H, H-6); 1.32-1.41 (m, 1H, H-4); 1.41-1.49 (m, 1H, H-5); 2.03-
2.09 (m, 1H, H-1); 2.09-2.16 (m, 1H, H-3); 2.16-2.22 (m, 1H, H-2); 2.34 (s, 3H, H-9 or H-
12); 2.38-2.45 (m, 1H, H-6); 2.48 (s, 3H, H-9 or H-12); 6.90 (t, 3JH-H =7.0 Hz, 1H, Harom); 
7.03-7.08 (m, 4H, Harom); 7.22-7.27 (m, 2H, H-8 or H-11); 7.32-7.39 (m, 3H, H-8 or H-11 and 
Harom); 7.44 (d, 3JH-H =7.0 Hz, 2H, H-7 or H-10); 7.51 (m, 4H, Harom); 7.82 (d, 3JH-H =7.5 Hz, 
2H, H-7 or H-10) ppm 
 
13C NMR (600 MHz; CDCl3): δ= 21.5 (C-9 or C-12); 21.6 (C-9 or C-12); 23.3 (C-5); 23.8 (C-
4); 27.9 (C-3); 30.7 (C-6); 63.1 (d, 3JC-P=6 Hz, C-2); 66.0 (d, 3JC-P=4 Hz, C-1); 117.7 (Carom); 
120.9 (Carom); 126.4 (d, 4JC-P=2 Hz, C-7 or C-10); 127.7 (d, 4JC-P=6 Hz, C-7 or C-10); 129.1 
(Carom); 129.3 (Carom); 129.4 (C-8 or C-11); 129.7 (C-8 or C-11); 134.9 (Cq-Me); 140.3 (Cq-
Me); 143.1 (Cq-S); 143.2 (Cq-arom); 143.9 (Cq-S); 144.4 (Cq-arom) ppm 
 
HRMS: calculated: 619.1728 found: 619.1707 
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5.3.2.12. (3aR,7aR)-2-(1H-pyrrol-1-yl)-1,3-ditosyloctahydro-1H-benzo [d][1,3,2] 
diazaphosphole (L12) 
 
The same procedure was used as previously in 5.5.2.11, instead of diphenylamine pyrrol was 
used for the synthesis. 
 
27: 1g, 2 mmol 
Pyrrol: 0.14 ml, 0.134 g, 2 mmol  
BuLi: 1.25 ml, 2 mmol 
Product: white solid, which is stable towards air and moisture 0.745 g, 72% yield  
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31P (600 MHz; C6D6): δ= 84.8 ppm 
 
1H (600 MHz; C6D6): δ= 0.37-0.47 (m, 1H, H-5); 0.52-0.63 (m, 1H, H-4); 0.98-1.07 (m, 1H, 
H-3); 1.07-1.20 (m, 3H, H-4, H-5 and H-6); 1.81 (s, 3H, H-9 or H-12); 1.84 (s, 3H, H-9 or H-
12); 2.09-2.15 (m, 1H, H-3); 2.47-2.54 (m, 1H, H-6); 2.73-2.79 (m, 1H, H-1); 3.18-3.24 (m, 
1H, H-2); 6.37-6.38 (m, 2H, H-2´); 6.63 (d, 3JH-H =8.6 Hz, 2H, H-8 or H-11); 6.70 (d, 3JH-
H=8.5 Hz, 2H, H-8 or H-11); 7.19 (d, 3JH-H =8.6 Hz, 2H, H-7 or H-10); 7.31-7.33 (m, 2H, H-
1´); 7.70 (d, 3JH-H =8.5 Hz, 2H, H-7 or H-10) ppm 
 
13C (600 MHz; C6D6): δ= 21.0 (C-9 or C-12); 21.1 (C-9 or C-12); 23.4 (C-5); 23.5 (C-4); 29.4 
(C-3); 30.7 (C-6); 63.9 (d, 3JC-P=6 Hz, C-2); 67.1 (d, 3JC-P=4 Hz, C-1); 113.0 (C-2´); 123.6 (d, 
3JC-P=13 Hz, C-1´); 127.4 (C-7 or C-10); 128.3 (C-7 or C-10); 129.8 (C-8 or C-11); 130.0 (C-
8 or C-11); 136.3 (Cq-Me); 138.2 (Cq-Me); 143.6 (Cq-S); 144.2 (Cq-S) ppm 
 
HRMS: calculated: 517.1259  found: 517.1255 
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5.3.2.13. Diastereomeric mixture M1 (Containing ligands L13a and L13b) 
 
To a Schlenk flask DMAP (0.757 g, 6.2 mmol) and 28 (0.537 g, 3.1 mmol) was introduced. 
Toluene (5 ml) was added and the solution was vigorously stirred for 10 minutes. (R,R)-21 
(1g, 3.1 mmol) was dissolved in toluene (3 ml) and this solution was added dropvise to the 
mixture. White precipitate formation was observed immediatelly. The reaction mixture was 
stirred at room temperature overnight, then the precipitate was filtered off over a short pad of 
alumina (ca. 4 cm, Ø=3 cm) and the short column was washed 3 times with 15 ml toluene. 
After removal of the solvent in vacuo, the product was obtained as transparent viscous oil 
which is sensitive towards air and moisture, but can be stored in cold for several months under 
inert atmosphere: 1.223 g, (93 % yield). 
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31P (600 MHz; C6D6): δ= 105.8 (L13a): 90.2 (L13b) ratio 1 : 1.1 
 
13C NMR (600 MHz; C6D6): δ= 21.4 (C-1´b and C-3´b); 21.7 (d, 3JC-P=6 Hz, C-1´a and C-
3´a); 25.9 (C-2a); 28.3 (C-2b); 29.5 (C-3b); 32.8 (C-3a); 42.2 (d, 3JC-P=18 Hz, C-5b); 49.7 (d, 
3JC-P=42 Hz, C-1a); 49.9 (d, 3JC-P=5 Hz, C-1b); 54.0 (d, 3JC-P=9 Hz, C-2´a and C-2´a); 54.2 (d, 
3JC-P=10 Hz, C-5a); 62.5 (d, 3JC-P=8 Hz, C-4a); 63.7 (d, 3JC-P=6 Hz, C-4b); 115.7 (d, 4JC-P=13 
Hz, C-6b); 116.5 (d, 4JC-P=12 Hz, C-6a); 117.7 (C-8b); 118.0 (C-8a); 125.7 (Cphenyl); 126.7 
(Cphenyl); 127.8 (Cphenyl); 127.9 (Cphenyl); 128.3 (Cphenyl); 128.5 (C-7b); 129.0 (Cphenyl); 129.1 
(C-7a); 129.3 (Cphenyl); 143.9 (Cq-phenyl-b); 146.6 (Cq-phenyl-a); 147.1 (d, 3JC-P=14 Hz, Cq-a); 
147.3 (d, 3JC-P=14 Hz, Cq-b) ppm 
 
HRMS: calculated: 429.2334  found: 429.2336 
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5.3.2.14. Diastereomeric mixture M2 (Containing ligand L14a and L14b) 
 
 
The same procedure as before in 5.5.2.13, but (S,S)-21 was used for the synthesis instead of 
(R,R)-21. The product is a white solid which is sensitive towards air and moisture, but can be 
stored in cold for several months under inert atmosphere: 1.265 g, 95% yield 
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31P (600 MHz; C6D6): δ=  108.0 (a) : 86.4 (b) (1 : 3) ppm 
 
13C (600 MHz; C6D6): δ= 21.4 (d, 3JC-P=11 Hz, C-1´b and C-3´b); 21.5 (d, 3JC-P=12 Hz, C-1´a 
and C-3´a); 25.9 (C-2a); 28.3 (C-2b); 29.0 (C-3b); 32.6 (C-3a); 41.9 (d, 3JC-P=17 Hz, C-5b); 
49.5 (d, 3JC-P=42 Hz, C-1a); 50.1 (d, 3JC-P=3 Hz, C-1b); 52.8 (d, 3JC-P=8 Hz, C-2´b and C-4´b); 
53.3 (d, 3JC-P=9 Hz, C-2´a and C-4´a); 54.9 (d, 3JC-P=5 Hz, C-5a); 61.6 (d, 3JC-P=8 Hz, C-4a); 
63.5 (d, 3JC-P=8 Hz, C-4b); 116.1 (d, 4JC-P=12 Hz, C-6a) 116.5 (d, 4JC-P=13 Hz, C-6b); 118.0 
(C-8b); 126.6 (Cphenyl-b); 126.9 (Cphenyl-a); 128.0 (Cphenyl-a and Cphenyl-b); 128.9 (C-7a); 129.0 
(Cphenyl-a); 129.1 (C-7b); 129.3 (Cphenyl-b); 143.8 (Cq-phenyl-b); 146.6 (Cq-phenyl-a); 146.8 (d, 3JC-
P=15 Hz, Cq-a); 147.9 (d, 3JC-P=12 Hz, Cq-b) ppm 
 
HRMS: calculated: 429.2334  found: 429.2325 
 
5.3.2.15.(3aS)-2-phenyl-N,N-bis((R)-1-phenylethyl)hexahydro-1H-pyrrolo[1,2c] [1,3,2] 
diazaphosphol-1-amine (L13a) 
 
In a 100 ml Schlenk flask (R,R)-bis(α-methyl-benzyl)-amine (1.113 g, 1.1 ml, 4.9 mmol) was 
dissolved in dry THF (10 ml) and cooled down to -78 oC with dry ice bath. BuLi (3.1 ml (1.56 
M in hexane) 4.8 mmol) was added dropvise and the solution was stirred for 30 minutes. 
After, 31 (1.19 g, 4.9 mmol) was added dropwise via syringe as a THF solution (10 ml). The 
mixture was allowed to warm to room temperature and stirred overnight while white 
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precipitate formed. Then, the solvent was removed and 15 ml toluene was added. The 
precipitated LiCl was filtrated off over a short pad of alumina (ca. 5 cm, Ø=3 cm) and the 
column was washed two times with 10 ml toluene. The product (2.008 g, 95% yield) was 
obtained as a transparent oil after removal of the solvent in vacuo. 
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31P (600 MHz; C6D6): δ= 105.8 ppm 
 
1H (600 MHz;C6D6): δ= 1.14-1.22 (m, 1H, H-3); 1.41-1.51 (m, 2H, H-2); 1.52-1.58 (m, 1H, 
H-3); 1.61 (d, 3JH-H= 7.1 Hz, 6H, H-1´and H-3´); 2.97-3.04 (m, 2H, H-1 and H-5 ); 3.39-3.46 
(m, 1H, H-1); 3.73-3.78 (m, 1H, H-5); 3.78-3.84 (m, 1H, H-4); 4.42-4.49 (m, 2H, H-2´and H-
4´); 7.00 (t, 3JH7-H8=7.3 Hz, 1H, H-8); 7.10-7.34 (m, 10H, Hphenyl); 7.36 (d, 3JH6-H7=8.3 Hz, 2H, 
H-6); 7.43 (dd, 3JH7-H6=8.3 Hz, 3JH7-H8=7.3 Hz, 2H, H-7) ppm 
 
13C (600 MHz; C6D6): δ= 21.5 (d, 3JC-P=12 Hz, C-1´and C-3´); 25.9 (d, 3JC-P=4 Hz, C-2); 32.6 
(C-3); 49.5 (d, 3JC-P=42 Hz, C-1); 54.0 (d, 3JC-P=9 Hz, C-2´ and C-2´); 54.2 (d, 3JC-P=7 Hz, C-
5); 62.5 (d, 3JC-P=8 Hz, C-4); 116.1 (d, 4JC-P=12 Hz, C-6); 118.0 (C-8); 127.0 (Cphenyl), 128.1 
(Cphenyl), 129.1 (C-7); 129.2 (Cphenyl); 146.6 (Cq-phenyl); 147.1 (d, 3JC-P=14 Hz, Cq) ppm 
 
HRMS: calculated: 429.2334  found: 429.2334 
 
 
5.3.2.16 (3aS)-2-phenyl-N,N-bis((S)-1-phenylethyl)hexahydro-1H-pyrrolo[1,2c][1,3,2] 
diazaphosphol-1-amine (L14a) 
 
The same procedure as before in 5.5.2.15, but (S,S)-bis(α-methyl-benzyl)-amine was used for 
the synthesis instead of (R,R)-bis(α-methyl-benzyl)-amine 
(S,S)-bis(α-methyl-benzyl)-amine: 1.133 g, 1.2 ml, 5.0 mmol 
31: 1.21 g, 5.0 mmol 
BuLi: 3.2 ml (1.56 M in THF), 5.0 mmol 
Product: white solid (1.793 g, 83% yield) 
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31P (600 MHz; C6D6): δ= 108.8 ppm 
 
1H (600 MHz; C6D6): δ= 1.09-1.15 (m, 1H, H-3); 1.34-1.44 (m, 2H, H-2); 1.55-1.63 (m, 1H, 
H-3); 1.71 (d, 3JH-H=6.8 Hz, 6H, H-1´and H-3´); 2.63-2.68 (m, 1H, H-5); 2.98-3.05 (m, 1H, H-
1); 3.34-3.41 (m, 1H, H-1); 3.47-3.53 (m, 1H, H-5); 3.69-3.74 (m, 1H, H-4); 4.36-4.43 (m, 
2H, H-2´and H-4´); 6.44 (d, 3JH6-H7=7.6 Hz, 2H, H-6); 6.82 (t, 3JH7-H8=7.3 Hz, 1H, H-8); 6.95 
(m, 4H, Hphenyl); 7.03-7.16 (m, 6H, Hphenyl); 7.19 (dd, 3JH6-H7=7.6 Hz, 3JH6-H8=7.3 Hz, 2H, H-7) 
ppm 
 
13C (600 MHz; C6D6): δ= 21.5 (d, 3JC-P=11 Hz, C-1´ and C-3´) ; 25.9 (C-2); 32.7 (C-3); 49.5 
(d, 3JC-P =41 Hz, C-1); 53.3 (d, 3JC-P=10 Hz, C-2´ and C-4´), 54.9 (d, 3JC-P=5 Hz, C-5); 61.6 
(d, 3JC-P=8 Hz, C-4); 116.1 (d, 4JC-P=12 Hz, C-6); 118.0 (C-8); 126.9 (Cphenyl), 127.9 (Cphenyl); 
128.9 (C-7); 129.0 (Cphenyl); 146.6 (Cq-phenyl); 146.8 (d, 3JC-P=15 Hz, Cq) ppm 
 
HRMS: calculated: 429.2334 found: 429.2334 
 
 
5.3.2.17.(3aS)-N,N,2-triphenylhexahydro-1H-pyrrolo[1,2-c][1,3,2]diazaphosphol-1-
amine (L22) 
 
The same procedure as before in 5.5.2.15, but diphenylamine was used for the synthesis 
instead of was used for the synthesis instead of (R,R)-bis(α-methyl-benzyl)-amine. 
 
Diphenylamine: 0.340 g; 2.0 mmol 
31: 0.500 g; 2.0 mmol 
BuLi: 1.25 ml (1.6 M in hexane), 2.0 mmol 
Product: white solid (0.420 g, 55% yield)  
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31P (600 MHz; C6D6): δ= 103.2 and 90.6 (100 : 1) ppm 
 
 
1
 H (600 MHz; C6D6): δ= 0.86-0.92 (m, 1H, H-3); 1.23-1.36 (m, 3H, H-2 and H-3); 2.49-2.58 
(m, 1H, H-5); 2.69-2.75 (m, 1H, H-5); 2.91-3.03 (m, 2H, H-1 and H-4); 6.78 (t, 3JH8-H7=7.4 
Hz, 1H, H-8); 6.79-6.83 (m, 2H, Harom); 7.02 (d, 3JH6-H7=8.6 Hz, 2H, H-6); 7.05-7.08 (m, 2H, 
Harom); 7.16 (dd, 3JH7-H6=8.6 Hz, 3JH7-H8=7.4 Hz, 2H, H-7); 7.07-7.11 (m, 4H, Harom); 7.23-
7.27 (m, 2H, Harom) ppm 
 
13C (600 MHz; C6D6): δ= 26.1 (C-2); 32.4 (C-3); 49.8 (d, 3JC-P=41 Hz, C-1); 54.1 (d, 3JC-P=5 
Hz, C-5); 62.3 (d, 3JC-P=8 Hz, C-4); 115.8 (d, 4JC-P=13 Hz, C-6); 116.2 (d, 4JC-P=4 Hz, Carom); 
118.8 (C-8); 123.6 (Carom); 124.9 (d, 4JC-P=7.7 Hz, Carom); 129.3 (Carom); 129.4 (C-7); 146.8 (d, 
3JC-P=17 Hz, Cq); 146.8 (d, 3JC-P=10 Hz, Cq-arom) ppm 
 
 
5.3.2.18. (3aS)-2-phenyl-1-(1H-pyrrol-1-yl)hexahydro-1H-pyrrolo[1,2-c][1,3,2] 
diazaphosphole (L23) 
 
The same procedure as before in 5.5.2.15, but pyrrol was used for the synthesis instead of 
(R,R)-bis(α-methyl-benzyl)-amine. 
 
Pyrrol: 0.14 ml; 0.135 g; 2.0 mmol 
31: 0.500 g; 2.0 mmol 
BuLi: 1.25 ml, (1.6 M in THF), 2.0 mmol 
Product: white solid (0.488 g, 90% yield)  
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31P (600 MHz; C6D6): δ= 100.8 : 89.1 (15:1) ppm 
 
1
 H (600 MHz; C6D6): δ= 1.03-1.09 (m, 1H, H-3); 1.17-1.27 (m, 2H, H-2); 1.35-1.43 (m, 1H, 
H-3); 2.61-2.66 (m, 1H, H-5); 2.76-2.83 (m,1H, H-1); 3.09-3.17 (m, 1H, H-1); 3.19-3.24 (m, 
1H , H-5); 3.70-3.74 (m, 1H, H-4); 6.39-6.42 (m, 2H, H-2´); 6.75 (t, 3JH8-H7=7.4 Hz, 2H, H-8); 
6.86 (d, 3JH6-H7=7.8 Hz, 2H, H-6); 7.00-7.03 (m, 2H, H-1´); 7.08 (dd, 3JH7-H6=7.8 Hz, 3JH7-
H8=7.4 Hz, 2H, H-7) ppm 
 
13C (600 MHz; C6D6): δ= 26.1 (d, 3JC-P=5 Hz, C-2); 31.2 (C-3); 49.4 (d, 3JC-P=37 Hz, C-1);  
53.6 (d, 3JC-P=6 Hz, C-5); 63.1 (d, 3JC-P=8 Hz, C-4); 111.5 (C-2´); 115.7 (d, 4JC-P=13 Hz, C-6); 
119.7 (C-8); 121.6 (d, 3JC-P=14 Hz, C-1´); 129.5 (C-7); 145.4 (d, 3JC-P=15 Hz, Cq) ppm 
 
HRMS: calculated: 271.12384 found: 271.12380 
 
 
5.3.2.19. (3aS)-2-phenyl-1-(piperidin-1-yl)hexahydro-1H-pyrrolo[1,2-c] [1,3,2] 
diazaphosphole (L15) 
 
 
To a stirred solution of 31 (0.600 g; 2.5 mmol) in 5 ml toluene 2 equivalent of neat piperidine 
(0.5 ml; 0.43 g; 5.0 mmol) was added via syringe. The mixture was allowed to stir at room 
temperature for overnight. After, the white precipitate was removed by filtration over a short 
pad of neutral alumina (5 cm, Ø=3 cm), and the column was washed 2 times with 10 ml 
toluene. The product (0.417 g, 58% yield) was obtained after removal of the solvent in vacuo. 
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31P (600 MHz; C6D6): δ= 114.7 and 95.7 (45: 1) ppm 
 
1H (600 MHz; C6D6): δ=1.12-1.19 (m, 1H, H-3); 1.23-1.41 (m, 8H, H-2, H-2´, H-3´and H-4´); 
1.50-1.57 (m, 1H, H-3); 2.77-2.81 (m, 1H, H-5); 2.95-3.10 (m, 5H, H-1, H-1´ and H-5´) ; 
3.42-3.48 (m, 2H, H-1 and H-5); 3.71-3.76 (m, 1H, H-4); 6.97 (t, 3JH8-H7=7.3 Hz, 1H, H-8); 
7.24 (d, 3JH6-H7=7.8 Hz, 2H, H-6); 7.39 (dd, 3JH7-H6=7.8 Hz, 3JH7-H8=7.3 Hz, 2H, H-7) ppm 
 
13C (600 MHz; C6D6): δ= 25.5 (C-3´); 25.7 (d, 3JC-P=5 Hz, C-2), 27.3 (d, 3JC-P=5 Hz, C-2´ and 
C-4´); 32.4 (C-3); 46.3 (d, 3JC-P=16 Hz, C-1´ and C-5´); 50.4 (d, 3JC-P=40 Hz, C-1); 54.3 (d, 
3JC-P=7 Hz, C-5), 62.7 (d, 3JC-P=8 Hz, C-4); 115.6 (d, 4JC-P=12 Hz, C-6); 118.2 (C-8); 129.2 
(C-7); 147.4 (d, 3JC-P=14 Hz, Cq) ppm 
 
HRMS: calculated: 289.1708  found: 289.1670 
 
 
5.3.2.20. (3aS)-2-phenyl-1-(pyrrolidin-1-yl)hexahydro-1H-pyrrolo[1,2-c] [1,3,2] 
diazaphosphole (L16) 
 
The same procedure as before in 5.5.2.19, but pyrrolidine was used for the synthesis instead 
of piperidine. 
 
Pyrrolidine:  0.42 ml; 0.356 g; 5.0 mmol 
31: 0.600 g; 2.5 mmol 
Product: white solid (0.406 g, 59% yield) 
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31P (600 MHz; C6D6): δ= 107.3 and 91.7 (80: 1) ppm 
 
1
 H (600 MHz; C6D6): δ= 1.17-1.23 (m, 1H, H-3); 1.37-1.47 (m, 5H, H-2´, H-3´and H-2); 
1.55-1.62 (m, 1H, H-3); 2.76-2.80 (m, 1H, H-5); 2.96-3.01 (m, 2H, H-1´and H-4´), 3.03-3.09 
(m, 1H, H-1); 3.14-3.19 (m, 2H, H-1´and H-4´); 3.39-3.47 (m, 2H, H-5 and H-1); 3.78-3.83 
(m, 1H, H-4); 6.84 (t, 3JH8-H7=7.4 Hz, 1H, H-8); 7.06 (d, 3JH6-H7=8.9 Hz, 2H, H-6); 7.27 (dd, 
JH7-H6=8.9 Hz,  JH7-H8=7.4 Hz, 2H, H-7) ppm 
 
13C (600 MHz; C6D6): δ=25.8 (d, 3JC-P=3 Hz, C-2´and C-3´); 26.5 (d, 3JC-P=4 Hz, C-2); 32.4 
(C-3); 46.6 (d, 3JC-P=14 Hz, C-1´and C-4´); 50.8 (d, 3JC-P=40 Hz, C-1); 54.7 (d, 3JC-P=5 Hz, C-
5); 63.1 (d, 3JC-P=8 Hz, C-4); 115.2 (d, 4JC-P=13 Hz, C-6); 118.0 (C-8); 129.3 (C-7); 147.4 (d, 
3JC-P=14 Hz, Cq) ppm 
 
HRMS: calculated: 275.1551 found: 275.1542 
 
 
5.3.2.21. 4-((3aS)-2-phenylhexahydro-1H-pyrrolo[1,2-c][1,3,2]diazaphosphol-1-yl) 
morpholine (L17) 
 
The same procedure as before in 5.5.2.19, but morpholine was used for the synthesis instead 
of piperidine. 
 
Morpholine: 0.150 ml; 0.143 g; 1.66 mmol 
31: 0.200 g; 0.83 mmol 
Product: white solid (0.148 g, 61% yield) 
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31P (600 MHz; C6D6): δ= 114.5 ppm 
 
1H (600 MHz; C6D6): δ= 1.10-1.17 (m, 1H, H-3); 1.30-1.37 (m, 2H, H-2); 1.48-1.56 (m, 1H, 
H-3); 2.48 (m, 2H, H-2´); 2.70-2.74 (m, 1H, H-5); 2.82-2.99 (m, 3H, H-3´and H-1); 3.31-3.44 
(m, 4H, H-1, H-5 and H-4´); 3.45-3.47 (m, 2H, H-1´); 3.57-3.64 (m, 1H, H-4); 6.86 (t, 3JH8-
H7=7.3 Hz, 1H, H-8); 7.06 (d, 3JH6-H7=7.8 Hz, 2H, H-6); 7.26 (dd, 3JH7-H6=7.8 Hz, 3JH7-H8=7.3 
Hz, 2H, H-7) ppm 
 
13C (600 MHz; C6D6): δ= 25.7 (d, 3JC-P=4 Hz, C-2), 32.3 (C-3); 45.6 (d,4JC-P=12 Hz, C-3´); 46.4 
(C-2´); 50.3 (d, 3JC-P=38 Hz, C-1); 54.4 (d, 3JC-P=6 Hz, C-5), 62.8 (d, 3JC-P=7 Hz, C-4); 67.7 (d, 
3JC-P=18 Hz, C-4´); 67.8 (d, 3JC-P=6 Hz, C-1´); 115.6 (d, 4JC-P=11 Hz, C-6); 118.5 (C-8); 129.2 
(C-7); 147.0 (d, 3JC-P=14 Hz, Cq) ppm 
 
 
HRMS: calculated: 291.1501 found: 291.1493 
 
 
5.3.2.22. (3aS)-N,N-diisopropyl-2-phenylhexahydro-1H-pyrrolo[1,2 ] [1,3,2] 
diazaphosphol-1-amine (L18) 
 
The same procedure as before in 5.5.2.19, but diisopropylamine was used for the synthesis 
instead of piperidine. 
 
Diisopropylamine: 0.47 ml; 0.336 g; 3.32 mmol 
31: 0.400 g; 1.66 mmol 
Product: white solid (0.441 g, 87% yield) 
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 31P (600 MHz; C6D6): δ= 107.0 ppm 
 
1H (600 MHz; C6D6): δ= 1.13 (d, 3JH-H=7.1 Hz, 6H, H-1´ and H-2´); 1.14-1.19 (m, 1H, H-3); 
1.25 (d, 3JH-H =7.1 Hz, 6H, H-4´ and H-5´); 1.36-1.43 (m, 2H, H-2); 1.54-1.60 (m, 1H, H-3); 
2.73-2.77 (m, 1H, H-5) ; 2.94-3.10 (m, 1H, H-1); 3.30-3.36 (m, 2H, H-3´ and H-6´); 3.36-3.42 
(m, 1H, H-1); 3.52-3.55 (m, 1H, H-5); 3.69-3.75 (m, 1H, H-4); 6.83 (t, 3JH8-H7=7.3 Hz, 1H, H-
8); 7.16 (d, 3JH6-H7=8.3 Hz, 2H, H-6); 7.27 (dd, 3JH7-H6=8.3 Hz, 3JH7-H8=7.3 Hz, 2H, H-7) ppm 
 
13C (600 MHz; C6D6): δ= 23.7 (d, 4JC-P=6 Hz, C-1´and C-2´); 24.8 (d, 4JC-P=10 Hz, C-4´ and 
C-6´); 25.7 (d, 3JC-P=5 Hz, C-2); 32.6 (C-3); 45.3 (d, 3JC-P=10 Hz, C-3´ and C-6´); 49.5 (d, 3JC-
P=42 Hz, C-1); 54.7 (d, 3JC-P=6 Hz, C-5); 61.8 (d, 3JC-P=7 Hz, C-4); 116.0 (d, 4JC-P=11 Hz, C-
6); 118.1 (C-8); 129.0 (C-7); 147.2 (d, 3JC-P=14 Hz, Cq) ppm 
 
HRMS: calculated: 305.2021 found: 305.2020 
 
  
5.3.2.23 (3aS)-N,N-dibutyl-2-phenylhexahydro-1H-pyrrolo[1,2-c][1,3,2]diazaphosphol-1-
amine (L19) 
 
The same procedure as before in 5.5.2.19, but dibutylamine was used for the synthesis instead 
of piperidine. 
 
Dibutylamine:  0.28 ml; 0.214 g; 1.66 mmol 
31: 0.200 g; 0.83 mmol 
Product: transparent oil (0.255 g, 92% yield) 
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31P (600 MHz; C6D6): δ= 118.2 and 97.6 (47:1) ppm 
 
1H (600 MHz; C6D6): δ= 0.84 (t, 3JH-H=7.3 Hz, 6H, H-4´); 1.10-1.30 (m, 5H, H-3´and H-3); 
1.31-1.46 (m, 6H, H-2´and H-2); 1.53-1.64 (m, 1H, H-3); 2.81-2.86 (m, 1H, H-5); 2.88-2.95 
(m, 2H, H-1´); 2.98-3.04 (m, 1H, H-1); 3.10 (m, 2H, H-5´); 3.44-3.50 (m, 1H, H-1); 3.52-3.56 
(m, 1H, H-5); 3.78-3.83 (m,1H, H-4); 6.82 (t, 3JH8-H7=7.3 Hz, 1H, H-8); 7.05 (d, 3JH6-H7=8.2 
Hz, 2H, H-6); 7.26 (dd, 3JH7-H6=8.2 Hz, 3JH7-H8=7.3 Hz, 2H, H-7) ppm 
 
13C (600 MHz; C6D6): δ= 14.1 (C-4´); 20.6 (C-3´); 25.9 (d, 3JC-P=4 Hz, C-2); 31.4 (C-2´); 32.7 
(C-3); 46.0 (d; 3JC-P=18 Hz, C-1´ and C-5´); 50.1 (d, 3JC-P=43 Hz, C-1); 54.4 (d, 3JC-P=7 Hz, 
C-5); 62.5 (d, 3JC-P=8 Hz, C-4); 115.6 (d, 4JC-P=12 Hz, C-6); 118.1 (C-8); 129.1 (C-7); 147.3 
(d, 3JC-P=14 Hz, Cq) ppm 
 
HRMS: calculated: 333.2334  found: 333.2331 
 
 
5.3.2.24.(3aS)-N-methyl-2-phenyl-N-((R)-1-phenylethyl)hexahydro-1H-pyrrolo[1,2-
c][1,3,2] diazaphosphol-1-amine (L20) 
 
 
To a stirred solution of 31 (0.800 g; 3.32 mmol) in 5 ml toluene, 1 equivalent of DMAP 
(0.406 g, 3.32 mmol) was added and the mixture was stirred for 10 minutes. (R)-N-methyl-1-
phenylethanamine (0.48 ml; 0.449 g; 3.32 mmol) was added neat via syringe and the mixture 
was allowed to stir for overnight at room temperature. The formed white precipitate was 
removed by filtration over a short pad of neutral alumina (5 cm, Ø=3 cm) and the column was 
washed two times with 10 ml toluene. The product was obtained as transparent oil after 
evaporation of the solvent in vacuo: 0.779 g, 70 % yield 
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31P (600 MHz; C6D6): δ= 118.5 : 97.8 (115 : 1) ppm 
  
1H (600 MHz; C6D6): δ= 1.09-1.15 (m, 1H, H-3); 1.33-1.44 (m, 2H, H-2); 1.40 (d, 3JH-H=7.0 
Hz, 3H, H-2´); 1.49-1.55 (m, 1H, H-3); 2.18 (d, 3JH-P=5.2 Hz, 3H, H-1´); 2.80-2.86 (m, 1H, 
H-5); 3.00-3.06 (m, 1H, H-1); 3.46-3.53 (m, 2H, H-5 and H-1); 3.69-3.72 (m, 1H, H-4); 4.88-
4.95 (m, 1H, H-3´); 6.86 (t, 3JH8-H7=7.3 Hz, 1H, H-8); 7.08 (t, 3JH8´-H7´=7.1 Hz, 1H, H-8´); 
7.11 (d, 3JH6-H7=8.7 Hz, 2H, H-6); 7.20 (m, 2H, H-7´); 7.28 (dd, 3JH7-H6=8.7 Hz, 3JH7-H8=7.3 
Hz, 2H, H-7); 7.34 (d, 3JH6´-H7´=8.7 Hz, 2H, H-6´) ppm 
 
13C (600 MHz; C6D6): δ= 18.0 (d, 3JC-P=7 Hz, C-2´); 25.9 (d, 3JC-P=4 Hz, C-2); 26.9 (C-1´); 
32.7 (C-3); 50.2 (d, 3JC-P=40 Hz, C-1); 54.3 (d, 3JC-P=7 Hz, C-5); 56.0 (d, 3JC-P=36 Hz, C-3´); 
62.7 (d, 3JC-P=8 Hz, C-4); 115.8 (d, 4JC-P=13 Hz, C-6); 118.3 (C-8); 126.7 (C-8´); 127.6 (C-
6´); 128.3 (C-7´); 129.2 (C-7); 144.1 (d, 3JC-P=3 Hz, Cq´); 147.0 (d, 3JC-P=13 Hz, Cq) ppm 
 
HRMS: calculated: 339.1864  found: 339.1863 
 
 
5.3.2.25. (3aS)-N,N-dibenzyl-2-phenylhexahydro-1H-pyrrolo[1,2-c][1,3,2]diazaphosphol-
1-amine (L21) 
 
The same procedure as before in 5.5.2.24, but dibenzylamine was used for the synthesis 
instead of (R)-N-methyl-1-phenylethanamine 
 
Dibenzylamine: 0.160 ml; 0.163 g; 0.83 mmol 
31: 0.200 g; 0.83 mmol 
DMAP: 0.101 g, 0.83 mmol 
Product: transparent oil which solidifies upon standing (0.252 g, 76 % yield) 
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 31P (600 MHz; C6D6): δ= 118.8 : 96.6 (68 : 1) ppm 
 
1H (600 MHz; C6D6): δ= 1.21-1.29 (m, 1H, H-3); 1.48-1.57 (m, 2H, H-2); 1.61-1.69 (m, 1H, 
H-3); 2.79-2.87 (m, 1H, H-5); 3.13-3.20 (m, 1H, H-1); 3.51-3.61 (m, 2H, H-1 and H-5); 3.77-
3.84 (m, 1H, H-4); 3.91 (dd, 2JH-H=15.5 Hz, 3JH-P=10.7 Hz, 2H, H-1´ and H-2´); 4.33 (dd, 2JH-
H=15.5 Hz, 3JH-P=6.7 Hz, 2H, H-1´ and H-2´); 6.90 (t, 3JH8-H7=7.3 Hz, 1H, H-8); 7.06-7.12 (m, 
4H, H-6 and Harom); 7.13-7.19 (m, 6H, H-7 and Harom); 7.28-7.31 (m, 4H, Harom) ppm 
 
13C (600 MHz; C6D6): δ= 25.9 (d, 3JC-P=5 Hz, C-2); 32.5 (C-3); 50.0 (d, 3JC-P=18 Hz, C-1´ and 
C-2´); 50.2 (d, 3JC-P= 40 Hz, C-1); 54.5 (d, 3JC-P=7 Hz, C-5); 62.3 (d, 3JC-P=7 Hz, C-4); 116.0 
(d, 4JC-P=13 Hz, C-6); 118.5 (C-8); 126.9 (Carom); 127.2 (Carom); 128.3 (Carom); 129.3 (C-7); 
142.2 (d, 3JC-P=8 Hz, Cq-arom); 146.9 (d, 3JC-P=15 Hz, Cq) ppm 
 
HRMS: calculated: 401.2021 found: 401.2025 
 
 
5.3.3  Borane adducts and metal complexes  
 
5.3.3.1 Preparation of borane complex of M1 (containing ligands L13a and L13b) 
 
To the stirred mixture of M1 (0.558, 1.3 mmol) BH3.THF (1M solution, 3 ml) was added 
dropwise via syringe and the mixture was stirred at room temperature for overnight. The 
volatiles were removed in vacuo, and the yellowish solid was purified by flash 
chromatography over neutral alumina with pentane/ethyl-acetate (5:1). The product was 
obtained as white solid which is stable towards air and moisture: 0.518 g, 90 % yield. 
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31P NMR (300 MHz; CDCl3): δ= 100.0 (L13a.BH3) and 87.4 (L13b.BH3) ppm 
 
5.3.3.2 Isolation of L13a.BH3 by crystallisation 
 
The diastereomeric mixture M1.BH3 (0.268 g, mmol) was dissolved in 5 ml CHCl3 and cold 
pentane was added dropwise. After addition of 25 ml pentane white crystals start to 
precipitate. The solution was kept at –30 oC for overnight. After filtration 62 mg of the 
(S,R,R,Rp).BH3 diastereomer can be separated.  
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31P NMR (300 MHz; C6D6): δ= 101.4 (m) ppm 
 
1H (300 MHz; C6D6): δ= 1.07-1.17 (m, 1H, H-3); 1.16-1.32 (m, 3H, H-BH3); 1.22 (d, 3JH-H=7 
Hz, H-1´and H-3´); 1.31-1.50 (m, 2H, H-2); 1.74-1.89 (m, 1H, H-3); 2.59-2.91 (m, 3H, H-1 
and H-5); 3.08-3.23 (m, 1H, H-5); 3.87-4.03 (m, 1H, H-4); 4.91-5.10 (m, 2H, H-2´and H-4´); 
6.90 (t, 3JH-H=7.6 Hz, H-8); 6.96-7.28 (m, 12H, Hphenyl and H-6); 7.35-7.48 (m, 2H, H-7) 
 
13C (300 MHz; C6D6): δ= 20.2 (C-1´and C-3´); 25.9 (d, 3JC-P=3 Hz, C-2); 32.1 (C-3); 46.1 (d, 
3JC-P =11Hz, C-1); 51.9 (d, 3JC-P=3 Hz, C-2´and C-4´); 60.3 (C-4); 119.2 (d, 4JC-P=5 Hz, C-6); 
121.5 (C-8); 127.3 (Cphenyl); 128.4 (Cphenyl); 128.9 (C-7); 129.0 (Cphenyl); 142.5 (d, 3JC-P=4 Hz, 
Cq); 143.7 (Cq-phenyl) ppm 
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Crystals for X-Ray measurements were obtained by slow diffusion of pentane into a CDCl3 
solution. For crystal structure analysis see Chapter 3.1.3.5. 
 
5.3.3.3  Liberation of the free M1 from M1.BH3 
 
M1.BH3 (55 mg, 0.12 mmol) was dissolved in 1 ml toluene and dry diethylamine (0.3 ml, 3.2 
mmol) was added via syringe. The solution was stirred overnight at room temperature 
(increasing the reaction temperature to 60 oC as described 45 leads to decomposition of the 
ligand).The solvent as well as the excess of diethylamine and the borane adduct of 
diethylamine were removed in vacuo for overnight. The resulting oily material was extracted 
with 4 ml pentane, giving 40 mg pure M1. (Yield: 78 %) 
 
31P NMR (C6D6): δ= 105.8 ppm : 90.02 ppm (ratio 1 : 0.9) ppm 
 
5.3.3.4 Separation of the diastereomers via metal complex formation for diastereomeric 
mixture M1  
 
Rhodium bis-cyclooctadienyl tetrafluoroborate (10 mg, 0.05 mmol) was dissolved in 5 ml 
dichloromethane. M1 (43 mg, 0.1 mmol, 2 eq of ligand with respect to the Sp diastereomer) 
was added dropwise as a 2 ml dichloromethane solution and the mixture was stirred at room 
temperature for 15 minutes while the deep orange colored solution turned to yellow, as a sign 
of coordination. After the solution was concentrated to 3 ml and 20 ml cold pentane was 
added dropwise to precipitate a yellow solid. The mixture was vigorously stirred for one hour, 
than the fine solid was allowed to sedimentate overnight. The colorless pentane layer was 
carefully removed with a syringe, and transferred to a Schlenk flask. After removal of 
pentane, colorless oil remained, which is the pure, non-coordinated Sp diastereomer (L13a). 
The yellow solid was additionally washed 2 times with 3 ml cold pentane and dried in vacuo. 
The product is the Rh complex of the Rp (L13b) diastereomer.  
yield: 33.8 mg of the [Rh(COD)(L13b)2]BF4  
 21 mg of the S,R,R,Sp (L13a) diastereomer (98 % yield) 
31P NMR (CD2Cl2): δ= 96.8 ppm (JP-Rh=184 Hz) for [Rh(COD)(L13b)2]BF4  
                 105.8 ppm for L13a 
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5.3.3.5 Attempt for coordintation of L4 with [Rh(NOD)(acac)] 
 
(1,5-norbornadiene)(2,4-pentadienato)rhodium (I) (5 mg, 0.017 mmol) was dissolved in THF 
(0.5 ml) in an NMR tube to give a yellow solution. TMS triflate (3 µl, 0.017 mmol) was 
added via syringe and the color darkened slightly. L4 (23 mg, 0.034 mmol) was added as a 
solid, after the tube was shaken. No further color change was observed. No coordination took 
place as indicated by 31P NMR: δ= 99.5 ppm.(free L4) 
 
5.3.3.6 Attempt for coordination of L4 with [Rh(acac)2CO2] 
 
(2,4-pentadienato)-dicarbonyl-rhodium(I) (13 mg, 0.05 mmol) was dissolved in 3 ml 
dichloromethane, the solution of L4 (70 mg, 0.1 mmol) was added by cooling, dropwise. No 
gas formation was observed. No coordination took place according to 31P NMR: δ= 99.5 ppm 
(free L4) 
 
5.3.3.7 Attempt for coordination of L4 with [Rh(COD)2BF4] 
 
Dicyclooctadiene-rhodium-tetrafluoroborate (38.7 mg, 0.1 mmol) was dissolved in 3 ml 
dichloromethane. L4 (140 mg, 0.2 mmol) was added dropwise at 0 oC in 3 ml 
dichloromethane. No color change could be observed. The solution was further stirred for 5 
hours at room temperature, then concentrated and introduced to 10 ml cold pentane via 
syringe. The free ligand precipitated as white solid: 31P NMR: δ= 99.5 ppm (free L4) 
 
5.3.3.8 Attempt for coordintation of L4 with [CpPd(Allyl)] 
 
[CpPd(Allyl)] (10 mg, 0.009 mmol) was introduced in an NMR tube in the glove box and 0.5 
ml of CDCl3 was added. Ligand L4 (12 mg, 0.018 mmol) was added as solid, but neither gas 
formation nor color change could be observed. 31P NMR indicated the presence of the free 
ligand: 31P NMR: δ=99.8 ppm (free L4) 
 
 
 
 
5.3.3.9 Rh complex formation for IR measurements with [Rh(CO)2Cl]2 
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The corresponding ligand was dissolved in 1 ml dichloromethane and this solution was added 
dropwise to the dichloromethane solution of [Rh(CO)2Cl]2. Sample was taken for NMR 
measurement. The rest of the solution was concentrated to 1 ml and with a Pasteur-pipette 
was added dropwise to the surface of a KBr pastille. After several minutes the solvent 
evaporated, and IR spectra were taken. 
 
5.4 Catalysis 
 
5.4.1 General procedure for Cu-catalyzed addition of Et2Zn to cyclohex-2-enone 
 
[(CuOTf)2·benzene] (2.6 mg, 0.005 mmol) was added to a ligand solution (0.011 mmol) in 
anhydrous toluene (1 mL) and the resulting mixture was stirred for 1 h at room temperature 
until the Cu precursor completely dissolved. Then the solution was cooled down to the 
indicated temperature with a cryostate. When the temperature stabilised, Et2Zn (400 µL, 0.4 
mmol, 1 M in toluene) was added via syringe, and the resulting yellow solution was allowed to 
stirr for 10 minutes. Subsequently, cyclohexenone (20 µl, 19.8 mg, 0.2 mmol) was added via 
syringe, the mixture was stirred at the desired reaction temperature for the indicated time and 
finally quenched with 2 ml saturated aqueous solution of NH4Cl.  
The organic layer was washed with brine (2 mL), distilled water (2 mL) and dried over 
Na2SO4. From this solution 0.3 ml was taken and diluted to 1 ml with toluene or 
dichloromethane (both HPLC grade) for GC analysis.  
 
5.4.2 Isolation of 3-ethylcyclohexanone 
 
In a Schlenk [(CuOTf)2·benzene] (130 mg, 0.25 mmol) was dissolved in 25 ml toluene. To the 
vigorously stirred suspension triphenylphosphine (288 mg, 1.1 mmol) was added as solid, in 
an argon stream. The mixture was stirred for 1 hour until the copper precursor fully dissolved. 
The resulted slightly yellow solution was cooled down to -20 oC and Et2Zn (1.1 M solution in 
toluene, 20 ml, 22 mmol) was added with a dropping funnel by cooling, followed by the 
addition of cyclohexenone (1 ml, 11 mmol). The reaction was followed with TLC. After 5 
hours the mixture was quenched with aqueous solution of NH4Cl, the organic phase was 
washed 2 times with 1 ml brine and dried over Na2SO4. 
The solvent was evaportated, and the resulted slightly yellow oily material was distilled by 
Kugelrohr at 170 oC (40 mbar), to give the product as a transparent liquid. 
Product: 1.25 g, 90% yield.  
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1H NMR (300 MHz, CDCl3): δ= 0.82 (t, 3JH-H=7.5 Hz, 3H, HCH3); 1.15-1.38 (m, 3H, HCH2 
and HCy); 1.46-1.67 (m, 2H, HCy); 1.76-2.02 (m, 3H, HCy); 2.09-2.39 (m, 3H, HCy) ppm 
 
13C NMR (300 MHz, CDCl3): δ=10.9; 25.0; 29.0; 30.6; 40.5; 41.2; 47.5; 211.5 ppm 
 
Conditions for Gas chromatography:  
Carrier gas: 0.6 bar H2; Column: 25 m Lipodex E; Temperature program: 90 oC isotherm; 
Detector: FID; Retention times:2-cyclohexenone: 6.0 min, (S)-3 ethylcyclohexanone: 6.4min, 
(R)-3 ethylcyclohexanone 6.8 min 
 
5.4.3 General procedure for Ni catalysed hydrovinylation of styrene: 
 
[Ni(allyl)Br]2  (2 mg, 0.006 mmol) was dissolved in 1.5 ml dichloromethane and 1.5 ml ligand 
solution (0.0012 mmol) was added via syringe. The mixture was cooled down to the indicated 
temperature and styrene (0.41 ml, 372 mg, 3.6 mmol) was added via syringe. The Schlenk 
was subsequently purged with ethene and NaBARF was added under ethene stream. The 
Schlenk was connected to the ethene line and the reaction was allowed to run for the indicated 
time. After, the mixture was quenched with saturated aqueous solution of ammonia, 0.41 ml 
ethylbenzene was added, and the organic phase was further extracted with brine and dried 
over Na2SO4. Finally the slightly yellow organic phase was pressed through a short pad of 
silica (which removed the color) and analysed with GC. For determination of conversion no 
dilution of the sample is needed. For determination of enantioselectivity 0.1 ml from the 
solution was taken and diluted to 1 ml with dichloromethane (HPLC grade).  
  
Conditions for Gas chromatography for determination of conversion: 
Carrier gas: 1.3 bar N2; Temperature program: 50 oC initial, 5 min isotherm, 8 oC/min to 
230oC; Column: 50 m Cp-Sil-Pona; Detector: FID; internal standard: ethylbenzene 
 
Retention times: 
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The compounds were identified by GC-MS. 
 
Conditions for Gas chromatography for determination of enantioselectivity 
Carrier gas: 1 bar H2 ;Temperature program: 60-85 (1 oC/min), 85-180 oC (20 oC/min); 
Column: 25 m Pb-OV5 + 25 m Lipodex 7; Detector: FID; Retention times:(R) 3-phenyl-1-
butene: 15.9 min, (S) 3-phenyl-1-butene: 16.2 min, (E+Z) 2-Phenyl-1-butene: 16.7 min 
  
5.4.4 Hydrogenation of dimethyl-itaconate  
 
Powdered and predried dimethylitaconate (0.313 g, 2 mmol) was transferred as solid to a 
stainless steel autoclave, and the autoclave was connected to vacuum for one hour. In a 
Schlenk flask the indicated Rh precursor was dissolved in 1 ml dichloromethane and 1 ml 
ligand solution was added dropwise at room temperature. The obtained yellow solution was 
transferred to the autoclave via syringe under argon stream. The autoclave was sealed and 
pressurised with 30 bar hydrogen. After overnight stirring at room temperature, the pressure 
was carefully released by opening the needle valve and the vessel was opened. The solution 
was passed through a Pasteur pipette filled with silica (cca 3 cm). From the obtained solution 
0.1 ml was diluted to 1 ml with dichloromethane (HPLC grade). This solution was analysed 
by GC. 
Conditions for the GC analysis: 
Carrier gas: 0.6 bar H2 ;Temperature program: 80 oC isotherm; Column: 25 m Lipodex E 
Detector: FID; Retention times: S-2-Methylsuccinic acid dimethyl ester: 6.5 min, R-2-
Methylsuccinic acid dimethyl ester: 6.8 min, Dimethyl itaconate: 14.4 min
Substance Retention time (min) 
Ethylbenzene 15.6  
Styrene 16.4  
3-phenyl-1 butene  20.1 
2-phenyl 1 butene (E) 20.5 
2-pheny-1 butene (Z) 22.8 
Oligomer (FW:160g/mol)  24.5-25.3 
Oligomer (FW:208g/mol)  35.7 and 41.3 
Oligomer (FW:236g/mol) 38.1-38.9 
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7. Appendices 
 
7.1. Abbreviations
 
Ac   acetyl, acetate 
Ar   aryl 
Acac    acetyl-acetonate 
BINOL  1,1’-Bi-2-naphthol 
BuLi    Butyl-lithium 
conv   conversion 
COSY   Correlated Spectroscopy, correlation spectrum 
Cp    cyclopentadiene 
COD   cycloocadiene 
DCM   dichloromethane 
DFT   Density Functional Theory 
DMAP  4-dimethylaminopyridine 
DMSO  dimethylsulfoxide 
ee   enantiomeric excess 
d.r   diastereomeric ratio 
Et   ethyl 
eq   equivalent(s) 
EWG   electron withdrawing group 
FID    flame ionisation detector 
GC    gas chromatography 
h   hour(s) 
HR-MS  High Resolution Mass Spectroscopy 
Hz   Hertz 
IR   infrared 
J   coupling constant 
LiAH   lithium aluminiumhydride 
m       multiplet  
m   meta 
Me   methyl 
min   minute(s) 
NOD   norbornadiene 
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NMR   Nuclear Magnetic Resonance 
NOE   Nuclear Overhauser Effect 
NOESY  Nuclaer Overhauser Effect Spectroscopy 
PTA    phosphorous triamide 
Ph   phenyl 
ppm   parts per million 
q   quartet 
r   reaction rate 
r.t.   room temperature 
s   singulet, strong  
t   time, triplet 
Tf   trifluormethanesulfonyl 
THF   tetrahydrofurane 
TLC   Thin Layer Chromatography 
Tos   p-toluenesulfonate 
TMS    trimethylsilyl 
y   yield 
*   symbol for a stereogenic center 
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7.2. Crystal structure data 
7.2.1. Crystal structure data for ligand L1
 
 
 
Empirical formula C38H36N3P 
Formula weight 565.69 g/mol 
Space group P2(1) 
Crystal system Monoclinic 
Z 2 
a / Ǻ 10.7743 
b / Ǻ 15.2175 
c / Ǻ 11.0639 
Cell volume / Ǻ3 1721.54 
Calculated density / g*cm-3 1.179 
T / K 110 
λ / Ǻ 0.71073 (MoKα) 
F(000) 684.0 
µ (MoKα) / mm-1 0.12 
Detector Bruker Smart APEX-CCD 
Independent reflections 5242 
Parameter 465 
Resolution of structure Direct methods 
Refinement method F2 
Hydrogen atoms Positions calculated 
R1 0.0422 
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ωR2 0.1060 
GOF 0.736 
Flack-x-Parameter -0.0054 (σ=0.0537) 
 
Atom positions:  
 
Atom x y z sof Ueq / A2 
P1           0.05598    0.30349    0.79392 1.00000 0.01657 
N1           0.21785    0.27494    0.85544 1.00000 0.01907 
N2           0.01430    0.22888    0.66815  1.00000 0.01645 
N3          -0.02834    0.25932    0.88336 1.00000 0.01660 
C22         -0.01137 0.16762    0.93026 1.00000 0.01877 
H22          0.05815    0.14173    0.89895 1.00000  
C1           0.31727    0.14695    0.98651  1.00000 0.02351 
H1           0.33288    0.18132    1.06151 1.00000  
C2           0.34616    0.05992    0.99679 1.00000 0.02594 
H2           0.37952    0.03383    1.07869 1.00000  
C3           0.32712    0.00796    0.88714  1.00000 0.02157 
C4           0.35415 -0.08370 0.89630 1.00000 0.02978 
H4           0.38334 -0.11086 0.97771 1.00000  
C5           0.33881 -0.13287 0.79036 1.00000 0.03361 
H5           0.35830  -0.19389 0.79805 1.00000  
C6           0.29396 -0.09363   0.66869 1.00000 0.02975 
H6           0.28412  -0.12835 0.59489 1.00000  
C7           0.26447  -0.00573 0.65623 1.00000 0.02248 
H7           0.23230    0.01937    0.57358 1.00000  
C8           0.28118    0.04823    0.76452 1.00000 0.01777 
C9           0.25386    0.14031    0.75516 1.00000 0.01611 
C10          0.26391    0.18769    0.86512   1.00000 0.01809 
C11          0.21526    0.18754    0.63097  1.00000 0.01503 
C12          0.30281    0.19289    0.55620 1.00000 0.01635 
C13          0.42870    0.15390    0.59539 1.00000 0.01918 
H13          0.45763    0.12297    0.67390 1.00000  
C14          0.50949    0.16026    0.52123 1.00000 0.02312 
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H14          0.59304    0.13298    0.54860  1.00000  
C15          0.47016    0.20653    0.40563 1.00000 0.02550 
H15          0.52663    0.21018    0.35495 1.00000  
C16          0.35059      0.24626    0.36625   1.00000 0.02354 
H16          0.32511    0.27850    0.28877 1.00000  
C17          0.26361    0.24018    0.43926 1.00000 0.01825 
C18          0.14015    0.28182    0.40025 1.00000 0.01963 
H18          0.11294    0.31296    0.32186  1.00000  
C19          0.05955    0.27799    0.47338  1.00000 0.01823 
H19         -0.02276 0.30690    0.44578  1.00000  
C20          0.09716    0.23131    0.59025 1.00000 0.01587 
C21          0.29400    0.33761    0.95034 1.00000 0.03405 
H21A         0.28211    0.32507    1.03288   1.00000  
H21B         0.26409    0.39747    0.92376   1.00000  
H21C         0.38680    0.33224    0.95794 1.00000  
C23          0.04273    0.16439    1.07577  1.00000 0.02575 
H23A         0.12596    0.19623    1.10467 1.00000  
H23B         0.05677    0.10307    1.10383 1.00000  
H23C        -0.01990  0.19181    1.11198  1.00000  
C24         -0.13125 0.10959    0.87680 1.00000 0.01948 
C25         -0.14218 0.05843    0.76932 1.00000 0.02520 
H25         -0.07644    0.06207    0.72903 1.00000  
C26         -0.24769 0.00226    0.72031 1.00000 0.03053 
H26         -0.25379   -0.03194 0.64683 1.00000  
C27         -0.34392   -0.00403 0.77819 1.00000 0.03300 
H27         -0.41620   -0.04237  0.74463 1.00000  
C28         -0.33427    0.04572    0.88493 1.00000 0.03133 
H28         -0.40006 0.04143    0.92508 1.00000  
C29         -0.22871  0.10219    0.93425 1.00000 0.02509 
H29         -0.22309   0.13607    1.00791  1.00000  
C30         -0.21488  0.36478    0.82290  1.00000 0.01770 
C31         -0.33637    0.32546    0.77061  1.00000 0.02192 
H31         -0.35483  0.27144    0.80444 1.00000  
C32         -0.43147 0.36459    0.66888  1.00000 0.02692 
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H32         -0.51368  0.33659    0.63284 1.00000  
C33         -0.40663 0.44390    0.62031  1.00000 0.02807 
H33         -0.47172 0.47065    0.55133 1.00000  
C34         -0.28674 0.48412    0.67248  1.00000 0.02650 
H34         -0.26955  0.53894    0.63988  1.00000  
C35         -0.19121 0.44452    0.77258 1.00000 0.02239 
H35         -0.10858  0.47227    0.80715 1.00000  
C36         -0.11114 0.31930    0.93157 1.00000 0.01865 
H36         -0.15895  0.28163    0.97634 1.00000  
C37         -0.02942 0.38427    1.03041 1.00000 0.02604 
H37A         0.03043    0.35180    1.10162 1.00000  
H37B        -0.08748 0.42091    1.06185 1.00000  
H37C         0.02113    0.42171    0.99105 1.00000  
C38         -0.12696   0.23370    0.59863 1.00000 0.02207 
H38A        -0.14965 0.29359    0.56677 1.00000  
H38B        -0.17652  0.21812    0.65614  1.00000  
H38C        -0.14855 0.19260    0.52681  1.00000  
C39          0.66978    0.01897    0.27904 1.00000 0.03433 
H39          0.58229 -0.00205 0.25270 1.00000  
C40          0.76858  -0.03239 0.35659 1.00000 0.03764 
H40          0.74906 -0.08835 0.38410 1.00000  
C41          0.89581  -0.00220 0.39405 1.00000 0.03356 
H41          0.96402 -0.03740 0.44748 1.00000  
C42          0.92412    0.07930    0.35385 1.00000 0.03071 
H42          1.01190    0.09968    0.37856  1.00000  
C43          0.82486    0.13088    0.27794   1.00000 0.02836 
H43          0.84420    0.18735    0.25195  1.00000  
C44          0.69721    0.10083    0.23940  1.00000 0.02876 
H44          0.62898    0.13610    0.18616  1.00000  
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7.2.2. Crystal structure data for ligand L4 
 
Empirical formula C36H42N3O4PS2 
Formula weight 675.84 g/mol 
Space group P2(1) 
Crystal system Monoclinic 
Z 2 
a / Ǻ 9.8249 
b / Ǻ 12.7119 
c / Ǻ 13.8102 
Cell volume / Ǻ3 1693.34   
Calculated density / g*cm-3 1.331 
T / K 130 
λ / Ǻ 0.71073 (MoKα) 
F(000) 722.0 
µ (MoKα) / mm-1 0.25 
Detector Bruker Smart APEX-CCD 
Independent reflections 9780 
Parameters 419 
Resolution of structure Direct methods 
Refinement method F2 
Hydrogen atoms Positions calculated 
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R1 0.0412 
ωR2 0.1072 
GOF 0.611 
Flack-x-Parameter 0.0758 (σ=0.0487) 
 
 
Atom positions:  
 
 
Atom x y z sof Ueq / A2 
P1           0.25988    0.78904    0.77998 1.00000 0.01831 
S2           0.23439    0.75345     0.57024  1.00000 0.02357 
S1           0.17410    0.95821    0.90101 1.00000 0.02470 
N3           0.42005    0.75833    0.83638  1.00000 0.01738 
N1           0.22729    0.92392    0.80091 1.00000 0.02207 
N2           0.29444    0.83042    0.66499 1.00000 0.01964 
O1           0.11586    0.86503    0.93508   1.00000 0.03501 
O4           0.23337    0.65009    0.61015 1.00000 0.03385 
O2           0.28038    1.01358    0.96653  1.00000 0.03509 
O3            0.31123    0.77379    0.49424  1.00000 0.03102 
C1          -0.34510 0.92740    0.45397  1.00000 0.03310 
H1A         -0.36449 0.94773    0.38425 1.00000  
H1B         -0.35124  0.98950    0.49496 1.00000  
H1C         -0.41304 0.87486    0.46588  1.00000  
C2          -0.20192 0.88159    0.47973 1.00000 0.02517 
C3          -0.10052 0.90663    0.42536 1.00000 0.02710 
H3          -0.12252 0.95336    0.37095 1.00000  
C4           0.03092    0.86492    0.44899  1.00000 0.02647 
H4           0.09887    0.88219    0.41099  1.00000  
C5           0.06306    0.79711    0.52925 1.00000 0.02246 
C6          -0.03543  0.77130    0.58407 1.00000 0.02938 
H6          -0.01318  0.72465    0.63852  1.00000  
C7          -0.16666 0.81370    0.55930 1.00000 0.03019 
H7          -0.23430 0.79609    0.59745 1.00000  
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C8          -0.26970  1.28209    0.75903 1.00000 0.03712 
H8A         -0.22327  1.35048    0.76069  1.00000  
H8B         -0.33913  1.28439    0.80140  1.00000  
H8C         -0.31530 1.26602    0.69120  1.00000  
C9          -0.16419  1.19807    0.79565 1.00000 0.02682 
C10         -0.16148 1.10376    0.74468 1.00000 0.03240 
H10         -0.22932 1.09075    0.68710    1.00000  
C11         -0.06109   1.02897    0.77705   1.00000 0.03182 
H11         -0.06071 0.96443     0.74242  1.00000  
C12          0.03889     1.04852     0.86015  1.00000 0.02262 
C13          0.03578    1.14079    0.91310 1.00000 0.02653 
H13          0.10320    1.15367    0.97094   1.00000  
C14         -0.06726  1.21401    0.88033  1.00000 0.02731 
H14         -0.07101 1.27667    0.91723 1.00000  
C15          0.30604    0.99613    0.74831  1.00000 0.02007 
H15          0.40637    0.99179    0.77968 1.00000  
C16          0.28644    0.94578    0.64670  1.00000 0.02162 
H16          0.19088    0.96282    0.61047   1.00000  
C17          0.38953    0.99148    0.58934  1.00000 0.02913 
H17A         0.37854    0.95757    0.52378 1.00000  
H17B         0.48538    0.97901    0.62523  1.00000  
C18          0.36186    1.10949    0.57752 1.00000 0.03393 
H18A         0.43364    1.14190    0.54556 1.00000  
H18B         0.27071    1.12074    0.53392 1.00000  
C19          0.36260    1.16338    0.67619 1.00000 0.03330 
H19A         0.33532    1.23790    0.66410  1.00000  
H19B         0.45812    1.16220    0.71532  1.00000  
C20          0.26517    1.11187    0.73618  1.00000 0.02713 
H20A         0.27449    1.14610    0.80150  1.00000  
H20B         0.16774     1.11863    0.70134  1.00000  
C21          0.54796    0.81098    0.81842  1.00000 0.01935 
H21          0.51869    0.85613    0.75880  1.00000  
C22          0.61083    0.88551    0.90175   1.00000 0.02735 
H22A         0.65896    0.84452    0.95809 1.00000  
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H22B         0.53697    0.92712    0.92189  1.00000 
 
H22C         0.67689    0.93270    0.87876   1.00000  
C23          0.64997    0.73110    0.79083   1.00000 0.01996 
C24          0.60238    0.65312    0.72254 1.00000 0.02233 
H24          0.50651    0.64964    0.69415 1.00000  
C25          0.69319    0.57996    0.69507  1.00000 0.02768 
H25          0.65903    0.52608    0.64918 1.00000  
C26          0.83330    0.58575    0.73463  1.00000 0.03199 
H26          0.89550    0.53543    0.71660 1.00000  
C27          0.88193    0.66422    0.79984  1.00000 0.03107 
H27          0.97845    0.66895    0.82586  1.00000  
C28          0.79165     0.73727    0.82855   1.00000 0.02477 
H28          0.82677    0.79137    0.87393 1.00000  
C29          0.43978    0.68030    0.91910  1.00000 0.01941 
H29          0.53926     0.65833    0.92980  1.00000  
C30          0.41768    0.72788    1.01666  1.00000 0.02745 
H30A         0.43689    0.67458    1.06874  1.00000  
H30B         0.32150    0.75181    1.00979  1.00000  
H30C         0.48047    0.78772    1.03395  1.00000  
C31          0.35547    0.58143    0.89244   1.00000 0.01981 
C32          0.41163    0.49797    0.84786  1.00000 0.02507 
H32          0.50280    0.50384    0.83475  1.00000  
C33          0.33707    0.40688    0.82243   1.00000 0.03184 
H33          0.37764    0.35086    0.79228  1.00000  
C34          0.20442     0.39617    0.84023  1.00000 0.03304 
H34          0.15258    0.33407    0.82081  1.00000  
C35          0.14762    0.47707    0.88679   1.00000 0.03196 
H35          0.05719    0.46980    0.90099 1.00000  
C36          0.22276    0.56909    0.91286 1.00000 0.02567 
H36          0.18308    0.62408    0.94494  1.00000  
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7.2.3. Crystal structure data for ligand L9 
 
 
 
 
Empirical formula C28H42N3O4PS2 
Formula weight 579.75 gmol 
Space group P2(1) 
Crystal system Monoclinic 
Z 4 
a / Ǻ 8.9879 
b / Ǻ 15.0349 
c / Ǻ 22.1226 
Cell volume / Ǻ3 2953.94 
Calculated density / g*cm-3 1.304 
T / K 130 
λ / Ǻ 0.71073 (MoKα) 
F(000) 1240.0 
µ (MoKα) / mm-1 0.27 
Detector Bruker Smart APEX-CCD 
Independent reflections 14579 
 161 
Parameter 685 
Resolution of structure Direct methods 
Refinement method F2 
Hydrogen atoms Positions calculated 
R1 0.0460 
ωR2 0.1274 
GOF 0.826 
Flack-x-Parameter 0.0418 (σ=0.0470) 
 
 
Atom positions:  
 
Atom x y z sof Ueq / A2 
S3           0.64096    0.92930    0.28279 1.00000 0.02430 
P2 0.82284    0.86131    0.39525   1.00000 0.01783 
S2 0.86449 0.39824 0.21955 1.00000 0.02065 
P1 0.68680 0.47620 0.11158 1.00000 0.01823 
S1 0.37720 0.51598 0.05880 1.00000 0.02131 
S4 1.13074 0.83256 0.44942 1.00000 0.02047 
O8 1.26447 0.88235 0.47184 1.00000 0.02573 
O2 0.25251 0.46356   0.03143 1.00000 0.02829 
O5 0.54476 0.86943 0.30978 1.00000 0.03308 
O6   0.59412 1.01923 0.26894 1.00000 0.03295 
N6 0.74825 0.91417 0.44869 1.00000 0.02125 
N3 0.75517 0.42597 0.05554   1.00000 0.02112 
O3 0.90959 0.31047 0.23894 1.00000 0.02917 
N4 0.79925 0.92905 0.32871 1.00000 0.02219 
N2 0.71033 0.39426 0.16975 1.00000 0.02034 
O7 1.04751 0.79144 0.49227 1.00000 0.02967 
O1 0.46789    0.56210    0.02113  1.00000 0.02897 
N1      0.49324    0.45240    0.10315 1.00000 0.02162 
N5            1.01296    0.89963    0.40769  1.00000 0.01825 
C53          0.83747    0.75808    0.59254 1.00000 0.05585 
H53A         0.93759    0.75125    0.61683  1.00000  
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H53B         0.83547    0.72889    0.55282  1.00000  
H53C         0.76202    0.73073    0.61428  1.00000  
O4           0.96653    0.45210    0.19130   1.00000  
C1           0.14188    0.80108    0.21299 1.00000 0.04434 
H1A          0.05121    0.77998    0.22810 1.00000  
H1B          0.11734    0.85399    0.18754 1.00000  
H1C          0.21918    0.81610    0.24773  1.00000  
C2           0.20054    0.72859    0.17519 1.00000 0.03115 
C3           0.12659    0.64847    0.16490 1.00000 0.03091 
H3           0.03780    0.63820    0.18227  1.00000  
C4           0.17868    0.58288    0.12994 1.00000 0.02499 
H4           0.12598    0.52814    0.12311 1.00000  
C5           0.30816    0.59752    0.10495 1.00000 0.02176 
C6           0.38382    0.67753    0.11397 1.00000 0.03670 
H6           0.47155    0.68773    0.09588 1.00000  
C7           0.33211    0.74183    0.14895  1.00000 0.04257 
H7           0.38555    0.79633    0.79633    1.00000  
C8           0.44965    0.36993    0.13311  1.00000 0.02191 
H8           0.46411    0.31841    0.10602  1.00000  
C9           0.29434    0.36207    0.15170  1.00000 0.02834 
H9A          0.21564    0.36828    0.11538 1.00000  
H9B          0.27960    0.40951     0.18125  1.00000  
C10          0.28355    0.27125    0.18078  1.00000 0.03830 
H10A         0.28694    0.22473    0.14935 1.00000  
H10B         0.18555    0.26630    0.19571 1.00000  
C11          0.41097    0.25468    0.23428   1.00000 0.04394 
H11A         0.39733    0.29475    0.26852 1.00000  
H11B         0.40422    0.19269    0.24870  1.00000  
C12          0.56747    0.26997    0.21708 1.00000 0.03324 
H12A         0.58867    0.22530    0.18665 1.00000  
H12B         0.64553    0.26493    0.25372  1.00000  
C13          0.86689    0.47690    0.02701 1.00000 0.03271 
H13A         0.96843    0.45497    0.04425 1.00000  
H13B         0.86109    0.53992    0.03941 1.00000  
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C14          0.85249    0.47377   0.04173 1.00000 0.04118 
H14A         0.84640    0.41092 -0.05524 1.00000  
H14B         0.94387    0.50008 -0.05438 1.00000  
C15          0.71706    0.52256 -0.07275 1.00000 0.04411 
H15A         0.71896    0.58424 -0.05700 1.00000  
H15B         0.62508    0.49334 -0.06285 1.00000  
C16          0.71093    0.52475 -0.14193 1.00000 0.04712 
H16A         0.62139    0.55768 -0.16054 1.00000  
H16B         0.70611    0.46381 -0.15784 1.00000  
H16C         0.80137    0.55417  -0.15193 1.00000  
C17          0.74804    0.33022    0.04303 1.00000 0.03000 
H17A         0.71088    0.32033   -0.00094 1.00000  
H17B         0.67590    0.30216    0.06682 1.00000  
C18          0.90310    0.28632    0.05994 1.00000 0.03464 
H18A         0.97257    0.31188    0.03390  1.00000  
H18B         0.94329    0.30108    0.10297  1.00000  
C19          0.90134   0.18602    0.05266  1.00000 0.04278 
H19A         1.00631    0.16390    0.05831 1.00000  
H19B         0.85380    0.17076    0.01056  1.00000  
C20          0.81618    0.13924    0.09823 1.00000 0.05079 
H20A         0.81318    0.07515     0.09005  1.00000  
H20B         0.71320    0.16245    0.09392  1.00000  
H20C         0.86754    0.15011    0.13994 1.00000  
C21          0.81536    0.45496    0.28313 1.00000 0.02042 
C22          0.77721    0.54368    0.27870 1.00000 0.02711 
H22          0.77773    0.57441    0.24121 1.00000  
C23          0.73796    0.58835    0.32893 1.00000 0.02773 
H23          0.71204    0.64960    0.32551  1.00000  
C24          0.73617    0.54421    0.38445 1.00000 0.02816 
C25          0.77493    0.45449    0.38759 1.00000 0.03561 
H25          0.77414    0.42315    0.42482 1.00000  
C26          0.81484    0.40964    0.33741  1.00000 0.03254 
H26          0.84145    0.34847    0.34046 1.00000  
C27          0.69424    0.59207    0.43888  1.00000 0.03992 
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H27A         0.66986    0.65413    0.42798  1.00000  
H27B         0.77900    0.59015    0.47251 1.00000  
H27C         0.60646    0.56322    0.45173    1.00000  
C28          0.76372    0.75378     0.04875   1.00000 0.04336 
H28A         0.75091    0.79656    0.01493 1.00000  
H28B         0.69269     0.70449    0.03908  1.00000  
H28C         0.86693    0.73071    0.05475 1.00000  
C29          0.73382     0.79945    0.10669  1.00000 0.02774 
C30          0.69012    0.88698    0.10721     1.00000 0.03270 
H30          0.67894    0.92017    0.07025 1.00000  
C31          0.66203    0.92789    0.16029 1.00000 0.03097 
H31          0.63177    0.98847    0.15976  1.00000  
C32          0.67853    0.87947    0.21442  1.00000 0.02309 
C33          0.91958    0.99489    0.32502 1.00000 0.01910 
H33          0.90307    1.04666    0.35158  1.00000  
C34          0.74850    0.75190    0.16140 1.00000 0.03221 
H34          0.77782    0.69117    0.16181 1.00000  
C35          1.07458     1.09508    0.27235  1.00000 0.02915 
H35A         1.09581    1.11572    0.23204  1.00000  
H35B         1.04626    1.14766    0.29501    1.00000  
C36          1.21713    1.05374    0.30771 1.00000 0.03212 
H36A         1.25528    1.00785    0.28190 1.00000  
H36B         1.29536    1.10033    0.31634 1.00000  
C37          1.19118    1.01139    0.36798   1.00000 0.02933 
H37A         1.28332    0.98002    0.38714 1.00000  
H37B         1.16680    1.05788    0.39660 1.00000  
C38          1.06114    0.94595    0.35455 1.00000 0.02005 
H38          1.08762    0.90020    0.32516 1.00000  
C39          1.18235    0.74811    0.40100 1.00000 0.01952 
C40          1.10167    0.66966    0.39496 1.00000 0.02863 
H40          1.01604    0.66212     0.41483  1.00000  
C41          1.14755    0.60206    0.35944  1.00000 0.03297 
H41          1.09235    0.54795    0.35542  1.00000  
C42          1.26997    0.61085    0.32997 1.00000 0.02632 
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C43          1.34789    0.69147    0.33520 1.00000 0.02785 
H43          1.43142    0.69943    0.31414    1.00000  
C44          1.30498    0.76026    0.37077 1.00000 0.02464 
H44          1.35891    0.81483    0.37433 1.00000  
C45          1.32088    0.53605    0.29305  1.00000 0.03661 
H45A         1.40842    0.55523    0.27490 1.00000  
H45B         1.23898    0.51945    0.26048 1.00000  
H45C         1.34847    0.48468    0.31968  1.00000  
C46          0.74882    1.00866    0.45931 1.00000 0.02877 
H46A         0.82519    1.03672    0.43765 1.00000  
H46B         0.77814    1.02011    0.50361  1.00000  
C47          0.59341    1.05207    0.43734  1.00000 0.03296 
H47A         0.55979    1.03569    0.39405 1.00000  
H47B         0.51914    1.02788    0.46174  1.00000 
 
C48          0.59588    1.15336    0.44292 1.00000 0.04375 
H48A         0.49074    1.17518    0.43740 1.00000  
H48B         0.64353    1.16948    0.48484  1.00000  
C49          0.67656    1.19962    0.39875  1.00000 0.05433 
H49A         0.67020    1.26404    0.40460  1.00000  
H49B         0.63056     1.18421    0.35699  1.00000  
H49C         0.78246    1.18129    0.40534 1.00000  
C50          0.63658     0.86306    0.47838  1.00000 0.03351 
H50A         0.64961     0.79874    0.47115  1.00000  
H50B         0.53359    0.87989    0.45920  1.00000  
C51          0.65331    0.87985    0.54676 1.00000 0.03101 
H51A         0.63538    0.94384    0.55335  1.00000  
H51B         0.57377    0.84618    0.56322 1.00000  
C52          0.80274    0.85511    0.58290 1.00000 0.04694 
H52A         0.81001    0.88350    0.62363 1.00000  
H52B         0.88244    0.88156    0.56227  1.00000  
C54          0.56741     0.36372    0.19008    1.00000 0.02094 
H54          0.54039    0.40690    0.22101 1.00000  
C55          0.72147    0.79106    0.21464  1.00000 0.03000 
H55          0.73217     0.75765    0.25150  1.00000  
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C56          0.94274    1.03041    0.26262  1.00000 0.02486 
H56A         0.85063    1.06117    0.24278 1.00000  
H56B         0.96460    0.98080    0.23590 1.00000  
 
 
7.2.4. Crystal structure data for ligand L13.BH3 
 
 
 
 
 
 
 
 
 
 
 
 
 
Empirical formula C27H35BN3P 
Formula weight 443.37 g/mol 
Space group P2(1) 
Crystal system Monoclinic 
Z 2 
a / Ǻ 7.9213 
b / Ǻ 18.329 
c / Ǻ 8.7923 
Cell volume / Ǻ3 1248.64 
Calculated density / g*cm-3 1.179 
T / K 263 
λ / Ǻ 1.54184 (MoKα) 
F(000) 476.0 
µ (MoKα) / mm-1 1.10 
Detector Bruker Smart APEX-CCD 
 167 
Independent reflections 4887 
Parameter 290 
Resolution of structure Direct methods 
Refinement method F2 
Hydrogen atoms Positions calculated 
R1 0.0731 
ωR2 0.2079 
GOF 1.025 
Flack-x-Parameter -0.0286 (σ=0.0403) 
 
Atom positions: 
 
Atom x y z sof Ueq / A2 
B1           0.02714   -0.29346   -0.30774 1.00000 0.06038 
H1A          0.00221   -0.28094   -0.42901 1.00000 
 
H1B          0.12474   -0.33449   -0.28262 1.00000 
 
H1C          0.07004   -0.24543   -0.24222 1.00000 
 
C7          -0.05532   -0.60350   -0.41739 1.00000 0.06599 
H7          -0.00736   -0.64903   -0.42813 1.00000 
 
C8          -0.17647   -0.57381   -0.53689  1.00000 0.06786 
H8          -0.21125   -0.59955   -0.62925 1.00000 
 
C14          0.26520   -0.49361    0.18399 1.00000 0.06446 
H14          0.33088 -0.52793 0.14414 1.00000  
C12         -0.00680   -0.56412   -0.28144 1.00000 0.05921 
H12          0.07412   -0.58380   -0.19979  1.00000 
 
C15          0.19106  -0.43575 0.09304 1.00000 0.05377 
H15          0.20736   -0.43213   -0.00843 1.00000 
 
C9          -0.24594   -0.50643   -0.52011 1.00000 0.05705 
H9          -0.32700   -0.48717   -0.60219  1.00000 
 
C11         -0.07530   -0.49658   -0.26406  1.00000 0.04812 
H11         -0.03934   -0.47089   -0.17178 1.00000 
 
C10         -0.19870   -0.46622   -0.38420  1.00000 0.04216 
C13 0.24100 -0.49992 0.33348 1.00000 0.06537 
H13 0.28716 -0.53950 0.39433 1.00000  
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C25         -0.42362   -0.18780   -0.50593 1.00000 0.09822 
H25A        -0.47506   -0.13979   -0.52560   1.00000  
H25B        -0.33975   -0.19440   -0.57096 1.00000  
C18     0.09381 -0.38321 0.14750 1.00000 0.04618 
C21 0.00960 -0.32376 0.03971 1.00000 0.05033 
H21          0.09056   -0.31199   -0.02716 1.00000  
P1          -0.17951   -0.32838   -0.25298 1.00000 0.04140 
C26         -0.33938   -0.19628   -0.33652 1.00000 0.07976 
H26A        -0.22061   -0.17957   -0.31669 1.00000 
 
H26B        -0.40166   -0.16913   -0.27101 1.00000 
 
N2          -0.27398   -0.39825   -0.36568 1.00000 0.04200 
C22         -0.02083   -0.25286    0.12015 1.00000 0.07616 
H22A        -0.07385   -0.21788 0.04372 1.00000 
 
H22B 0.08752 -0.23406 0.17610 1.00000 
 
H22C        -0.09533   -0.26193  0.19136 1.00000 
 
C27         -0.41372   -0.37169   -0.48914 1.00000 0.05952 
H27A        -0.50008   -0.40938   -0.51961  1.00000 
 
H27B        -0.36917   -0.35757   -0.57961 1.00000 
 
C16    0.14816 -0.44752 0.39344 1.00000 0.06260 
H16     0.13350 -0.45111 0.49541 1.00000 
 
C17     0.07693 -0.38959 0.30105 1.00000 0.05382 
H17 0.01622 -0.35402 0.34284 1.00000  
N3          -0.34807   -0.27397   -0.30922  1.00000 0.05532 
N1          -0.15268   -0.34978   -0.06688  1.00000 0.04380 
C24         -0.55725   -0.24499   -0.53762 1.00000 0.08042 
H24A        -0.57277   -0.26199   -0.64411  1.00000 
 
H24B        -0.66667   -0.22655   -0.52074  1.00000 
 
C23         -0.49101   -0.30672   -0.42351 1.00000 0.05761 
H23         -0.58261   -0.32273   -0.37144  1.00000 
 
C19         -0.29087   -0.37582 0.01429 1.00000 0.04682 
H19         -0.23506   -0.37794 0.12467 1.00000 
 
C5          -0.25817   -0.51134 0.05133 1.00000 0.05776 
H5          -0.16413   -0.50188 0.13165 1.00000 
 
C6          -0.30431   -0.58245 0.01545 1.00000 0.07782 
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H6          -0.24230   -0.62037 0.07126 1.00000 
 
C4          -0.34754   -0.45308   -0.02858  1.00000 0.04749 
C1          -0.44264   -0.59738   -0.10339 1.00000 0.08091 
H1          -0.47398   -0.64545   -0.12889 1.00000 
 
C3          -0.49181   -0.46967   -0.14653  1.00000 0.05853 
H3          -0.55912   -0.43241   -0.19964   1.00000 
 
C20         -0.43975   -0.32115 0.00536 1.00000 0.06573 
H20A        -0.39362   -0.27360 0.03505 1.00000 
 
H20B        -0.51222   -0.33625 0.07457 1.00000 
 
H20C        -0.50640   -0.31946   -0.09910  1.00000 
 
C2          -0.53272   -0.54196   -0.18287    1.00000 0.07344 
H2          -0.62479   -0.55259   -0.26427  1.00000 
 
 
 
7.2.5. Crystal structure data for ligand L18 
 
 
 
 
 
Empirical formula C17H28N3P 
Formula weight 305.40 g/mol 
Space group P2(1) 
 170 
Crystal system Monoclinic 
Z 2 
a / Ǻ 8.3022 
b / Ǻ 7.5669 
c / Ǻ 13.7374 
Cell volume / Ǻ3 849.51 
Calculated density / g*cm-3 1.194 
T / K 273 
λ / Ǻ 0.71073 (MoKα) 
F(000) 332.0 
µ (MoKα) / mm-1 0.15  
Detector Bruker Smart APEX-CCD 
Independent reflections 4196 
Parameter 194 
Resolution of structure Direct methods 
Refinement method F2 
Hydrogen atoms Positions calculated 
R1 0.0329 
ωR2 0.0891 
GOF 1.012 
Flack-x-Parameter -0.0831 (σ=0.0742) 
 
Atom positions: 
 
Atom x y z sof Ueq / A2 
C5 0.20571 -0.32080 -0.79758 1.00000     0.02716 
H5           0.31130   -0.36150   -0.77475 1.00000      
C4           0.14386   -0.32574   -0.89708  1.00000     0.03014 
H4           0.20649   -0.36927   -0.94159   1.00000      
C6           0.11361 -0.25631   -0.73073 1.00000     0.02177 
H6           0.15853   -0.25303   -0.66377 1.00000      
C3          -0.01358   -0.26463   -0.92982 1.00000     0.03056 
H3          -0.05650   -0.26667   -0.99707 1.00000      
C1          -0.04650   -0.19586   -0.76265 1.00000     0.01704 
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C10         -0.33979   -0.29043   -0.47786 1.00000     0.02443 
H10A        -0.39458   -0.33257   -0.42552  1.00000      
H10B        -0.27908   -0.38703   -0.50056 1.00000      
C7          -0.07726   -0.12780   -0.59105   1.00000     0.02030 
H7A          0.02191   -0.05743   -0.57880  1.00000      
H7B         -0.05165   -0.24607   -0.56574 1.00000      
C2          -0.10797   -0.20069   -0.86424 1.00000     0.02519 
H2          -0.21346   -0.16043   -0.88785 1.00000      
C9          -0.22832   -0.13410   -0.44340 1.00000     0.02511 
H9A         -0.12337   -0.17353   -0.40741 1.00000      
H9B         -0.27831   -0.05527   -0.40165 1.00000      
N2          -0.14268   -0.13389   -0.69621 1.00000     0.01749 
C8          -0.20956   -0.04401   -0.54045 1.00000     0.02032 
H8          -0.18897    0.08269   -0.52998 1.00000      
C11         -0.46155   -0.21068   -0.56290   1.00000     0.02180 
H11A        -0.50206   -0.30034   -0.61156  1.00000      
H11B        -0.55367   -0.15866   -0.53864 1.00000      
N1          -0.36851   -0.07331   -0.60664  1.00000     0.01795 
P1          -0.35152   -0.09419   -0.72847 1.00000     0.01553 
N3          -0.35019    0.10806   -0.77845 1.00000     0.01716 
C13         -0.13757    0.30388   -0.82618 1.00000     0.02979 
H13A        -0.09245    0.20253   -0.85373 1.00000      
H13B        -0.05106    0.38416   -0.80026 1.00000      
H13C        -0.21375    0.36197   -0.87680  1.00000      
C12         -0.22576    0.24502   -0.74315 1.00000     0.02079 
H12         -0.14340    0.18898   -0.69272 1.00000      
C17         -0.52630    0.04755   -0.94202 1.00000     0.02753 
H17A        -0.43007    0.04476   -0.97183 1.00000      
H17B        -0.61639    0.09373   -0.98855 1.00000      
H17C        -0.55177   -0.07001   -0.92326 1.00000      
C15         -0.49553    0.16551 -0.85046 1.00000     0.02143 
H15         -0.47156    0.28408    -0.87281 1.00000      
C14         -0.29414    0.40059   -0.69358 1.00000     0.03284 
H14A        -0.37318     0.46183   -0.74118 1.00000      
 172 
H14B        -0.20679    0.47979   -0.66754   1.00000      
H14C        -0.34566    0.35847   -0.64071   1.00000      
C16         -0.64901    0.18090   -0.80445 1.00000     0.03129 
H16A        -0.67994    0.06592   -0.78464 1.00000      
H16B        -0.73633    0.22960   -0.85203 1.00000      
H16C        -0.62750    0.25689   -0.74768 1.00000      
 
7.2.6. Crystal structure data for ligand L20 
 
 
Empirical formula C20H26N3P 
Formula weight 339.41 g/mol 
Space group P2(1) 
Crystal system Monoclinic 
Z 2 
a / Ǻ 9.9489 
b / Ǻ 8.5447 
c / Ǻ 11.1601 
Cell volume / Ǻ3 941.70 
Calculated density / g*cm-3 1.197 
T / K 273 
λ / Ǻ 0.71073 (MoKα) 
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F(000) 364.0 
µ (MoKα) / mm-1 0.15  
Detector Bruker Smart APEX-CCD 
Independent reflections 4649 
Parameter 321 
Resolution of structure Direct methods 
Refinement method F2 
Hydrogen atoms Positions calculated 
R1 0.0411 
ωR2 0.1055 
GOF 0.807 
Flack-x-Parameter -0.0307 (σ = 0.0710) 
 
 
Position of atoms: 
 
Atom x y z sof Ueq / A2 
H17 -0.84235 -0.59020 -0.23162 1.00000  
C17 -0.78865 -0.49060 -0.23562  1.00000 0.04102 
H16 -0.82203 -0.40714 0.07626 1.00000  
H18 -0.72480 -0.52465 -0.39930 1.00000  
C16 -0.78113 -0.39226 -0.13723 1.00000 0.03617 
C18         -0.71833   -0.45284   -0.33244      1.00000 0.04914 
C15         -0.70278   -0.25665   -0.13387      1.00000 0.03016 
C19 -0.64061   -0.31838   -0.32807   1.00000 0.04063 
H15         -0.69933   -0.18758   -0.06765    1.00000 
 
H11A        -0.35110   -0.47365   -0.47262      1.00000 
 
H19         -0.59500   -0.28984   -0.39022 1.00000 
 
C14         -0.63073   -0.21854   -0.22844 1.00000 0.02716 
H10B        -0.15721   -0.48488   -0.56192   1.00000  
H20A        -0.39273   -0.27282   -0.10018  1.00000  
C11         -0.30717   -0.37520   -0.48992    1.00000 0.03699 
 H11B        -0.38009   -0.31447   -0.53400 1.00000  
C10         -0.18390   -0.39806   -0.55879    1.00000 0.04786 
 174 
H10A        -0.19662   -0.37150   -0.64668 1.00000  
C13         -0.53838   -0.07603   -0.22950  1.00000 0.02680 
H8          0.07707   -0.39727   -0.32196 1.00000  
N2          -0.25648   -0.29196   -0.37746    1.00000 0.02919 
 C20         -0.33674   -0.20754   -0.11934  1.00000 0.03245 
H20B        -0.25886   -0.25793   -0.13616 1.00000  
H13         -0.56113   -0.02802   -0.30955     1.00000  
H12C        -0.53361   -0.00765   -0.04475  1.00000  
H12B        -0.64720    0.08060   -0.14105    1.00000  
N3          -0.39627   -0.12612   -0.22712     1.00000 0.02490 
H20C        -0.31918   -0.13594   -0.05600 1.00000  
C12         -0.55464    0.04386   -0.13012  1.00000 0.04236 
C8          -0.10750   -0.30053   -0.36251   1.00000 0.03107 
C9          -0.07167   -0.29878   -0.49210 1.00000 0.03729 
H9A          0.01590   -0.33928   -0.49864 1.00000  
P1          -0.32289   -0.11191   -0.35364  1.00000 0.02277 
H12A        -0.50194    0.13392   -0.14595 1.00000 
 
H9B         -0.07623   -0.19021   -0.52519   1.00000 
 
H7B         -0.04412   -0.20007   -0.19934   1.00000 
 
C7          -0.05767   -0.16340   -0.28182 1.00000 0.03136 
 N1          -0.16145   -0.04261   -0.30358    1.00000 0.02750 
H7A          0.02540   -0.12463   -0.30459 1.00000  
H2          -0.31983    0.19584   -0.32557 1.00000  
C1          -0.14497    0.10075   -0.24400 1.00000 0.02913 
C2          -0.24255    0.21915   -0.26649 1.00000 0.03597 
H6           0.03522    0.04973   -0.14059  1.00000  
 C6          -0.03102    0.13216   -0.15935 1.00000 0.03555 
C3          -0.22904    0.36106   -0.20659 1.00000 0.04152 
H3          -0.29627    0.43156   -0.22522 1.00000 
 
C5          -0.01994    0.27481   -0.09974 1.00000 0.04322 
C4          -0.11714    0.38925   -0.12139 1.00000 0.04519 
H5           0.05610    0.29200   -0.03834 1.00000  
H4          -0.10668    0.48426   -0.08432 1.00000 
 
 
 175 
7.3. List of all ligands 
 
Ligand code Structure 
L1 
N
N
Me
Me
P N
Ph
Ph
 
L2 
N
N
Me
Me
P N
Ph
Ph
 
L3 
N
N
Tos
Tos
P N
Ph
Ph
 
L4 
N
N
Tos
Tos
P N
Ph
Ph
 
L5 
N
N
Me
Me
P N
Ph
Ph
 
L6 
N
N
Me
Me
P N
Ph
Ph
 
L7 
N
N
Tos
Tos
P N
 
L8 
N
N
Tos
Tos
P N
 
L9 
N
N
Tos
Tos
P N
nBu
nBu
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L10 
N
N
Tos
Tos
P N
Ph
 
L11 
N
N
Tos
Tos
P N
Ph
Ph
 
L12 
N
N
Tos
Tos
P N
 
L13a 
Ph
N
Ph
N
N
P
Ph
 
M1 (L13a + L13b) 
Ph
N
Ph
N
N
P
Ph Ph
N
Ph
N
N
P
Ph
+
 
L14a 
Ph
N
Ph
N
N
P
Ph
 
M2 (L14a + L14b) 
Ph
N
Ph
N
N
P
Ph Ph
N
Ph
N
N
P
Ph
+
 
L15 
N
N
N
P
Ph
 
L16 
N
N
N
P
Ph
 
L17 
N
N
N
P
Ph
O
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L18 
N
N
N
P
Ph
iPr
iPr
 
L19 
N
N
N
P
Ph
nBu
nBu
 
L20 
N
N
N
P
Ph
Ph
 
L21 
N
N
N
P
Ph
Ph
Ph
 
L22 
N
N
N
P
Ph
Ph
Ph
 
L23 
N
N
N
P
Ph
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7.4  NMR spectra of PTA applying different isolation techniques 
 
7.4.1 13C NMR spectrum of M1 using only cellite for the isolation 
 
-250255075100125150175200225250
13 C-cpdsn (300 MHz) in C6D6
DMAP 
(aromatics)
DMAP 
(methyl)
 
 
7.4.2 1H NMR spectrum of M1 using only cellite for the isolation 
 
0123456789
DMAP 
(aromatics)
DMAP 
(methyl)
1 H NMR, (300 MHz) in C6D6
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7.4.3 1H NMR spectrum of M1 using alumina for the isolation 
 
1.01.52.02.53.0.3.54.04.55.05.56.06.57.07.58.08.5
1 H NMR, (300 MHz) in C6D6
no DMAP no DMAP no DMAP 
 
 
7.4.3 13 C NMR spectrum of M1 using alumina for the isolation 
 
102030405060708090100110120130140150
13 C-cpdsn (300 MHz) in C6D6
no DMAP 
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